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Abstract 
CHRISTINA M. PEREZ: The Role of Hypoxia in Air Pollutant-Induced Cardiovascular 
Dysfunction 
(Under the direction of Aimen K. Farraj and Daniel L. Costa) 
 
Diesel exhaust (DE) is a major contributor to traffic-related urban air pollution and 
has been associated with cardiovascular dysfunction in humans, especially susceptible 
individuals. DE is a complex pollutant consisting of particles and toxic gases such as 
acrolein. Although the mechanisms that mediate adverse cardiovascular health effects are 
unclear, epidemiological evidence has linked exposure to air pollution to drops in blood 
oxygen saturation, suggesting that hypoxia may play a role. Acute and repeated hypoxia is 
associated with carotid body-mediated cardiovascular effects which overtime lead to 
hypertension and predisposition to cardiac arrhythmia. Thus, my overarching hypothesis for 
this dissertation project is that air pollutant-induced hypoxia mediates the adverse 
cardiovascular effects of air pollution exposure. To test this hypothesis, we 1) characterized 
the impacts of short-term exposure to DE on cardiovascular physiology in rats, 2) 
characterized the cardiovascular response to exposure to the DE component acrolein, and 
determined if acrolein exposure increases the risk of adverse cardiovascular responses to a 
cardiac stressor (i.e, hypoxic atmosphere) in hypertensive rats, and 3) determined if inhibition 
of the sensory response to hypoxia attenuated air-pollutant-induced cardiovascular 
dysfunction. Exposure to DE caused PR prolongation and ST depression, a marker of 
myocardial ischemia, only in hypertensive rats exposed to the gaseous components of DE. 
Because the gaseous components appeared to be driving the responses, studies were
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conducted to assess the effects of acrolein. Exposure to acrolein caused increases in heart rate 
and blood pressure. These responses were confined to the hypertensive rat, and subsequent 
stress testing with hypoxic atmosphere (10% FiO2) confirmed enhanced sensitivity with 
increased diastolic blood pressure in the hypertensive rat. We also found that acrolein 
exposure significantly decreased arterial pO2, and carotid body inhibition prevented acrolein-
induced blood pressure increases and impaired contractility responses in hypertensive rats. 
This suggests that air pollutants may cause hypoxia and that the cardiac responses following 
pollutant exposure may be mediated by the carotid body.  This research describes a novel 
mechanism that mediates the adverse cardiovascular effects of air pollutant exposure and fills 
important data gaps in our understanding of air pollution-induced cardiovascular dysfunction. 
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Chapter 1 
 
Introduction 
 
History of Air Pollution Epidemiology and Policy 
 Air is all around us. Air sustains life and brings growth, but it is also vulnerable to 
pollution from human industry and global progress. In the twenty-first century, we recognize 
that the decisions we make affect the environment around us, and numerous companies are 
investing in “green” energy and more efficient practices. Despite this invigorated desire to 
protect the air we breathe, the history of air pollution epidemiology is rich with stories of 
human progress mixed with environmental destruction and an ever evolving understanding of 
the relationship between human health and our air. It was not long ago that major 
industrialized cities of the world boasted some of the worst breathing conditions, a fact that 
still remains true for many developing countries. Revisiting these situations is important in 
realizing both how far we have come in our understanding of the health effects of air 
pollution exposure but also as a warning that our environment is an ever changing entity that 
must be consistently protected to ensure human health.  
The British industrial revolution that began in the late 1770’s presents some of the 
most widely read accounts of the horrific air quality in London caused by excessive use of 
coal. Charles Dickens’s Bleak House, published in 1852, opens with this detailed description 
of the air in industrial London: 
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London. Michaelmas term lately over, and the Lord Chancellor sitting in 
Lincoln's Inn Hall. Implacable November weather … smoke lowering down 
from chimney-pots, making a soft black drizzle, with flakes of soot in it as big 
as full-grown snowflakes—gone into mourning, one might imagine, for the 
death of the sun… Fog everywhere. Fog up the river, where it flows among 
green aits and meadows; fog down the river, where it rolls defiled among the 
tiers of shipping and the waterside pollutions of a great (and dirty) city. 
(Dickens, Bleak House). 
Despite well documented accounts of severe air pollution during the 1800s and even 
for centuries before that time, the link between air pollution exposure and adverse effects on 
human health did not become apparent until the early twentieth century with three key air 
pollution events. In 1930, an acute air pollution event occurred in the Meuse Valley of 
Belgium leading to the death of sixty residents and numerous cattle (Firket, 1936). The 
narrow, 15 mile strip of land held 14 different industrial centers including coke ovens, steel 
mills, and zinc smelters. A temperature inversion in December caused abnormally high levels 
of air pollution that led to a 10.5 times increase in mortality and left almost 6000 residents ill 
with respiratory disease and complaints of eye and throat irritation (Jun, 2009). Despite the 
severity of this incident, additional events would have to occur to solidify the link between 
air pollution exposure and adverse effects on human health. In the fall of 1948, a heavy smog 
settled over Donora, Pennsylvania, a town located on a river with multiple industries 
including a steel mill and zinc production facility. The steady accumulation of air pollutants 
from the factories caused increased mortality and over 40% of the town’s residents to be 
affected with acute illness during the high air pollution episode (Jun, 2009). Several years 
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later, the infamous “London smog” of 1952 forever linked the association between dangerous 
levels of air pollution and increased morbidity and mortality. This acute air pollution event 
led to over 4000 excess deaths and a dramatic rise in hospital admissions for cardiovascular 
and respiratory related injuries (Logan, 1953). Similar to the other classic acute air pollution 
events, many of the deaths occurred in patients with pre-existing cardiovascular or 
respiratory diseases. These three examples as well as many other events that occurred during 
the 1960’s and 1970’s led to the understanding that exposure to air pollution can increase 
morbidity and mortality in human populations and set the stage for both policy changes to 
monitor air pollution and more in-depth studies to decipher how air pollution effects human 
health.  
By the late 1940’s in the United States, there were a few state-initiated laws involving 
air pollution control, but it was not until 1955 that the federal government passed the Air 
Pollution Control Act, the first federal legislation that allocated funds to study the effects of 
air pollution (Roman and Saundry, 2007).  The Clean Air Act of 1963 was the first federal 
legislation involving the control of air pollution, and the subsequent Air Quality Act in 1967 
expanded the federal government’s ability to monitor and control air pollution levels. These 
laws and others created the groundwork for the landmark Clean Air Act amendment in 1970 
which resulted in a radical shift in the role of the federal government regarding air pollution 
control and research. The Clean Air Act of 1970 established emission standards for both 
stationary and mobile sources of air pollution and allowed the development of the National 
Ambient Air Quality Standards (NAAQS). On December 2, 1970, the United States 
Environmental Protection Agency (US EPA) was created to implement the new laws now 
governing the country. The US EPA established six criteria pollutants including ozone (O3), 
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sulfur dioxide (SO2), particulate matter (PM), nitrogen dioxide (NO2), carbon monoxide 
(CO), and lead (Pb) that would be included in the NAAQS with appropriate standards being 
reviewed every five years in order to monitor the evolving understanding of the different 
pollutants and ensure human health (US EPA http://epa.gov/air/caa/caa_history.html). In 
addition to the criteria pollutants, the US EPA set standards for Hazardous Air Pollutants 
(HAPs) and stationary sources of air pollution. Since the implementation of this 
revolutionary act, our regulation of air pollution from multiple sources has greatly evolved 
and our understanding of the link between air pollution exposure and adverse effects on 
human health has increased exponentially.  
Despite huge advancements in policy and scientific understanding, the regulation of 
air pollution levels in the United States and abroad remains a daunting necessity with a 
variety of challenges. In the United States, our landscape has changed from several large 
industrial cities surrounded by unspoiled expanses of rural lands to a suburban sprawl with 
air pollution spread diffusely over the landscape (Costa and Amdur, 1996). This change in air 
pollution dynamics tests the government’s ability to regulate air pollution levels on such a 
vast scale and highlights the necessity of increased awareness and increased regulation 
outside of the traditional industrialized city centers. On a global scale, high levels of air 
pollution are still a common problem in developing countries. The World Health 
Organization (WHO) recently released more stringent standards for global levels of the six 
criteria pollutants, but most cities in developing countries such as Asia, Africa, and Latin 
America have baseline air pollution levels that greatly exceed WHO recommendations (Chen 
and Khan, 2008). These recommendations focus mainly on outdoor air pollution, but for 
many nations, indoor air pollution from biomass burning is a major source of particle and gas 
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exposure and greatly increases an individual’s overall exposure to air pollution (Fullerton et 
al., 2008). Although the following information will focus primarily on the health effects of 
air pollution in United States cities, it is critical to understand that regulating air pollution 
levels to protect human health is as relevant today as it was when the Clean Air Act was 
passed in 1967. The history of air pollution epidemiology is a continuing mosaic with pieces 
from a variety of nations and governments. Through past examples of acute air pollution 
events and the modern challenges we face domestically and abroad, it is critically important 
to understand that the air we breathe not only sustains our lives but presents a rich history of 
human evolution, environmental awareness, and the importance of public health policy in 
protecting human health.  
 
Modern Epidemiology and Health Effects of Criteria Air Pollutants 
Studies decades after the acute air pollution events in the 1930’s to 1950’s established 
strong links between exposure to air pollution and increased human morbidity and mortality. 
The exact health effects of air pollution exposure and what components were causing those 
responses still need to be deciphered. Numerous epidemiological studies have demonstrated 
clear adverse health effects associated with the each of the criteria pollutants. The current 
NAAQS standard for O3 is 75 ppb over an 8 hour period (NAAQS US EPA). Ozone 
exposure has been associated with increased mortality (Levy et al., 2005), asthma 
exacerbation (Dockery and Pope, 1994), and increased hospital and emergency room visits 
(Choi et al., 2011). In addition, individuals with underlying pulmonary and cardiovascular 
disease have increased susceptibility to ozone exposure (Burnett et al., 2001). The current 
NAAQS standard for CO is 9 ppm over an 8 hour period (NAAQS US EPA), and prolonged 
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CO exposure has been associated with altered redox status and ion homeostasis as well as 
adverse effects on cardiovascular health (Reboul et al., 2012). The national standard for NO2 
is 100 ppb during a 1 hour period (NAAQS US EPA), but epidemiological studies have 
calculated that each increase of 5 ppb NO2 is associated with a 12% increase in mortality 
from cardiovascular disease (Chen et al., 2013). Another criteria air pollutant strongly 
associated with adverse exposure effects is SO2 with a national standard of 75 ppb for every 
1 hour period (NAAQS US EPA). Exposure to SO2 has been linked to increased risk of 
myocardial infarction and increased hospitalizations for cardiovascular events (Amancio and 
Nascimiento, 2012). In addition to these major components of air pollution, PM has been 
strongly associated with adverse health effects and a significant amount of research has 
characterized the response to this dynamic pollutant. 
 
Health Effects of Particulate Matter (PM) 
Since the establishment of the NAAQS, an enormous amount of research has been 
conducted to characterize the effects of each criteria pollutant. Although all criteria pollutants 
are dangerous to human health and important to consider in any air pollution exposure, PM 
has probably been the most intensely studied over the last two decades. There are three major 
categories of PM based on size. The first is PM10, or particulate matter less than or equal to 
10µm in aerodynamic diameter. The current NAAQS standard for coarse particulate matter is 
150 ug/m
3 
over a 24 hour period (NAAQS US EPA).  The second is PM2.5, or particulate 
matter less than or equal to 2.5 µm in aerodynamic diameter. The current NAAQS standard 
for fine (PM2.5) particulate matter is 35 µg/m
3 
over a 24-hour period (NAAQS US EPA). 
Finally, ultrafine particles (UFPs) are defined as particles less than or equal to 0.1 µm in 
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diameter (Brook et al., 2010). There is no current standard for UFPs. While each of these 
particle size ranges has been associated with adverse health outcomes in humans, most of the 
evidence implicates fine and coarse PM. 
Several key epidemiological studies defined the adverse health effects of PM 
exposure. The Harvard Six Cities Studies which began in 1974 estimated the effects of air 
pollution on mortality in 8111 adults in six different US cities including Portage, Wisconsin; 
Topeka, Kansas; Watertown, Massachusetts; St. Louis, Missouri; Harriman, Tennessee; and 
Steubenville, Ohio (Dockery et al., 1993). The study found that residents in the most polluted 
city had a 1.26-fold higher likelihood of air pollution associated mortality than the least 
polluted cities, and this mortality was associated with PM2.5 and sulfate exposure (Dockery et 
al., 1993). In addition, the increased mortality after air pollution exposure was most strongly 
associated with lung cancer and cardiopulmonary diseases after an individual’s smoking 
habits were taken into account (Dockery et al., 1993). Several years later, the link between 
PM exposure and cardiopulmonary disease was further demonstrated with the analysis of a 
cohort from an American Cancer Society study that found that 45% of the deaths associated 
with PM were due to cardiovascular disease and 8% of deaths were due to respiratory disease 
(Pope et al., 2004). Specifically, the deaths due to cardiovascular disease were predominately 
due to ischemic heart disease, dysrhythmias, heart failure, and cardiac arrest (Pope et al., 
2004). The association between air pollution exposure and increased mortality due to 
cardiopulmonary disease has been further strengthened by subsequent epidemiological 
studies. 
Additional studies demonstrated that inhalation of particulate matter (PM) associated 
with ambient air pollution causes adverse effects on cardiovascular function. Peters et al. 
8 
 
(2004) found that increases as small as 10-20µg/m
3 
PM2.5 caused significant increases in the 
risk of myocardial infarction up to 1 day after exposure. In addition, individuals who had 
been hospitalized for coronary artery disease showed increases in T wave area (suggesting 
impairment in myocardial repolarization) after exposure to ambient levels of black carbon 
(Zanobetti et al., 2010) PM inhalation has also been associated with myocardial ischemia 
(Gold et al., 2005; Wellenius et al., 2003) and arrhythmias
 
(Brook et al., 2004), especially in 
susceptible populations such as the elderly and those with underlying cardiovascular disease. 
Epidemiological studies indicate that these effects are not immediate, usually manifesting 
some time after exposure. Patients with implanted cardioverter defibrillators had increased 
incidence of life-threatening arrhythmias up to 2 days after air pollution exposure (Peters et 
al., 2000). These findings suggest that exposure to air pollution alters cardiovascular 
physiology and increases conditional susceptibility to triggers of thrombosis and arrhythmia. 
Moreover, the fact that these effects happen at lower exposure concentrations than those 
shown to elicit effects in animal studies indicates that the responses are more complicated 
than the standard monotonic dose-response relationship of traditional toxicology. Several 
mechanisms have been proposed to account for these responses to air pollution exposure 
including autonomic imbalance, systemic inflammation-mediated vascular dysfunction, and 
direct actions of particles on the heart and vasculature (Donaldson et al., 2001; Schulz et al., 
2005; Utell et al., 2002). Much work remains to further delineate these mechanisms in order 
to provide biological plausibility for the health effects observed after short-term fluctuations 
in ambient levels of PM. 
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Diesel Exhaust 
There are many sources of PM in the environment, but diesel exhaust is one of the 
major contributors to fine and ultrafine PM air pollution (EPA/600/8-90/057F 2002). 
Vehicular traffic is a dominant source of ambient PM, particularly in urban environments, 
and studies have shown that proximity to traffic sources (e.g., highway or tunnel) is a major 
determinant of cardiovascular health outcomes (Hoek et al., 2002; Hoffman et al., 2006; Van 
Hee et al., 2009).  Peters et al. (2004) found that exposure to traffic with high levels of DE 
was associated with onset of myocardial infarction. Similarly, a study in eight European 
countries attributed hospitalizations for acute coronary syndrome in older patients to 
exposure to DE (Le Tertre et al., 2002).  In a controlled human exposure study, Mills et al. 
(2007) found that DE exposure accentuated exercise-induced electrocardiographic ST 
depression (potential indication of myocardial ischemia) in subjects with known coronary 
artery disease and exercise-induced ischemic ECG changes. While DE is a significant 
contributor to PM, it is also a source of other pollutants constituting a complex mixture of 
particulate and gaseous components.  DE also consists of a mixture of gases including 
nitrogen oxides (NOx), sulfur oxides (SOx), carbon monoxide (CO), and volatile organics 
including aldehydes, benzene, and polycyclic aromatic hydrocarbons. The complex 
composition of DE makes attributing specific health effects to one or more components 
within DE challenging.  
 
Acrolein 
  One notable toxic component of DE is acrolein, a pulmonary irritant that has been 
associated with reflex pulmonary irritation and changes in autonomic tone. Acrolein is an 
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α,β-unsaturated aldehyde that is formed during the combustion of organic materials and is a 
toxic components of cigarette smoke and internal combustion engine exhaust (Baeuchamp et 
al., 1985). The most recent national scale assessment (NATA) released by the US EPA has 
listed acrolein as the number one national noncancer hazard driver (NATA 2005). Acrolein is 
a widespread environmental pollutant and ambient levels of 0.04 - 0.08 ppm have been 
measured (Costa and Amdur, 1996). Cigarette smoke, however, contains up to 90 ppm 
acrolein (Esterbauer et al., 1991), and acrolein levels in sidestream tobacco smoke are as 
high as 10 ppm (Esterbauer et al., 1991). Acrolein is highly reactive and will immediately 
bind and deplete glutathione levels in cells as well as form adducts by reacting with protein 
residues (Keher and Biswal, 2000). Acrolein can cause oxidative stress and inhibit cell 
proliferation in vivo and can also illicit a host of reflex responses due to its high reactivity. 
Acrolein exposure in primary human hepatocytes resulted in increased apoptosis, decreased 
intracellular glutathione, and activation of stress-signaling MAP-kinases (Mohammad et al., 
2012). In human bronchial smooth muscle cells, acrolein exposure causes induction of IL-8 
and leads to phosphorylation of MAP kinase substrates (Moretto et al., 2012). In addition, 
intravenous injection of acrolein in rats causes significant increases in blood pressure that are 
reversed with guanethidine, a sympatholytic drug (Green and Egle, 1983). DE and its 
components present highly relevant pollutants to utilize in controlled experiments to 
characterize the cardiovascular effects of air pollution exposure.  
 
Susceptibility to Air Pollution 
 Many of the adverse responses to air pollution occur in susceptible subpopulations, 
groups with a heightened risk for an adverse endpoint compared with the general population 
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(Brook et al., 2010). Multiple epidemiological studies have demonstrated that adverse events 
following PM exposure are heightened in the elderly (Pope et al., 2002) and in individuals 
with diabetes (Zanobetti and Schawart, 2001), preexisting heart disease (Katsouyanni et al., 
2001) or heart failure (Goldberg et al., 2001). Individuals with pre-existing coronary artery 
disease had a significant increase in the risk of a cardiac event after PM exposure even if they 
did not experience any symptoms of the underlying disease (Pope et al., 2006). In addition, 
increases in PM2.5 have been associated with more hospitalizations for heart failure than any 
other cardiopulmonary disease (Dominici et al., 2006), and daily increases in PM10 have been 
shown to cause increases in heart failure hospitalizations in older adults (Schwartz and 
Morris, 1995). Obesity and current smoking status have also been suggested as susceptibility 
markers for air pollution exposure (Miller et al., 2007). Because many of the adverse 
responses observed during and after air pollution exposure occur in susceptible groups, it is 
critical to model susceptibility in experimental studies to more accurately reflect 
physiological responses. 
 
Modeling Susceptibility 
To understand the mechanisms behind adverse effects of air pollution exposure in 
susceptible populations, researchers model exposures in the laboratory using rodents with 
underlying disease. One of the primary rodent models used to study the cardiovascular 
effects of air pollution is the Spontaneously Hypertensive (SH) rat. The mechanisms 
accounting for the elevated sensitivity of the SH rat are uncertain, but may relate to the 
structural, biochemical, and physiological characteristics of the cardiovascular system 
attendant to prolonged hypertension.  Previous studies have shown that SH rats have, on 
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average, 40 mmHg higher mean arterial pressure than background control rats with normal 
blood pressure (El-Mas and Abdel-Rahman, 2005) as well as greater arterial wall thickness
 
(Mulvany and Halpern, 1977). The hypertensive rat was developed in 1963 when two Wistar 
Kyoto rats with spontaneous hypertension were mated (Hulstrom, 2012). Although the exact 
genetic determinates of spontaneous hypertension in this model are not fully characterized, 
the hypertensive phenotype of the SH rat is believed to be related to vascular damage leading 
to arterial hypertension in the juxtamedullary cortex of the kidney resulting in dysfunction 
(Hulstrom, 2012). Over time, hypertension leads to structural and biological remodeling of 
the left ventricle characterized by hypertrophy, fibrosis, and changes in membrane channels, 
cellular energetics and ion regulation that combine to heighten myocardial sensitivity 
(Bernardo et al., 2010).  Such remodeling has been demonstrated in SH rats (Goltz et al., 
2007) and may account for the differences between the SH rat and rats with normal blood 
pressure. It has previously been demonstrated that exposure to both particulate or gaseous air 
pollutants causes exaggerated cardiovascular effects in rat models of hypertension and heart 
failure (Carll et al., 2012; Farraj et al., 2011; Hazari et al., 2009; Lamb et al., 2012).   
 
Mechanisms of Adverse Cardiovascular Effects After PM Exposure  
Our understanding of the mechanisms underlying air-pollution induced 
cardiovascular function has increased substantially since the first epidemiological studies 
suggested a link between PM exposure and increased cardiovascular morbidity/mortality. 
While multiple mechanisms have been postulated, there are three widely-acknowledged 
hypothesized mechanisms of action. One postulates that health effects result from the 
translocation of PM and/or its components into the systemic circulation with injury resulting 
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from the direct interaction of PM/components with blood vessel walls and/or the 
myocardium.  Fine and ultrafine PM can deposit deep within the lung and penetrate through 
the lung tissue to the capillaries (Peters et al., 2006). Researchers have found that some UFPs 
were able to translocate to the liver within 4 to 24 hours post exposure, and entered the 
olfactory bulb and possibly crossed the blood-brain barrier (Oberdorster et al., 2004).  
Despite evidence for translocation of particles, this mechanism is probably the least 
understood with limited evidence to support such effects.  
 The second mechanism of PM-induced cardiovascular dysfunction postulates that PM 
inhalation triggers a local pulmonary oxidative injury and inflammation.  This local response 
leads to systemic oxidative stress and inflammation characterized by an increase in activated 
white blood cells, platelets, and cytokine expression. This activation of immune components 
causes inflammation of the liver and increased vasoconstriction leading to higher 
thrombogenecity and coagulation (Brooks et al., 2010). The exact pathway by which PM 
inhalation leads to oxidative stress and inflammation is multivariable and complex with 
particle size and site of deposition being large determents of the response. UFPs may have 
the ability to enter lung cells directly and interact with mitochondria (Muhlfeld et al., 2008) 
while larger particles are taken up by macrophages through the innate immune response 
(Møller et al., 2010). Some particles, such as metals, may generate reactive oxygen species 
(ROS) directly or through biotransformation, while others may interfere with iron 
homeostasis and generate ROS’s through Fenton reactions (Ghio and Cohen, 2005). This 
increased oxidative stress can lead to inflammation with increased signaling of  toll-like 
receptors (TLR) and mitogen activated protein kinases that lead to the production of pro-
inflammatory transcription factors such as NF-κB (nuclear factor-κB) and the increased 
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production of inflammatory cytokines (Nel et al., 2006). Perhaps the major consequence of 
PM-induced systemic inflammation is the targeting of the vascular endothelium, the inner 
lining of the blood vessel wall. Under normal physiological conditions, the endothelium 
mediates vascular dilation to maintain normal blood pressure and ensure adequate organ 
perfusion, prevents platelet activation and clot formation, and inhibits adhesion of leukocytes 
(Madden, 2012).  Evidence in both humans and animal models has shown that PM causes 
endothelial injury thus promoting vasoconstriction, thrombosis, and inflammation (Krishna et 
al., 1998).  These effects can lead to atherosclerotic plaque progression, coronary vasospasm, 
and myocardial ischemia (Madden, 2012). 
The third mechanism for PM-induced cardiovascular dysfunction postulates that PM 
inhalation triggers lung reflexes that modify autonomic nervous system control of 
cardiovascular function (ANS). The ANS controls many of the visceral functions and is 
composed of two branches, the sympathetic branch that is responsible for the “fight or flight” 
response and the parasympathetic branch that is responsible for returning the body to a 
homeostatic baseline. One of the ways that researchers can measure changes in the ANS in 
both humans and experimental animal models is by measuring heart rate variability (HRV). 
HRV is the degree of difference in the interbeat intervals of successive heartbeats, and is an 
indicator of the balance between the sympathetic and parasympathetic arms of the autonomic 
nervous system (Rowan et al., 2007).  The heart is a dynamic organ and must be able to 
respond to changes in the body’s activity level. High HRV is traditionally considered positive 
because the heart has the ability to respond to rapidly changing environments. Low HRV, 
reflecting increased sympathetic tone (Rowan et al., 2007), is associated with an increased 
risk of cardiac arrhythmia (Corey et al., 2006) and an increased risk of mortality in people 
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with heart disease (Bigger et al., 1993).  An association between high ambient PM and low 
HRV has been observed in several different studies in both healthy individuals and those 
with cardiovascular disease (Chuang et al., 2005; Schulz et al., 2005; Vallejo et al., 2006).  
Exposure to PM causes significant reduction in HRV and is associated with increased risk of 
myocardial infarction, cardiac arrhythmias, and sudden cardiac death, especially in 
susceptible populations (Sinnreich et al., 1998; Singh et al., 2003). The elderly and 
individuals with preexisting cardiovascular diseases have been shown to have significant 
decreases in HRV after exposure to PM (Liao et al., 1999). The response of the autonomic 
nervous system is an orchestrated series of events that is influenced by a variety of sensory 
responses in the lungs and vasculature. The established link between air pollution exposure 
and changes to autonomic function presents an important relationship between reflex 
responses and environmental exposures. 
 
Autonomic Reflex Arcs and Their Perturbation by Air Pollution Exposure 
 The body has a complex and multivariate system that responds to environmental 
stressors by triggering autonomic reflexes.  One of the first responses that occurs after 
inhalation of certain air pollution components or different irritants is activation of pulmonary 
neural reflexes that send information to the brain through various airway sensory receptors. 
The activation of these receptors depends on location of particle deposition as well as 
chemistry and reactivity of the irritant. In addition to activation of pulmonary sensory 
mechanisms, the baroreceptor response may also be elicited. Baroreceptors are localized 
mechanoreceptors in the body that respond to changes in blood pressure through a negative 
feedback mechanism. Baroreceptors sensing elevations in blood pressure will communicate 
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with the brainstem to decrease heart rate and subsequently blood pressure. In addition to the 
pulmonary reflex response and the baroreceptor response, the body also utilizes a 
chemoreceptor response that senses changes in blood gases and leads to downstream 
responses to maintain homeostasis. It is important to note that the reflex responses in the lung 
communicate with the baroreflex and chemoreflex responses, and each pathway influences 
the other responses to coordinate the body’s homeostatic control of breathing and heart rate 
at baseline and following exposure to a stimulus such as air pollution. 
 
Pulmonary Neural Reflexes/Lung-Airway Sensory Receptors 
There are three major types of sensory receptors in the lungs and airways: C-fibers, 
rapidly adapting pulmonary receptors (RARs or irritant receptors), and slowly adapting 
pulmonary receptors (SARs or stretch receptors) (Coleridge et al., 1984). Inhalation of 
cigarette smoke, SO2, and acrolein have been shown to activate pulmonary C fibers leading to 
reflex bronchospasm, apnea, and bradycardia (Lee et al., 1987).  These responses were 
inhibited with capsaicin treatment of the vagus nerve, the predominate parasympathetic 
signaling pathway, to block conduction of C fibers and with bilateral vagotomy (Wang et al., 
1996). It has been observed that an increase in inspiration occurs only after C fiber afferents 
are blocked, showing that the irritant response to air pollutants occurs through a combination 
of C fiber and RAR receptor activation with C fiber activation being the predominate driver 
of the response (Lee et al., 1992). A variety of ion channels are responsible for the responses 
seen in the different pulmonary receptors. One of the most well characterized responses in 
the lung is ion channel activation following exposure to hypoxia, or low ambient oxygen. 
Acute hypoxia will lead to pulmonary vascoconstriction while chronic hypoxia will lead to 
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pulmonary vascular remodeling. Acute hypoxia increases cytosolic Ca
2+
 through inhibition 
of voltage gated K
+ 
(Kv) and tandem pore domain K
+
 (KT) channels, activation of voltage 
gated Ca
2+
 channels (VDCC), and alteration of Ca
2+
 storage in the sarcoplasmic reticulum 
(SR) in pulmonary artery smooth muscle cells (PASMCs) (Mauban et al., 2005; Fig. 1.1). 
The complex pulmonary sensory and ion channel response to irritants and environmental 
stressors such as hypoxia also elicits a host of responses in the cardiovascular system. 
 
Figure 1.1. The role of ion channels in the response to hypoxia. (Reprinted with permission 
from Mauban et al., 2005). 
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In addition to causing changes in tidal volume and breathing frequency, pulmonary 
reflex responses also influence cardiovascular responses to air pollutants. Inhalation of 
irritants in the upper airway tract causes reflex bradycardia coupled with increases or 
decreases in heart rate depending on the airway site (Widdicombe and Lee., 2001). 
Administration of atropine prevents bradycardia, showing that the response is predominately 
vagally driven (Widdicombe and Lee,  2001). In the lower airways, C fibers and RARs will 
respond strongly to inhaled irritants and lead to pronounced bradycardia and hypotension 
(Lee et al., 2001). The pulmonary and cardiovascular systems are intimately related, and 
airway reflexes originating in the larynx have been shown to cause cardiac dysrrythmia and 
ST depression (Prys-Roberts et al., 1971). The lung and heart are intimately connected, and 
physiologically, the two systems are always referred to as the cardiopulmonary system. Many 
of the responses in the lungs from sensory receptor activation will lead to a host of 
downstream events affecting heart rate and blood pressure. The mechanism by which the 
body responds to changes in blood pressure is through the baroreceptor response, and like the 
reflex pulmonary response, activation of baroreflex receptors will lead to downstream 
responses that are meant to maintain homeostasis and allow the body to respond to diverse 
stimuli.  
 
Baroreceptor Reflex Responses 
The baroreceptor reflex is the body’s way of maintaining control of blood pressure. 
Baroreceptors are stretch sensitive mechanoreceptors located in the carotid sinus and aortic 
arch, and each location is innervated by the glossopharyngeal nerve and vagus nerve, 
respectively, which communicate downstream with the nucleus of the solitary tract (NTS) in 
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the brainstem (Williamson et al., 2006). The baroreceptor reflex functions through a negative 
feedback mechanism where an increase in blood pressure will be sensed by the receptors and 
causes a reflex decrease in heart rate and blood pressure. The same is true for decreases in 
blood pressure eliciting a reflex increase in heart rate and subsequently blood pressure. 
Studies using isolated carotid sinuses found that when pressure was lowered in the sinus, it 
caused a reflex increase in systemic arterial blood pressure and heart rate (Walgenbach and 
Shepard, 1984). Upon receiving input from the baroreceptors, the NTS communicates with 
regions of the brain controlling the autonomic nervous system and leads to an inhibition of 
the sympathetic nervous system and an activation of the parasympathetic nervous system 
(Lohmeier and Iliescu, 2011). The baroreceptor reflex is crucial in day-to-day homeostatic 
control, but it has also been implicated in the response to air pollution exposure. 
Multiple studies have reported significant changes in blood pressure and baroreflex 
sensitivity following air pollution exposure. In a cohort of German citizens, individuals living 
in close proximity to high traffic had higher arterial blood pressure and greater prevalence of 
hypertension than individuals living in low traffic areas (Fuks et al., 2011).  Exposure to 
particulate matter causes significant increases in diastolic blood pressure in healthy adults 
and this increase was coupled with decreases in heart rate variability (Brook et al., 2009). 
The baroreceptor reflex has important influence over changes in heart rate variability through 
its communication with the brainstem. In addition to changes in blood pressure and 
autonomic control, healthy non-smokers exposed to sidestream cigarette smoke had 
significant increases in muscle sympathetic nerve activity (Hausberg et al., 1997). Rats 
exposed to carbon nanotubes had alterations to baroreflex sequences (Legramante et al., 
2009), and exposure to concentrated ambient particles (CAPs) in dogs resulted in increases in 
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arterial blood pressure and significantly greater baroreflex sensitivity that was reversed with 
alpha-adrenergic blockade (Bartoli et al., 2009). These studies demonstrate both the 
importance of the baroreceptor reflex in controlling blood pressure changes and the 
relationship between exposure to air pollution and baroreflex activation. The baroreceptor 
reflex is a mechano-reflex that responds to changes in blood pressure mainly through stretch 
receptors, but the body also utilized chemoreceptors that respond the stimuli such as air 
pollutants. 
 
Chemoreceptor Reflex Response- Carotid Body Reflex Response to Hypoxia 
Both the pulmonary and baroreceptor reflex responses are integrated in the peripheral 
chemoreflex receptors, including the carotid body. Hypoxia is defined as the lack of 
sufficient oxygen to tissues. In mammals, the response to systemic hypoxia is controlled by 
the carotid body. The carotid body is a cluster of chemo-sensitive cells located at the 
bifurcation of the carotid artery and serves as the major chemoreceptor for pO2 levels in 
mammals (Conde et al., 2004). In response to hypoxia, the carotid body releases excitatory 
neurotransmitters that elicit reflex hyperventilation to compensate for reduced oxygen levels 
through a HIF-1 mediated pathway (Roux et al., 2000; Liu et al., 2003; Lopez-Barneo et al., 
2008). Carotid body signaling then leads to increased sympathetic activation, which increases 
blood pressure, ventilation, heart rate, and arrhymogenicity (Lopez-Barneo et al., 2008).  The 
carotid body response is also closely linked with baroreceptor response, and signals from 
both will be integrated in the brainstem (Fig. 1.2; McGraw Hill Companies). Chronic 
hypoxia is associated with increased myocyte apoptosis and is implicated in cardiac 
remodeling and progression to heart failure (Bao et al., 2011). In addition, hypoxia has been 
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shown to cause atrial fibrillation, AV block, and ventricular tachycardia as well as changes in 
autonomic balance associated with ventricular arrhythmias (Davies et al., 1993). Many of 
these responses occur after carotid body sensing of hypoxia and present a potential pathway 
to explain the role of hypoxia in air-pollutant induced cardiovascular function. 
The body has a very specific response to hypoxic environments known as the hypoxia 
ventilatory response (HVR). The first step is a reflex increase in ventilation, which is 
followed by a gradual decrease or plateau if hypoxia is chronic. These responses are heavily 
influenced by the pulmonary reflex response discussed previously. The body is actually 
much more sensitive to changing levels of carbon dioxide than it is to oxygen, and the central 
chemoreceptor in the medulla will respond to hypercapnia and increase the HVR. Peripheral 
chemoreceptors, including the carotid bodies and aortic bodies, sense changes in oxygen and 
carbon dioxide levels and communicate with the nucleus tractus solitarius which has 
downstream communication with the respiratory network and can stimulate movement of the 
diaphragm (Richard and Koehle, 2012). This will also lead to increased minute volume and, 
in some cases, hypertrophy of the carotid body, especially in the event of chronic hypoxia. 
Individuals who suffer from obstructive sleep apnea (OSA) and chronic obstructive 
pulmonary disease (COPD) experience chronic intermittent hypoxia (CIH) characterized by 
short episodes of hypoxia followed by normoxia (Iturriaga et al., 2005). In OSA, obstruction 
of the upper airway during sleep causes both hypoxia and hypercapnia, which stimulate the 
carotid body chemoreceptors. This causes a reflex increase in ventilation, sympathetic tone 
and arterial blood pressure. The stimulation of these pathways is accompanied by both 
chemoreceptor and pulmonary mechanoreceptor activation, restoring normal ventilation, 
often causing individuals to awake from sleep (Iturriaga et al., 2005). In addition to 
22 
 
immediate reflex responses, approximately half of all people who suffer from OSA will 
develop arterial hypertension, and other individuals develop pulmonary hypertension and 
have effects on cardiac output (Quan and Gersh, 2004). Evidence of the cardiovascular 
effects in sleep apnea patients combined with pulse oximetry data from humans exposed to 
air pollutants suggests a potential link between pollutant exposure and acute hypoxia that 
warrants further study. It was recently found that cardiac arrhythmias in particulate-exposed 
heart failure mice were in part due to altered sensitivity of the carotid body (Wang et al., 
2012), demonstrating that the chemoreflex response of the carotid body may be a potential 
mechanism by which air pollution causes adverse responses.   
Figure 1.2. Chemoreceptor reflex control of blood pressure. (Reprinted with permission from 
McGraw Hill Companies). 
 
 
23 
 
Air Pollution and Normal Blood Oxygen Levels  
In humans, oxygen saturation is usually measured by pulse oximetry with a device 
placed on the finger that measures arterial blood oxygen saturation using light absorbance. 
While pulse oximetry devices exist for animal models, more reliable measurements are 
obtained by taking serial blood draws and measuring blood gas analytes with a specialized 
machine. Most modern blood gas analyzers measure a host of factors including oxygen 
saturation (SaO2), partial pressure of oxygen (pO2) and carbon dioxide (pCO2), Na
+
, K
+
, and 
Ca
++
. The body will respond to changes in blood oxygen levels almost immediately, and 
small changes in carbon dioxide and oxygen levels can also impact important ions that effect 
cellular repolarization. Many of these effects are mediated by the carotid body, and present 
an important but surprisingly unappreciated focus of air pollution studies. 
Exposure to air pollutants causes a host of responses in the cardiovascular system 
including changes in heart rate, blood pressure, and increased arrhythmias. Episodes of 
hypoxia elicit similar responses, and studies with pulmonary irritants have reported apnea as 
a dominant reflex response to pollutant exposures (Hazari et al., 2008). Several 
epidemiological studies have found significant decreases in oxygen saturation after exposure 
to air pollutants. Pulse oximetry recordings in adults exposed to concentrated ultrafine 
particles showed a 0.5% mean decrease in arterial O2 saturation (Gong et al., 2005). In 
addition, healthy elderly adults exposed to concentrated ambient particles had significant 
decreases in oxygen saturation during exposure (Gong et al., 2004). Recent work by Wang et 
al. (2012) in heart failure mice demonstrated that cardiac arrhythmias with particulate-
exposure were in part due to altered sensitivity of the carotid body.  Furthermore, exposures 
to the air pollutants tobacco smoke (Adgent, 2006), sulfur dioxide and nitrogen dioxide 
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(Hoppenbrouwers et al., 1981) have been linked to abnormal cardiopulmonary sensitivity 
responses to hypoxia. These studies demonstrate the potential for hypoxia to mediate the 
adverse cardiovascular events following air pollution exposure and establish a strong 
justification for research focusing on hypoxia as a potential mechanism for air-pollutant 
induced cardiovascular dysfunction. 
 
Overarching Hypothesis/Purpose of Research 
Despite documented decreases in oxygen saturation during pollutant exposure, a 
direct link between air pollution-induced hypoxia and adverse cardiovascular effects has not 
been established, and the exact mechanism leading to adverse cardiovascular events remains 
unclear. Preliminary results show that exposure to components of DE, such as acrolein, 
trigger immediate irritant responses characterized by apnea and bradycardia, suggesting that 
air pollution exposure may leads to hypoxia. Hypoxia has adverse effects on heart rate, blood 
pressure, and sympathetic activation in heart rate variability and can precipitate adverse 
cardiovascular responses. Thus, my overarching hypothesis for this dissertation project is that 
air pollutant-induced cardiovascular dysfunction (e.g., increased arrhythmias, autonomic 
imbalance, changes in cardiac function, and/or deficits in repolarization) is in part mediated 
by systemic hypoxia (i.e., low arterial blood oxygen levels). The primary purpose for this 
research effort is to better define mechanisms of actions of air pollutants to establish 
biological plausibility for the spikes in human cardiovascular morbidity and mortality 
associated with small fluctuations in ambient air pollution.   This may help reduce 
uncertainty in standard setting and ultimately contribute to a reduction in the risk associated 
with exposure.   
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Hypothesis
A ir Pollutants
Hypoxia (Low PO2)
Increased 
Sympathetic Activity
Carotid Body Br a instem
•Altered HRV
•Arrythmogenesis
•Conduction deficits
•Ion channel dysfunction
•Oxidative stress
Cardiac effects
Increased BP
Increased HR
 
To achieve this goal, the following Specific Aims were carried out: 
Specific Aim (SA) 1. Characterize the impacts of short-term exposure to DE on 
cardiovascular physiology in rats. DE was studied because it is a significant contributor to 
ambient PM and traffic-related adverse clinical outcomes. Thus, DE is an ideal model 
pollutant to examine the role of hypoxia in the mediation of cardiovascular dysfunction.  The 
goal of this study was to perform a comprehensive assessment of the electrocardiographic 
response to DE exposure in the rat. SA 1 will contribute valuable knowledge to the field by 
providing a comprehensive characterization of the electrocardiographic impacts of exposure 
before, during, and after exposure to both whole and filtered diesel exhaust in hypertensive 
and normal rats. In addition, we will determine if DE exposure causes changes in heart rate 
variability as well as pulmonary and cardiac toxicity and inflammation. This study will 
enable the determination of the effects of the classes of components within DE (particulate 
versus gas), shedding light on the drivers of toxicity within DE and inform on the role of pre-
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existing cardiovascular disease in sensitivity to the effects of air pollution. I hypothesized 
that DE exposure will cause concentration-dependent cardiac dysfunction in SH, but not 
normal rats, and that exposure to whole DE will elicit greater effects than particle-free DE.  
Specific Aim 2. Characterize the cardiovascular response to exposure to the DE 
component acrolein, and determine if acrolein exposure increases the risk of adverse 
cardiovascular responses to a cardiac stressor (i.e, hypoxic atmosphere) in hypertensive 
rats. Acrolein is a component of DE that has been associated with reflex pulmonary irritation 
and changes in autonomic tone. The US EPA has listed acrolein as the number one non-
cancer hazard driver in the United States, showing that the effects of acrolein exposure 
warrant additional research. Epidemiological studies indicate that the cardiovascular effects 
of air pollution inhalation are not immediate, usually manifesting some time after exposure. 
For example, patients with implanted cardioverter defibrillators had increased incidence of 
life-threatening arrhythmias up to 2 days after air pollution exposure (Peters et al., 2000). 
These findings suggest that exposure to air pollution alters cardiovascular physiology and 
increases conditional susceptibility to triggers of thrombosis and arrhythmia. Our lab has 
previously found using other stress tests (e.g., exercise or exposure to an agent that triggers 
cardiac arrhythmia) that air pollutant exposure disrupts homeostasis such that individuals 
respond abnormally to normally tolerable stressors. Thus, sensitivity to hypoxia will reflect 
the degree to which homeostatic mechanisms have been compromised. The goal of Aim 2 is 
to determine if acrolein confers increased susceptibility to a cardiac stressor and determine if 
this response is exaggerated in hypertensive rats. Acrolein was selected as the model 
pollutant for this study because of the exaggerated effects observed with DE gases. I 
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hypothesized that acrolein exposure will modify the response to hypoxia in hypertensive but 
not normal rats.   
Specific Aim 3. Determine if inhibition of the sensory response to hypoxia will 
attenuate air-pollutant-induced cardiac dysfunction. Although all of the mechanisms 
mediating the adverse cardiovascular health effects of air pollution are unclear, 
epidemiological evidence has linked exposure to air pollution to drops in blood oxygen 
saturation, suggesting that hypoxia may play a role. Acute and repeated hypoxia is associated 
with carotid body-mediated cardiovascular effects which overtime lead to hypertension and 
predisposition to cardiac arrhythmia. The goal of Aim 3 is two fold: 1) determine if acrolein 
exposure causes hypoxia by measuring oxygen levels in arterial blood and 2) determine if 
inhibition of the carotid body, the major sensory organ involved in hypoxia sensing and the 
triggering of reflex cardiorespiratory responses, leads to a reduction in cardiac abnormalities 
associated with acrolein exposure. I hypothesized that inhibition of hypoxic sensing by the 
carotid body will lead to the reduction and/or absence of air pollutant-induced cardiac 
dysfunction. ECG, HRV, blood pressure, and cardiac contractility were assessed in this 
study.  
 
 
 
 
 
Chapter 2 
 
Divergent Electrocardiographic Responses to Whole and Particle-Free 
Diesel Exhaust Inhalation in Spontaneously Hypertensive Rats 
 
Diesel exhaust (DE) is a major contributor to traffic-related fine PM2.5. While inroads 
have been made in understanding the mechanisms of PM related health effects, DE’s 
complex mixture of PM, gases and volatile organics makes it difficult to determine how the 
constituents contribute to DE’s effects. We hypothesized that exposure to particle-filtered DE 
(gases alone) will elicit less cardiac effects than whole DE (particles plus gases). In addition, 
we hypothesized that Spontaneously Hypertensive (SH) rats will be more sensitive to the 
electrocardiographic effects of DE exposure than Wistar Kyoto rats (WKY; background 
strain with normal blood pressure).  SH and WKY rats, implanted with telemeters to monitor 
electrocardiogram (ECG) and heart rate (HR), were exposed once for 4 hrs to 150ug/m
3
 or 
500ug/m
3
 of whole (wDE; gases plus PM) or filtered (fDE; gases alone) DE, or filtered air.  
Exposure to fDE, but not wDE, caused immediate electrocardiographic alterations in cardiac 
repolarization (ST depression) and atrioventricular conduction block (PR prolongation) as 
well as bradycardia in SH rats.  Exposure to wDE, but not fDE, caused post-exposure ST 
depression and increased sensitivity to the pulmonary C fiber agonist capsaicin in SH rats.  
The only notable effect of DE exposure in WKY rats was a decrease in heart rate. Taken 
together, hypertension may predispose to the potential cardiac effects of DE and components 
of DE may have divergent effects with some eliciting immediate irritant effects (e.g., gases) 
while others (e.g., PM) trigger delayed effects potentially via separate mechanisms. 
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Introduction 
Inhalation of fine particulate matter (PM) air pollution at concentrations frequently 
encountered in ambient air sheds increases cardiovascular morbidity and mortality (Brook et 
al., 2010), especially in individuals with pre-existing cardiovascular diseases (Brook and 
Rajagopalan, 2009).  Vehicular traffic is a dominant source of ambient PM particularly in 
urban environments (Zhu et al., 2002) and studies have shown that proximity to traffic 
sources (e.g., highway or tunnel) is a major determinant of cardiovascular health outcomes 
(Hoek et al., 2002; Hoffman et al., 2006; Van Hee et al., 2009).  Diesel exhaust (DE), largely 
emanating from heavy duty diesel engines, is a significant source of fine (PM2.5) and ultrafine 
PM air pollution (EPA/600/8-90/057F 2002), and is a major contributor to near roadway 
emissions and near road-related adverse clinical outcomes. Peters et al. (2004) found that 
exposure to traffic with high levels of DE was associated with onset of myocardial infarction. 
Similarly, a study in eight European countries attributed hospitalizations for acute coronary 
syndrome in older patients to exposure to DE (Le Tertre et al., 2002).  In a controlled human 
exposure study, Mills et al. (2007) found that DE exposure accentuated exercise-induced 
electrocardiographic ST depression in subjects with known coronary artery disease and 
exercise-induced ischemic ECG changes. 
Several mechanisms of ambient PM effects have been postulated including 
pulmonary receptor mediated modulation of autonomic balance, systemic 
inflammation/oxidative stress leading to altered vasomotor regulation, and direct actions 
through particles entering systemic circulation
 
(Brook et al., 2010). DE is a chemically 
complex source of ambient PM and thus defining modes of action is challenging.  In addition 
to PM, DE also consists of a mixture of gases including nitrogen oxides (NOx), sulfur oxides 
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(SOx), carbon monoxide (CO), and volatile organics including aldehydes, benzene, and 
polycyclic aromatic hydrocarbons. While DE PM has been linked to altered cardiovascular 
effects (Anselme et al., 2007; Mills et al., 2011a), other studies have shown that DE gases 
affect health adversely. In addition to noting the effects of PM, Berger et al. (2006) found 
that increased risk of supraventricular tachycardia in men with coronary heart disease was 
associated with NO2, and Dockery et al. (2005) found similar responses associated with 
exposure to NO2 and CO, gases known to originate from DE. In addition, atherosclerotic 
mice exposed to DE gases showed increased endothelin-1 induced vasoconstriction and 
altered T wave morphology (Campen et al., 2005).  
Abnormal impulse formation and conduction can lead to clinically important heart 
rhythm disorders and even sudden cardiac death.  Despite clear associations with cardiac 
dysfunction, it is unclear what modifying effects DE components may have when in 
combination on heart rate and cardiac electrophysiology in individuals with pre-existing 
cardiovascular disease.  We have previously shown that exposure to PM (Farraj et al., 2009; 
Carll et al., 2010) or the irritant acrolein (Hazari et al., 2009) in rat models of hypertension or 
heart failure causes bradycardia, increased parasympathetic tone, ST depression, and 
arrhythmia.  In addition, we have previously shown that air pollution exposure (acrolein) 
enhances sensitivity of pulmonary C fibers (Hazari et al., 2008), suggesting that air pollution 
exposure may modify chemoreflex responses and potentially autonomic effects.  Given the 
heightened sensitivity to air pollution in individuals with cardiovascular disease, we 
hypothesized that 1) Spontaneously Hypertensive (SH) rats will be more sensitive to the 
electrocardiographic effects of a single DE exposure than similarly exposed Wistar Kyoto 
rats (WKY; background strain with normal blood pressure), 2) exposure to particle-filtered 
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DE (gases alone) will elicit less cardiac effects than exposure to whole DE (particles plus 
gases), and 3) the pulmonary chemoreflex response to capsaicin (C fiber agonist) provocation 
will be potentiated 24 h after DE exposure.  Physiological endpoints were monitored during 
and up to one day after exposure to two different concentrations of DE as studies have shown 
that exposure to traffic-related air pollution can trigger short term effects within hours after 
exposure (Peters et al., 2004). 
 
Materials and Methods 
Animals  
Twelve week-old male Spontaneously Hypertensive (SH) (n = 65) and Wistar Kyoto 
(WKY) normotensive (n = 15) rats (Charles River, Raleigh, NC) were housed in plastic cages 
(one per cage), maintained on a 12-hr light/dark cycle at approximately 22°C and 50% 
relative humidity in our Association for Assessment and Accreditation of Laboratory Animal 
Care-approved facility, and held for a minimum of 1 week before implantation. The 
Institutional Animal Care and Use Committee of the U.S. Environmental Protection Agency 
approved all protocols.  Food (Prolab RMH 3000; PMI Nutrition International, St. Louis, 
MO) and water were provided ad libitum, and all rats were randomized by weight. 
 
Radiotelemetry Implantation  
Animals (SH rats; n = 7 per group; 35 total and WKY rats; n = 5 per group; 15 total) 
were anesthetized with a ketamine/xylazine solution (80 mg/ml ketamine HCL and 12 mg/ml 
xylazine HCL; 1 ml/kg i.p.; Sigma Chemical Co., St. Louis, MO), and were implanted with 
radiotelemeters as previously described (Watkinson et al., 1995).  Briefly, an aseptic surgical 
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technique was used to implant a radiotelemetry transmitter (Model TA11CTA-F40; Data 
Science International, Inc., St. Paul, MN) in the abdominal cavity. Electrode leads were 
guided through the abdominal musculature through stab wounds. Leads were tunneled 
subcutaneously and secured in a lead II configuration. Body heat was maintained during and 
after surgery using a heating pad. Animals recovered for two weeks after surgery before 
inhalation studies. 
 
Diesel exhaust generation and exposure  
Rats were assigned to exposure groups and acclimated to exposure chambers for 1 
hour once per day beginning two days before exposure. On the exposure day, rats were 
allowed to acclimate to the chambers for 1 hour and then baseline data was recorded for the 
next hour. SH rats were then exposed once to filtered air, 150ug/m
3
 filtered diesel exhaust 
(fDE) or whole diesel exhaust (wDE), or 500 ug/m
3
 fDE or wDE for 4 hours in whole body 
exposure chambers. We hypothesized that the highest concentration of fDE and wDE would 
cause the most severe effects. Because of this, WKY rats were exposed to only 500 ug/m
3
 
fDE or wDE for 4 hours in whole body exposure chambers. wDE for exposure experiments 
was generated using a 4.8 kW (6.4 hp) direct injection single-cylinder 0.320 L displacement 
Yanmar L70 V diesel generator operated at a constant 3600 rpm. Resistance heating elements 
provided a constant 3 kW load.  Low sulfur diesel fuel (32 ppm), purchased from a local 
distributor was available from a large storage tank. Engine lubrication oil (Shell Rotella, 
15W-40) was changed before each set of exposure tests. From the engine, the exhaust was 
mixed with particulate (HEPA) filtered room air.  wDE concentrations were based on the fine 
particulate matter (PM2.5; Mass Median Aerodynamic Diameter < 2.5 microns) fractions of 
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the diluted exhaust. Approximately 85 L/min of the exhaust was directed to a cone diluter 
and mixed with approximately 595 L/min (7:1 dilution) of high efficiency particulate air 
(HEPA) filtered room air. The diluted exhaust then traveled approximately 12 m through 
7.1 cm diameter stainless steel tubing to a Hazelton 1000 (984 L) exposure chamber housed 
in an isolated animal exposure room. Target wDE concentration of the diluted exhaust was 
500 g of particulate matter (PM)/m3 (high) and 150 g of PM/m3 (low) which was routed to 
filtered and unfiltered exposure chambers. Multiple human and rodent studies have 
performed DE studies at concentrations similar to and/or greater than the present study (Mills 
et al., 2007; Harkema et al., 2009). The filtered chamber was operated at the same pressure, 
temperature, flow-rate and gas concentrations as the whole particle chamber. The only 
difference was that the filtered chamber pulled its exposure gas through a Solberg (Itaska, IL) 
filter housing (model number is CSL-851-200HC) containing a HEPA canister filter. The 
housing has an inlet to the outside of the pleated canister filter and discharges through the 
core. The housing was equipped with 2 inch NPT thread inlet and exit ports. The HEPA 
canister filter (part number HE-851) had a height of 8.75 inches and an OD of 5.75 inches. 
This filter features a 99.97% removal efficiency standard to 0.3 micron and a temperature 
range from -15° F to 220° F. Although the filtered chamber had nearly no PM present, it still 
contained all the diluted combustion gases as the unfiltered chamber. The chamber 
concentrations were controlled by periodic adjustments of dilution air based on continuous 
mass concentrations determined by tapered element oscillating microbalance (TEOM, 
Rupprecht and Patashnick Co., series 1400, Albany, NY) instruments. These instruments 
include a heated (50 °C) chamber that could theoretically vaporize low temperature volatiles. 
Control animals were placed in a third chamber supplied with the same HEPA filtered room 
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air. The chambers were operated at the same flow rate (424 L/min) resulting in 
approximately 25 air exchanges per hour. Integrated 4 h filter samples (14.1 L/min) were 
collected daily from each chamber and analyzed gravimetrically to determine particle 
concentrations. Continuous emission monitors (CEMs) were used to measure chamber 
concentrations of PM by TEOM, oxygen (O2, Beckman Corp., model 755, La Habra, CA), 
carbon monoxide (CO, Thermo Electron Corp., model 48, Franklin, MA), nitrogen oxides 
(NO and NO2, Teledyne Technology Co., model 200A4, San Diego, CA), and sulfur dioxide 
(SO2, Thermo Electron Corp, model 43c, Franklin, MA). Samples were extracted through 
fixed stainless steel probes in the exposure chambers. Gas samples were passed through a 
particulate filter prior to the individual gas analyzers. Dilution of air was adjusted 
periodically to maintain target PM concentrations as measured by the TEOM. Particle size 
distributions were characterized during each exposure using an engine exhaust particle sizer 
(EEEPS, TSI Inc., model 3090, St. Paul, MN). Chamber temperatures, relative humidity, and 
noise were also monitored, and maintained within acceptable ranges.  
 
Radiotelemetry Data Acquisition  
Radiotelemetry methodology (Data Sciences International, Inc.) allowed constant 
monitoring of electrocardiographic data in unrestrained, un-anesthetized rats from 
implantation until sacrifice. Electrocardiographic data was monitored by remote receivers 
(DataART3.01; Data Sciences International, Inc.) positioned under the home cages within the 
animal facility, and under the exposure cages within the exposure chambers. The exposure 
cages were modified with plastic siding to limit signal noise from metal interference and 
positioned away from other animals to prevent signal crosstalk. In home cages, sixty-second 
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segments of ECG waveforms were acquired and saved at 15-minute intervals from surgical 
recovery through sacrifice not including the exposure period.  Pre-exposure baseline data was 
collected from home cages, as well as a 30 min baseline in exposure cages after a l hour 
acclimation period. During the 4 hr exposure, sixty-second segments were acquired and 
saved at 5-minute intervals. After exposure, rats were monitored in home cages until 
sacrifice, approximately 18 hrs after the end of exposure. Heart rate (HR) was automatically 
obtained from the ECG waveforms with data acquisition software (DataART3.01; Data 
Sciences International, Inc.). 
 
Electrocardiogram, Arrhythmia Identification and Heart Rate Variability (HRV) Analysis  
 ECGAuto software (EMKA Technologies, Falls Church, VA) was used
 
for automated 
analyses of ECG wave amplitudes and segment durations
 
and areas, as well as for the visual 
identification and enumeration
 
of cardiac arrhythmias. Several parameters were determined 
for each ECG waveform: PR
 
interval; R amplitude and interval; QRS duration, amplitude, 
and area; ST interval, amplitude,
 
and area; and T-wave amplitude and
 
area; QT interval, heart
 
rate–corrected QT interval (QTc). To account for potential effects of normal circadian 
rhythm,
 
ECG parameters were quantified over four 6-hour periods for
 
time-matched 
comparisons between pre-exposure and post-exposure
 
periods while the rats were 
unrestrained in their home cages.
 
The times analyzed included 12 AM–6 AM, 6 AM–12 PM, 
12 PM–6 PM, and 6 PM–12 AM. ECG parameters during exposure were analyzed in terms of 
baseline (1-hr recordings
 
while in the exposure chambers immediately before the beginning
 
of exposure) and Hours 1–4 (constituting the entire exposure period between 7:00 AM and 
11:00 AM).
  
For magnitude change, exposure values were subtracted from the baseline 
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values. Magnitude changes were assessed to allow for comparisons between strains and 
exposures and are presented where appropriate. Most of the data are presented as baseline vs. 
exposure information and is separated by hour in some cases. 
Cardiac arrhythmic events were identified in part by using the Lambeth conventions 
(Walker et al., 1988) as a guideline for the identification of arrhythmias in rats.  Arrhythmias 
were identified as atrial premature beats (APB), ventricular premature beats (VPB), sinoatrial 
blocks (SAB) atrioventricular blocks (AVB), or ventricular tachycardia (VT). Arrhythmias 
were quantified and totaled over an 18 hour period prior to exposure (this corresponded to 
the same times assessed after exposure), during the 4 hour exposure period, or during the 18 
hour period beginning immediately after exposure. Total arrhythmia counts during exposure 
were quantified (total of 48 two-minute segments during 4 h exposure period).  To arrive at 
counts per hour, the total amount of time sampled in minutes (96) was divided by the number 
of minutes per hour (60).   
For the analysis of HRV, thorough visual inspection was conducted
 
to identify and 
exclude arrhythmias, artifacts, and 1-min
 
ECG waveforms lacking distinguishable R waves 
for more than
 
30 sec. The analysis of HRV generated heart rate (HR) and
 
time-domain 
measures, including mean time between adjacent QRS
 
complex peaks (the RR interval), a 
standard deviation of the
 
RR interval (SDNN), SDNN normalized for the effects of heart
 
rate 
[SDNN/(RR interval x 100)], and the square root of the mean of
 
squared differences of 
adjacent RR intervals (RMSSD).  The SDNN represents overall HRV, whereas
 
RMSSD 
represents parasympathetic influence over HR. The
 
analysis of HRV also calculated 
frequency domain parameters,
 
particularly low frequency (LF) and high frequency (HF), and
 
the ratio of these two frequency domains (LF/HF). LF is generally
 
believed to represent a 
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combination of sympathetic and parasympathetic
 
tones, whereas HF indicates cardiac vagal 
(parasympathetic)
 
tone, and LF/HF serves as an index of sympathovagal balance. 
 
Necropsy, Blood Collection, and Bronchoalveolar Lavage  
Rats were deeply anesthetized with an intraperitoneal injection of Euthasol (200 
mg/kg Na pentobarbital and 25 mg/kg phenytoin; Virbac Animal Health, Fort Worth, TX). 
The 35 SH rats and 15 WKY rats implanted with radiotelemeters were sacrificed 18 hrs after 
exposure. The remaining 30 SH rats were sacrificed 1 hr after exposure.  Blood samples were 
collected from the abdominal aorta with a syringe. The trachea was cannulated, and the lungs 
were lavaged with a total volume of 35 ml/kg of Ca21, Mg21, and phenol red-free 
Dulbecco’s PBS (SAFC Biosciences, Lenexa, MD), divided into two equal aliquots. 
Cytospins and cell differentials from lavaged cell samples, assays for total protein 
(Coomassie Plus Protein Reagent; Pierce, Rockford, IL), albumin (Diasorin, Inc., Stillwater, 
MN), lactate dehydrogenase (Thermo DMA, Louisville, CO), and N-acetyl-b-d-
glucosaminidase (Roche Diagnostics, Mannheim, Germany) in lavage supernatants, and 
serum C-reactive protein and creatine kinase (kit from Diasorin, Inc.; standard from Kamiya 
Biomedical Co., Seattle, WA) were analyzed as previously described (Ghio et al. 2002).  
 
Capsaicin challenge 
A separate cohort of 15 male age-matched SH rats (not implanted with telemeters) 
were used for this challenge test. Intravenous capsaicin challenge was performed as 
described by Hazari et al. (2008). Capsaicin (Sigma-Aldrich, St. Louis, MO) was prepared as 
a stock solution (500μg/ml) in a vehicle of 10% Tween 80, 10% ethyl alcohol, and 80% 
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saline. On the day of the experiment solutions with incremental capsaicin concentrations 
were made by diluting the stock solution in saline based on individual animal body weights. 
Briefly, 24 hrs after exposure, animals were anesthetized with urethane (1.5g/kg, i.p.), 
supplemental doses of the anesthetic were administered intravenously as necessary to abolish 
pain reflex. Body temperature was maintained at ~36ºC with a heating pad. The left jugular 
vein was cannulated with P.E. 50 polyethylene tubing for the administration of capsaicin. 
The cannula was exteriorized through an airtight port in the whole-body plethysmograph 
(Buxco Electronics, Inc, Wilmington, NC).  The flow signal was integrated to give VT, and f 
was computed from the amount of time it took for one breath.  A flow threshold of 
approximately 60% of the peak inspiratory flow was programmed using Biosystems XA 
software (Buxco Electronics, Inc, Wilmington, NC) into the analyzing computer.  To be 
registered the flow signal had to drop below this threshold, indicating an adequate 
inspiration.  Ti was calculated as the time between the start of the breath, or where the flow 
last crossed zero flow, and the start of expiratory flow, or the point where the flow signal 
rose to zero.  Te was calculated as the difference between the length of the breath and the 
inspiratory time.  A breath was “rejected” when the expired volume differed by more than 
2/3 the inspired volume.  The parameters were measured and recorded on a breath-by-breath 
basis and averaged over 10-sec intervals.  For each dose, 0.1 ml of capsaicin was first 
injected into the catheter and then flushed into the animal with 0.2ml of physiological saline.  
The volume of the catheter was approximately 0.2 ml.  Administration of capsaicin in this 
manner initiated the pulmonary chemoreflex apneic response (rapid decrease in f and 
increase in Te).  At least 15 min elapsed between doses to allow complete recovery.  Data 
from ten breaths immediately preceding the capsaicin injection were pooled to represent the 
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baseline values.  Animals were euthanized with an overdose of Na pentobarbital after the 
experiment. 
 
Real-Time Polymerase Chain Reaction (PCR) 
Total RNA was isolated from the left ventricle of the heart, using the TriZol 
(Invitrogen, Carlsbad, CA) method of RNA isolation.  RNA concentration and integrity were 
confirmed using the NanoDrop ND-1000 Spectrophotometer (Thermo Scientific, 
Wilmington, DE) and the Agilent 2100 Bioanalyzer (Thermo Scientific), respectively.  RNA 
was converted to complementary DNA (cDNA) using the TaqMan Reverse Transcription 
Reagents (Roche; Applied Biosystems, New Jersey).  Real-Time PCR was performed using 
the TaqMan Universal PCR Master Mix and TaqMan Gene Expression Assays: Hmox1 
(Rn01536933_m1), IL-6 (Rn01410330_m1), and Gapdh housekeeping gene 
(Rn01462661_g1) (Roche; Applied Biosystems, New Jersey). Reaction plates (96 wells) 
were run on the Applied Biosystems 7900HT Real-Time PCR System (Applied Biosystems, 
New Jersey) with the following temperature cycle: RT 50°C for 2 min, activation at 95°C for 
10 min, amplification for 40 cycles at 95°C for 15 sec and 60°C for 1 min. Results were 
analyzed using the Sequence Detection System 2.2.2 (Applied Biosystems, New Jersey). 
 
Statistics  
ECG and HRV data included 5 different treatment groups (Air, 150ug/m
3
 fDE or 
wDE, and 500 ug/m
3
 fDE or wDE). The statistical analyses of the ECG and HRV data in this 
study were performed using SAS version 9.2 software (SAS Institute Inc, Cary NC).  We 
used PROC MIXED of SAS since it offers greater flexibility for the modeling of repeated 
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measures data than PROC GLM. It is also suitable for analysis of large, unbalanced data with 
missing data at random. A linear mixed model with restricted maximum-likelihood 
estimation analysis,  least squares means and repeated measures ANOVA was used to 
determine which TIME*TRT  interactions were statistically significant between baseline and 
exposure. Multiple comparison adjustment for the p values and confidence limits for the 
differences between the least squares means was done using adjust=Tukey HSD (Honest 
Significant Difference) test. All the biochemical, differential, lung physiology and molecular 
data were analyzed using GraphPad Prism (GraphPad Software, Inc., La Jolla, CA) with a 
one, two, or three-way analysis of variance (ANOVA) model examining the main effects of 
each model as well as the interactive effects of two- and three-way ANOVA models. p < 0.05 
was considered statistically significant. 
 
Results 
Exposure Characterization 
Table 2.1 lists average particle and gas exposure concentrations, particle size and 
number. Chamber temperature and humidity were 72.45 ± 0.69 
o
F and 43.58 ± 1.27 % 
respectively for all chambers. 
 
Heart Rate 
 Heart rates decreased in SH rats during exposure to both 150 µg/m
3 
and 500 µg/m
3
 
fDE when compared to heart rates before exposure (Fig. 2.1A-D).  By the second hour of 
exposure, SH rats exposed to 150 µg/m
3
 fDE had a 16% decrease in heart rate, from 361 ± 8 
beats/min to 311 ± 9 beats/min (p<0.05; Fig. 2.1B).  For SH rats exposed to 500 µg/m
3
 fDE, 
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heart rates decreased by 11.4% by the second hour of exposure, from 348 ± 6 beats/min to 
312 ± 4 beats/min (p<0.05; Fig. 2.1B).  For WKY rats, exposure to 500 µg/m
3 
wDE caused a 
14.9% decrease in heart rate by hour 4 from 353 ± 8 beats/min to 308 ± 4 beats/min (p<0.05; 
Fig. 2.2D).  No changes in heart rate were measured in SH or WKY rats exposed to filtered 
air. 
 
Heart Rate Variability 
 There were no significant changes were in SDNN or RMSSD during exposure in SH 
(Table 2.3) or WKY rats (data not shown).  All SH rats including those exposed to air had 
significant decreases in LF/HF during exposure, likely an effect due to chamber stress (Table 
2.3). 
 
Electrocardiogram and Arrhythmia 
 Exposure of SH rats to 500 µg/m
3
 fDE increased PR interval during hour 2 of 
exposure, an effect that persisted throughout hours 3 and 4 of exposure (Fig. 2.3). There were 
no significant changes in PR interval in SH rats exposed to filtered air, 150 µg/m
3
 fDE or 
wDE, 500 µg/m
3
, or WKY rats under any exposure condition. 
Only SH rats exposed to 150 µg/m
3
 fDE exposed had a significant increase in 
negative amplitude during exposure (% change, p-value) (Figure 2.4A).  Although still 
reduced after exposure (a decrease of 160%), this difference was not statistically significant 
(Figure 2.4B).  There were no changes in the amplitude of the ST segment in any of the other 
exposure groups.  No changes in ST segment amplitude were seen in WKY rats. 
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 SH rats exposed to 150 ug/m
3
 fDE had significant increase in negative ST area during 
exposure (Table 2.2), while only exposure to 500 ug/m
3
 wDE caused significant increases in 
negative ST area 18 hours after exposure (data not shown). Negative ST area is an 
electrocardiographic parameter that measures the area under the curve between the S wave 
and the peak of the T wave and can be used to infer changes in repolarization. During 
exposure, 150 µg/m
3
 fDE caused negative ST area to increase from -0.78 ± 0.02 mVsec to -
0.94 ± 0.01 mVsec, a 17% decrease (p < 0.05). When 18 hours of post exposure data is 
averaged, 500µg/m
3
 wDE caused negative ST area to increase from -1.23 ± 0.01 mVsec to -
1.32 ± 0.01 mVsec, a 6.8% decrease (p < 0.05).  
There were no significant effects in any of the measured arrhythmias during or after 
exposure in any of the exposure groups in either strain. 
 
Capsaicin Challenge 
Capsaicin (1, 2, 4, 8ug/kg, i.v.) caused a dose-dependent increase in Te in air exposed 
SH rats (Figure 2.5). A single exposure to 500 µg/m3 wDE significantly potentiated the 
chemoreflex apneic response to capsaicin in SH rats (this assay was not performed in WKY 
rats); a greater than 60% increase in the apneic period at the two highest doses.  
 
Heart Weight 
  SH rats had on average higher average heart weight than WKY rats (means, SEMs, 
and p values).  There were no significant effects of exposure on heart weight in either strain 
(data not shown). 
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Oxidative Stress and Pulmonary Inflammation 
There were no significant effects of exposure on the measured systemic and 
pulmonary markers of oxidative stress and inflammation in either strain at either 1 or 24 hr 
after exposure (data not shown).  
 
Real-Time PCR 
 There were no significant gene expression expression changes in HO-1 or IL-6 in the 
left ventricles of SH and WKY rats both 1 hr and 24 hrs after exposure.   
 
Discussion 
 The current study demonstrates that exposure to filtered and whole DE affects 
electrocardiographic parameters in SH rats, but not WKY rats, corroborating studies that 
demonstrate enhanced sensitivity to the effects of air pollution in susceptible clinical 
subgroups having underlying cardiovascular disease including hypertension (Brook and 
Rajagopalan, 2009).  Only exposure to the gaseous components of DE (fDE) caused heart 
rate slowing, PR prolongation, and ST segment depression during exposure in SH rats.  
Conversely, exposure to the high concentration of whole DE (wDE, both particles and gases) 
caused ST depression after exposure in SH rats and was associated with elevated post-
exposure sensitivity to the pulmonary C fiber agonist capsaicin, suggesting that the gaseous 
components of DE may activate separate pathways than the gas/particle mixture of wDE. 
Exposure to fDE, but not wDE, in SH rats caused electrocardiographic alterations 
during exposure indicative of changes in the early phase of repolarization (ST depression) 
and atrioventricular conduction slowing (PR prolongation).  In contrast, exposure to wDE 
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caused ST depression only after exposure.  The exact reason for this disparity is unclear and 
is discussed below. Nonetheless, multiple studies have reported ST segment depression with 
both particulate and gaseous air pollution exposure.  In a cohort of adults with stable 
coronary heart disease, PM levels two days before clinic visits were positively associated 
with increased risk of ST segment depression during an exercise test (Pekkanen et al., 2002), 
and were attributed to the gaseous pollutants NO2 and CO (Pekkanen et al., 2002).  Likewise, 
ST segment depression has also been reported after exercise in elderly patients exposed to 
black carbon (Gold et al., 2005).  Although the mechanism behind ST depression is unclear, 
previous studies have shown that combustion related gases in DE such as volatile 
organics/aldehydes and alkanes cause coronary \vasoconstriction (Campen et al., 2005). In 
addition, air pollution exposure causes variability in T wave morphology and repolarization 
and may lead to myocardial vulnerability and the potential for adverse myocardial events 
(Henneberger et al., 2005). While the ST segment changes are suggestive of ischemia, 
measurements of biological indicators of ischemia were not carried out in this study and will 
be needed to confirm ischemia in future studies. Moreover, this is the first study to report DE 
induced PR prolongation.  PR prolongation is fairly common irrespective of the presence of 
disease and is usually associated with increased vagal tone (Sapire et al., 1979).  These 
findings are similar to our previous findings with inhaled PM (Farraj et al., 2009; Farraj et 
al., 2011) and suggest that air pollution exposure secondarily impacts intra-myocardial 
conduction.   
While cardiac responses were the focus of this study, there were also respiratory 
observations, some of which may have linkage to the cardiac responses and may explain the 
divergence in cardiac responses with whole DE and DE gases alone.  Previous reports from 
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our laboratory have demonstrated that stimulation of irritant receptors in the airways with 
acrolein or DE can initiate cardiac responses.  Capsaicin is an agonist for the transient 
receptor potential channel (TRP) V1 receptor found on pulmonary C fibers; it causes reflex 
bronchospasm and is useful as a challenge regimen to determine enhanced sensitivity to 
pulmonary irritation and injury (Hazari et al., 2008).  In this study, only SH rats exposed to 
high wDE had significant increases in Te, a measure of apnea, after i.v. injection of capsaicin 
24 hrs after exposure, suggesting enhanced sensitivity to capsaicin induced respiratory 
dysfunction.  The discrepancy in effects with whole and filtered DE suggests the activation 
of separate mechanisms. Traditionally, air pollution toxicity is believed to occur through 
three major pathways: 1) irritant or sensory receptor activation leading to changes in 
autonomic balance, 2) activation of systemic inflammatory pathways that impact vascular 
function, and 3) direct effects of translocated PM (Brook et al., 2010).  While there was no 
evidence of inflammatory changes in the heart, lung, and circulation, the immediacy of 
effects with fDE exposure (HR slowing, PR prolongation, and ST depression during 
exposure) suggest the activation of irritant pathways while the delayed effects with wDE 
exposure suggest non-irritant pathways that are potentially mediated by oxidative or 
inflammatory pathways. There were no significant HRV changes after exposure to DE. 
Interestingly, Mills et al. (2011b) had similar finding showing that exposure to 300ug/m
3 
DE 
did not affect HRV in human volunteers. Although there was no evidence of altered HRV 
with fDE during exposure, high fDE did cause bradycardia and accompanying PR 
prolongation that are associated with increased vagal tone.  Conversely, the delayed response 
with the wDE (i.e., ST segment depression after exposure) was accompanied by exaggerated 
sensitivity to capsaicin, suggesting potential mediation by neurogenic/neuroimmune 
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mechanisms.  Further work is needed to decipher the mechanisms that mediate these 
responses.  
The divergence in responsiveness is likely due to the distinct composition of fDE and 
wDE. Several studies have shown that several components within DE, including particles, 
particle/organic compound mixtures, and organic compounds found in the gas phase are 
capable of eliciting adverse cardiovascular effects (Ris, 2007).  For example, atherosclerotic 
mice exposed to gaseous components of DE had increased coronary vasoconstrictive 
responses (Campen et al., 2005). Epidemiological studies have also shown that gaseous 
components of ambient air pollution also drive some of the adverse cardiovascular effects of 
air pollution.  For example, pollutant models excluding the effects of PM2.5 found increased 
resting diastolic blood pressure due to ozone concentrations in patients with pre-existing 
cardiovascular disease (Zanobetti et al., 2004).  In addition, gaseous and particulate 
components of DE interact and these interactions may have driven some of the divergent 
responses seen in this study.  The carbonaceous core of diesel particles creates a high surface 
area vehicle suitable for absorption of a number of organic compounds including volatile 
organic compounds (VOCs) and polyaromatic hydrocarbons (PAHs) that can then be 
transported more deeply into the lung (Sosnowski et al., 2011).  In addition, Kamm et al. 
(1999) found that the surface properties of diesel soot were significantly altered after 
interaction with ozone.  Thus the composition of the exhaust affects particle and chemical 
characteristics, which in turn might affect both the nature of the cardiopulmonary responses 
and their time to onset.   
While DE exposure decreased heart rate in both strains of rats, only the hypertensive 
rat had significant electrocardiographic changes during and after exposure to DE.  The 
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mechanisms accounting for the elevated sensitivity of the SH rat are uncertain, but may relate 
to the structural, biochemical, and physiological characteristics of the cardiovascular system 
attendant to prolonged hypertension.  Previous studies have shown that SH rats have, on 
average, 40 mmHg higher mean arterial pressure than background control rats with normal 
blood pressure at the stage of life used in the present study (El-Mas and Abdel-Rahman, 
2005) as well as greater arterial wall thickness
 
(Mulvany and Halpern, 1977).  Over time 
hypertension leads to structural and biological remodeling of the left ventricle characterized 
by hypertrophy, fibrosis, and changes in membrane channels, cellular energetics and ion 
regulation that combine to heighten myocardial sensitivity (Bernardo et al., 2010).  Such 
remodeling has been demonstrated in SH rats (Goltz et al., 2007) and may account for the 
differences in responsiveness to DE among the SH and WKY rat.  The potential effects of the 
low DE concentration on electrocardiographic response in WKY rats are unknown and 
should be determined in future studies. 
Collectively, the present findings demonstrate for the first time that whole DE and 
particulate-free DE from the same diesel engine source trigger divergent electrocardiographic 
responses.  As illustrated with DE in this study, the specific composition of ambient 
pollutants at any one location likely exacts unique physicochemical characteristics that 
influence both the quality and magnitude of toxicity. The complex composition of DE makes 
these divergent responses likely and also displays the challenge in determining mechanisms 
controlling responses to multipollutant environments. The mixing of particles and gases 
likely results in the generation of multiple new byproducts not found in particles or gases 
alone. Thus, as evident from the data, traditional dose-response relationships may not readily 
apply.    DE exhaust exposure also caused little to no effect in healthy rats, stressing the 
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necessity of modeling susceptible human populations. Future studies should model additional 
susceptible populations such as the elderly or individuals suffering from asthma. Taken 
together, these findings highlight the need for additional studies that focus on the effects of 
multi-pollutant exposures to more accurately assess the comparative cardiopulmonary 
toxicity of different air sheds. 
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Table 2.1.  Summary of concentrations and characteristics of the diesel exhaust particles and 
gases within the animal exposure chambers.
a 
 
 
a
Tapered element oscillating microbalance (TEOM), O2, CO, NO, NO2, and SO2 data 
represent mean values from continuous measurements taken over the exposure periods ± 
standard error (SE).  TEOM was not taken at control or filtered chambers since the 
particulate matter was not adjustable. 
b
Filter data represent mean values from one measurement from all chambers per day taken 
over the exposure periods ± SE.  
c
Particle number count and size was determined using a TSI Engine Exhaust Particle Sizer 
Model 3090. Instrument was operated during another study utilizing the same conditions. No 
data was available to the 150 ug/m
3 
filtered diesel exhaust because the instrument was on 
loan during this study. Based upon a number of studies, particle size and count is almost 
equivalent to the value for 500µg/m
3
 fDE. 
 
 
 
Constituent Units     
  Filtered Air 
Control 
150µg/m
3
  
Filtered DE 
500µg/m
3
  
Filtered 
DE 
150µg/m
3
 
Whole DE 
500µg/m
3
 
Whole DE 
Particle mass 
concentration 
(filter)
b
 
µg/m
3
 32.5 ± 8.5 15 ± 2 21 ± 5 168 ± 32 425 ± 31 
Oxygen (O2) % 21 ± 0 20.7 ± 0 20.6 ± 0 20.8 ± 0.0 20.6 ± 0 
Carbon monoxide 
(CO) 
ppm <1 6 ± 0 18 ± 0 6 ± 0 19 ± 0 
Nitrogen oxide 
(NO) 
ppm <0.5 4 ± 0 13 ± 0 5 ± 0 13 ± 0 
Nitrogen dioxide 
(NO2) 
ppm <0.5 <0.5 <0.5 <0.5 <0.5 
Sulfur dioxide 
(SO2) 
ppm <0.5 <0.5 <0.5 <0.5 <0.5 
Particle number 
concentration
c
 
#/cm
3
 1441 ± 400 N/A
c 
1428 ± 
182 
459333 ± 
53446 
2.1 x10
6
 ± 
696 x10
3
 
Number median 
Particle Diameter
c
 
nm 26 ± 6 N/A
c 
25 ± 6 60 ± 0 69 ± 9 
Volume Median 
Particle Diameter
c
 
nm 141 ± 34 N/A
c 
133 ± 30 98 ± 30 113 ± 21 
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Table 2.2. 4 hour average of electrocardiographic parameters in Spontaneously Hypertensive 
rats during exposure. * denotes a significant change from baseline (p < 0.05). Values 
represent means ± standard error.  
Exposure Timing QRS 
(msec) 
QTc 
(msec) 
Negative ST 
Area (mV x 
sec) 
T Wave Area 
(mV x sec) 
Air Baseline 36.04 ± 
0.69 
91.45 ± 
0.61 
-0.88 ± 0.04 1.59 ± 
0.10 
 Exposure 34.69 ± 
0.32 
90.77 ± 
0.22 
-0.86 ± 0.01 1.83 ± 
0.04 
fDE 150µg/m
3 Baseline 30.10 ± 
0.96 
93.38 ± 
0.57 
-0.78 ± 0.02 3.37 ± 
0.14 
 Exposure 32.71 ± 
0.28 
93.16 ± 
0.16 
-0.94 ± 0.01* 2.04 ± 0.04* 
fDE 500µg/m
3
 Baseline 30.27 ± 
0.60 
90.96 ± 
0.41 
-1.03 ± 0.04 1.84 ± 
0.07 
 Exposure 29.79 ± 
0.16 
87.74 ± 
0.15* 
-1.05 ± 0.01 1.89 ± 
0.03 
wDE 150µg/m
3
 Baseline 38.49 ± 
1.15 
88.20 ± 
0.57 
-0.74 ± 0.04 1.94 ± 
0.10 
 Exposure 40.66 ± 
0.40 
90.75 ± 
0.19* 
-0.82 ± 0.01 1.87 ± 
0.03 
wDE 500µg/m
3
 Baseline 40.96 ± 
1.08 
94.00 ± 
0.57 
-1.12 ± 0.04 1.66 ± 
0.07 
 Exposure 41.38 ± 
0.36 
93.23 ± 
0.19 
-1.10 ± 0.02 1.44 ± 
0.03 
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Table 2.3. 4 hour average of heart rate variability parameters in Spontaneously Hypertensive 
rats during exposure. * denotes a significant change from baseline (p < 0.05). Values 
represent means ± standard error. 
Exposure Timing SDNN RMSSD LF HF LF/HF 
Air Baseline 6.14 ± 
0.38 
3.76 ± 
0.48 
1.45 ± 0.52 0.74 ± 0.91 2.26 ± 0.37 
 
 Exposure 8.74 ± 
0.75* 
 
3.97 ± 
0.47 
1.15 ± 0.26 0.90 ± 0.14 1.28 ± 
0.14* 
fDE 
150µg/m
3 
Baseline 8.50 ± 
0.38 
4.00 ± 
0.98 
2.10 ± 0.46 0.60 ± 
0.065 
2.73 ± 0.47 
 Exposure 8.50 ± 
1.00 
 
4.20 ± 
0.96 
1.00 ± 
0.29* 
1.15 ± 
0.25* 
1.5 ± 0.32* 
fDE 
500µg/m
3
 
Baseline 7.70 ± 
0.77 
3.49 ± 
0.72 
0.84 ± 0.18 0.50 ± 0.09 2.54 ± 0.58 
 Exposure 7.93 ± 
0.56 
 
3.19 ± 
0.24 
0.73 ± 0.12 0.84 ± 0.10 1.07 ± 
0.16* 
wDE 
150µg/m
3
 
Baseline 8.38 ± 
0.69 
4.78 ± 
0.62 
1.26 ± 0.27 0.76 ± 0.11 1.72 ± 0.13 
 Exposure 8.09 ± 
0.65 
 
3.89 ± 
0.46 
0.89 ± 0.16 1.08 ± 0.24 1.14 ± 0.14 
wDE 
500µg/m
3
 
Baseline 7.82 ± 
0.64 
4.34 ± 
0.84 
2.35 ± 0.83 0.95 ± 0.28 2.33 ± 0.28 
 Exposure 7.75 ± 
0.57 
 
3.64 ± 
0.42 
0.87 ± 
0.20* 
1.01 ± 0.24 1.10 ± 
0.12* 
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Figure 2.1. fDE causes decreases in heart rate (HR) during exposure in SH rats. Panels A, B, 
C and D relate to heart rate responses measured 1, 2, 3 and 4 hours after exposure, 
respectively. Baseline HR is compared to the average HR value during each hour of 
exposure. Means and standard errors are reported. Significant differences (p < 0.05) are 
denoted with a *. 
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Figure 2.2. wDE causes decreases in heart rate (HR) during exposure in WKY rats. Panels 
A, B, C and D relate to heart rate responses measured 1, 2, 3 and 4 hours after exposure, 
respectively. Baseline HR is compared to the average HR value during each hour of 
exposure. Means and standard errors are reported. Significant differences (p < 0.05) are 
denoted with a *. 
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Figure 2.3. SH rats exposed to fDE have increased PR interval during exposure. Panels A, B, 
C and D relate to PR responses measured 1, 2, 3 and 4 hours after exposure, respectively. 
Baseline PR interval is compared to the average PR interval value during each hour of 
exposure. Means and standard errors are reported. Significant differences (p < 0.05) are 
denoted with a *. 
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Figure 2.4. SH rats exposed to fDE had increased negative ST amplitude during and after 
exposure. Magnitude of ST segment shift compared to baseline (A) during exposure, and (B) 
18 hrs after exposure to low and high dose whole diesel exhaust (wDE) and PM filtered 
diesel exhaust (fDE).  SH rats exposed to 150ug/m
3
 fDE had significant ST depression 
during exposure.  Significant differences (p < 0.05) are denoted with a *. 
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Figure 2.5. SH rats exposed to wDE have increased susceptibility to apnea after capsaicin 
challenge. SH rats were exposed to air, 500 µg/m
3
 fDE, or 500 µg/m
3
 wDE and then i.v. 
injected with 1, 2, 4, and 8 µg/kg capsaicin 24 hours after exposure.  Means and standard 
errors are reported. Significant differences (p < 0.05) are denoted with a *. 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
 
Hypoxia Stress Test Reveals Exaggerated Cardiovascular Effects in Hypertensive Rats after 
Exposure to the Air Pollutant Acrolein 
 
Exposure to air pollution increases the risk of cardiovascular morbidity and mortality, 
especially in susceptible populations with cardiovascular disease. Despite increased risk, 
adverse responses are often delayed and require additional stress tests to reveal latent effects 
of exposure. The goal of this study was to use an episode of “transient hypoxia” as an 
extrinsic stressor to uncover latent susceptibility to environmental pollutants in a rodent 
model of hypertension.  We hypothesized that exposure to acrolein, an unsaturated aldehyde 
and mucosal irritant found in cigarette smoke, diesel exhaust, and power plant emissions 
would increase cardiopulmonary sensitivity to hypoxia, particularly in hypertensive rats. 
Spontaneously hypertensive (SH) and Wistar Kyoto (WKY; normotensive) rats, implanted 
with radiotelemeters, were exposed once for 3 hours to 3 ppm acrolein gas or filtered air in 
whole body plethysmograph chambers and challenged with a 10% oxygen atmosphere (10 
minutes) 24 hours later.  Acrolein exposure increased heart rate, blood pressure, breathing 
frequency, and minute volume in hypertensive rats and also increased the heart rate 
variability parameter LF, suggesting a potential role for increased sympathetic tone.  
Normotensive rats only had increased blood pressure during acrolein exposure. The hypoxia 
stress test after acrolein exposure revealed increased diastolic blood pressure only in 
hypertensive rats and increased minute volume and expiratory time only in normotensive 
rats.  These results suggest that hypertension confers exaggerated sensitivity to air pollution 
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and that the hypoxia stress test is a novel tool to reveal the potential latent effects of air 
pollution exposure.  
 
Introduction 
Exposure to air pollution increases cardiovascular morbidity and mortality, especially 
in individuals with pre-existing cardiovascular diseases (Brook et al., 2010).  
Epidemiological studies indicate that these effects are not immediate, usually manifesting 
some time after exposure. For example, Peters et al. (2004) showed that humans exposed to 
traffic were more susceptible to myocardial infarction up to 24 hours after exposure. In 
addition, patients with implanted cardioverter defibrillators had increased incidence of life-
threatening arrhythmias up to 2 days after air pollution exposure (Peters et al., 2000). These 
findings suggest that exposure to air pollution alters cardiovascular physiology and increases 
conditional susceptibility to triggers of thrombosis and arrhythmia. Moreover, the fact that 
these effects happen at lower exposure concentrations than those shown to elicit effects in 
animal studies indicates that the responses are more complicated than the standard monotonic 
dose-response relationship of traditional toxicology. The reduced capacity to compensate to 
daily stressors may account for the “lagged” responses associated with air pollution 
exposure.  The study of the factors that determine the capacity to compensate fully presents a 
potentially informative approach when seeking to uncover and explain the latent effects of air 
pollution exposure. 
A stress test is a common way to reveal enhanced sensitivity or the potential for 
adverse responses because increased cardiovascular effort causes reduced oxygen availability 
to tissues and may provoke autonomic imbalance (Goldberger et al., 2006).  Numerous 
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studies have shown that stress tests trigger many adverse cardiovascular effects including 
increased cardiac arrhythmias and deleterious changes in heart rate (HR), heart rate 
variability (HRV), an indirect indicator of cardiac autonomic tone, and ECG parameters 
(Watanabe et al., 2001).  Recently, exercise stress was used to demonstrate that exposure to 
diesel exhaust during exercise in men with coronary artery disease caused myocardial 
ischemia (Mills et al., 2007).  Analogous effects, including increases in cardiac arrhythmia 
and myocardial ischemia, were demonstrated in rats infused with the sympathomimetic 
dobutamine one day after exposure to diesel exhaust (Hazari et al., 2012).  In addition, rats 
exposed to particulate matter or acrolein had exaggerated sensitivity to aconitine, an agent 
that causes myocardial calcium loading (Hazari et al., 2009).  These results are consistent 
with epidemiological evidence for a time lag in responses and highlight the value of stress 
tests in unmasking latent responses. 
We have previously demonstrated that exposure to both particulate or gaseous air 
pollutants, including acrolein, causes exaggerated cardiovascular effects in rat models of 
hypertension and heart failure (Carll et al., 2012; Farraj et al., 2011; Hazari et al., 2009; 
Lamb et al., 2012). While the mechanisms responsible for these effects are unclear, recent 
work by Wang et al. (2012) demonstrated that cardiac arrhythmias in particulate-exposed 
heart failure mice were in part due to altered sensitivity of the carotid body, a key organ 
involved in oxygen sensing and initiating reflex cardiopulmonary changes to maintain 
homeostasis.  Furthermore, exposures to the air pollutants tobacco smoke (Adgent, 2006), 
sulfur dioxide and nitrogen dioxide (Hoppenbrouwers et al., 1981) have been linked to 
abnormal cardiopulmonary sensitivity responses to hypoxia. These findings suggest that the 
response to hypoxia may be useful in unmasking the latent effects of air pollution. The 
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purpose of this study was to: 1) examine the utility of a novel hypoxia stress test in revealing 
the potential latent effects of air pollution, and 2) given that hypertensive individuals have 
exaggerated sensitivity to low atmospheric oxygen (Yu et al., 1999), test the hypothesis that 
acrolein exposure will modify the response to hypoxia in hypertensive, but not normal rats.  
HR, blood pressure, ECG, and HRV were measured during acrolein exposure and one day 
later during hypoxia challenge.   
 
Materials and Methods 
Animals  
Twelve week-old male Spontaneously Hypertensive (SH) (n = 6) and Wistar Kyoto 
(WKY) normotensive (n = 6) rats (Charles River, Raleigh, NC) were housed in plastic cages 
(one per cage), maintained on a 12-hr light/dark cycle at approximately 22°C and 50% 
relative humidity in our Association for Assessment and Accreditation of Laboratory Animal 
Care-approved facility, and held for a minimum of 1 week before exposure. Food (Prolab 
RMH 3000; PMI Nutrition International, St. Louis, MO) and water were provided ad libitum, 
and all rats were randomized by weight. After all experiments were performed, rats were 
deeply anesthetized with an intraperitoneal injection of Euthasol (200 mg/kg Na 
pentobarbital and 25 mg/kg phenytoin; Virbac Animal Health, Fort Worth, TX) and 
euthanized by exsanguination. The Institutional Animal Care and Use Committee of the U.S. 
Environmental Protection Agency (US EPA) approved all protocols. 
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Telemeter Implantation 
Animals were implanted with radiotelemetry transmitters to monitor heart rate (HR), 
blood pressure (BP), and heart rhythms and electrocardiographic intervals (Model TL11M2-
C50-PXT; Data Science International, Inc., St. Paul, MN).  Charles River Laboratories 
performed all telemetry implantation surgeries in accordance with methods specified by the 
vendor (Charles River Laboratories, 2005).  Animals were shipped to the US EPA 10 days 
after implantation surgeries, and animals were allowed to recover for 1 week at the US EPA 
before exposures began. 
A separate cohort of SH (n = 5) and WKY (n = 5) rats were implanted with femoral 
artery catheters in accordance with methods specified by the vendor (Charles River 
Laboratories, 2005).  Animals were shipped to the US EPA within 1 week of surgery.  The 
catheters were flushed with saline, locked with heparin and plugged immediately upon 
arrival and every two days thereafter until exposure began.  
 
Acrolein Exposure and Hypoxia Stress Test 
A paired design was utilized to control for baseline differences in HR, BP, and ECG 
rhythms between rats.  SH and WKY rats were first exposed to air control for 3 hours and 
then underwent a hypoxia stress test 24 hours later. The hypoxia stress test was performed 24 
hours after acrolein exposure to uncover latent responses consistent with the delay between 
exposure and adverse health effect observed in some epidemiological studies (Peters et al., 
2000; Peters et al., 2004). Exposure to subatmospheric oxygen has been used as a stress test 
in humans with hypertension to demonstrate exaggerated cardiorespiratory responses to 
hypoxia (Ledderhos et al., 2002). After 5 days, these same rats were exposed to 3 ppm 
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acrolein for 3 hours and then underwent a second hypoxia stress test 24 hours later (Please 
refer to Figure 3.3A).  We assumed that a period of 5 days between the initial hypoxia stress 
test and the subsequent exposures would allow residual effects, if any, of the initial hypoxia 
stress test to lapse.  This was confirmed by the absence of any differences in air-exposed rats 
at baseline relative to the previous air and hypoxia exposures.  
All exposures (air and acrolein) as well as the hypoxia stress test took place in whole 
body plethysmography chambers (WBP; Model PLY3213, Buxco Electronics, Inc, 
Wilmington, NC), which continuously and non-invasively monitor ventilatory parameters in 
conscious animals.  All rats were acclimated to the chambers for 1 hour on the two days prior 
to both air and acrolein exposure.  On exposure days, rats were allowed to acclimate to 
exposure chambers for 30 minutes, and then baseline data were recorded for the next 30 
minutes.  For air exposure, rats were exposed to filtered air in whole-body plethysmography 
chambers for 3 hours. HR, systolic and diastolic BP, ECG waveforms, and ventilatory data 
were collected during the entire exposure period. After exposure, animals were returned to 
their home cages.  Twenty-four hours after air exposure, animals underwent a hypoxia stress 
test.  Animals were placed in whole-body plethysmography chambers and allowed to 
acclimate for 30 minutes.  A 30 minute baseline was then recorded. After baseline 
measurements, animals were kept at 20% oxygen concentration (ambient O2 concentration) 
for 5 minutes before the hypoxia stress test.  To reduce the PO2 in the chamber, 100% 
nitrogen (N2) gas was delivered to a glass mixing chamber where the gas was mixed with dry 
filtered air to achieve a fraction of inspired O2 (FIO2) of 10% at a flow rate of 2 L/min. 
Oxygen levels were monitored continuously with an O2 sensor attached directly to the 
chamber, and an FIO2 of 10% was maintained for 10 minutes.  Nitrogen was then turned off, 
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and the FIO2 oxygen saturation rose to 20% (Figure 3.3B).  Rats were then kept in the 
chambers for an additional 15 minutes.  HR, systolic and diastolic BP, ECG waveforms, and 
ventilatory data were collected continuously during the stress test. 
Five days after air exposure and the hypoxia stress test when all latent 
preconditioning was absent, these same rats were exposed to 3 ppm acrolein for 3 hours in 
the same whole-body plethysmography chambers. The concentration of acrolein (3 ppm) is 
higher than ambient levels, but it may represent concentrations in high combustion areas 
(Hazari et al., 2008). In addition, cigarette smoke contains up to 90 ppm acrolein (Esterbauer 
et al., 1991), and acrolein levels in sidestream tobacco smoke are as high as 10 ppm 
(Esterbauer et al., 1991). Acrolein gas was metered from a 1000 ppm cylinder into a glass 
mixing chamber where the gas was mixed with dry filtered dilution air to achieve a final 
concentration of 3 ppm of acrolein with a total flow of 6 L/min.  The actual chamber 
concentration was measured using an HP5890 gas chromatograph (GMI Inc., Ramsey, MN) 
equipped with manual injection, a flame ionization detector and a DB-VRX capillary 
column.  The plethysmograph pressure was monitored using Biosystems XA software 
(Buxco Electronics, Inc, Wilmington, NC).  Using respiratory-induced fluctuations in 
ambient pressure, respiratory parameters including tidal volume, breathing frequency, 
inspiratory time and expiratory time were calculated and recorded on a breath-by-breath basis 
and averaged over 10 second intervals. HR, systolic and diastolic BP, ECG waveforms, and 
ventilatory data were collected during the exposure, and animals were returned to their home 
cages after exposure.  Rats underwent a hypoxia stress test 24 hours later as previously 
described. Because the data collected were repeated measures, the data during acrolein 
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exposure and the subsequent hypoxia stress test are presented as % change from air exposure 
and the initial hypoxia stress test, respectively. 
 
Validation of Hypoxia Stress Test 
The hypoxia stress test was validated by measuring arterial blood O2 saturation 
(SaO2) during hypoxia challenge in a separate cohort of rats.  Rats implanted with femoral 
artery catheters were acclimated to whole body plethysmography chambers (WBP; Model 
PLY3213, Buxco Electronics, Inc, Wilmington, NC), for 1 hour on the two days prior to 
hypoxia validation.  On the day of validation, the exteriorized catheter was extended with a 1 
ml PE50 catheter attached to a 23 gauge adapter and run through a pre-measured hole in the 
wall of the plethysmograph to allow for blood draws outside of the sealed exposure chamber.  
Rats were acclimated to the exposure chambers for 30 minutes and then underwent a 250µl 
blood draw while conscious and unrestrained within the chamber.  This served as the 
baseline blood sample. Nitrogen was metered into the chamber to reduce the FIO2 to 10%, 
and a second 250µl blood sample was taken after the FIO2 stabilized at 10%.   The addition 
of N2 was discontinued, and a final 250µl blood sample was taken 15 minutes after the 
oxygen content of the chamber stabilized at an FIO2 of 20%. For each blood draw, the pin 
was removed from the tip of the catheter, and the heparin was allowed to exit the catheter.  
When only blood remained, a 23-gauge adapter attached to a 1 ml syringe was placed on the 
end of the catheter and used to draw a 250µl sample.  The blood sample was immediately 
read on an OPTI CCA-TS Blood Analyzer (OPTI Medical Systems, Inc.) using the OPTI 
Cassette E-Ca which measures blood pH, PCO2, PO2, Na
+
, K
+
, Ca
2+
, total hemoglobin (tHb), 
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oxygen saturation (SaO2), and hematocrit (Hct).  The catheter was flushed with saline and 
locked with heparin after each blood draw.  
 
Whole-body Plethysmograph Data Acquisition and Analysis 
All exposures were performed in whole-body plethysmography chambers (Buxco 
Electronics, Sharon, CT).  The plethysmography methodology permitted continuous 
monitoring of breathing frequency, tidal volume, minute volume, inspiratory time and 
expiratory time. Animals were acclimated to plethysmographs for 1 hour each day on the two 
days prior to exposure before both air and acrolein exposure.  Plethysmography chambers 
(model PLY3213; Buxco Electronics) were calibrated each day before every animal loading.  
A bias flow regulator delivered fresh air (1.8 L/min) to each cylindrical chamber, preventing 
CO2 buildup within the chamber. Unrestrained animals were placed in individual cylindrical 
plethysmograph boxes containing a built-in reference chamber for measuring respiration-
induced pressure fluctuations. Data were channeled to computer software (BioSystem XA; 
Buxco Electronics) that calculated respiratory parameters.  Data were collected continuously 
for each parameter, and automated breath-by-breath analyses were performed using a 
rejection algorithm to eliminate breaths that were outside a given range.  On exposure day, 
animals were acclimated to the chambers for 30 minutes before any readings were taken.  
After acclimation, 30 minutes of baseline data were taken, and animals were exposed to 
either control air or 3ppm acrolein for 3 hours.  After exposure, rats were removed and 
returned to home-cages. 
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Radiotelemetry Data Acquisition  
Radiotelemetry methodology (Data Sciences International, Inc.) enabled constant 
monitoring of ECG data in unrestrained, un-anesthetized rats from implantation until 
euthanasia. Remote receivers (DataART3.01; Data Sciences International, Inc.) positioned 
under the home cages, and under the plethysmographs during exposure collected the ECG 
data and transferred it to the computer for storage.  In home cages, sixty-second segments of 
ECG waveforms were acquired and saved at 15-minute intervals from surgical recovery 
through euthanasia not including the exposure period.   Pre-exposure baseline data were 
collected from home cages, as well as a 30 min baseline in exposure cages after a 30 min 
acclimation period.  During the 3 hr exposure, sixty-second segments were acquired and 
saved at 5-minute intervals.  After exposure, rats were monitored in home cages until 
euthanasia, approximately 18 hrs after the end of the final hypoxia challenge.  HR and BP 
were automatically obtained from the ECG and BP waveforms, respectively, with data 
acquisition software (DataART3.01; Data Sciences International, Inc.). 
 
Electrocardiogram, Arrhythmia Identification and Heart Rate Variability (HRV) Analysis  
ECGAuto software (EMKA Technologies, Falls Church, VA) was used
 
for automated 
analyses of ECG wave amplitudes and segment durations
 
and areas, as well as for the visual 
identification and enumeration
 
of cardiac arrhythmias.  Several parameters were determined 
for each ECG waveform: PR
 
interval; R amplitude and duration; QRS area; ST interval, 
amplitude,
 
and area; and T-wave amplitude and
 
area; QT interval, and heart
 
rate-corrected QT 
interval (QTc).  ECG parameters during
 
exposure were analyzed in terms of baseline (30 min 
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recordings
 
while in the exposure chambers immediately before the beginning
 
of exposure) 
and Hours 1–3 (constituting the entire exposure period between 8:00 AM and 11:00 AM). 
Cardiac arrhythmic events were identified in part by using the Lambeth conventions 
(Walker et al., 1988) as a guideline for the identification of arrhythmias in rats.  Arrhythmias 
were identified as atrial premature beats (APB), ventricular premature beats (VPB), sinoatrial 
blocks (SAB), atrioventricular blocks (AVB), or ventricular tachycardia (VT). Arrhythmias 
were quantified, counted and totaled over an 18 hour period prior to exposure (this 
corresponded to the same times assessed after exposure), during the 4 hour exposure period, 
or during the 18 hour period beginning immediately after exposure. Total arrhythmia counts 
during exposure were quantified (total of 48 two-minute segments during 3 h exposure 
period) and expressed as counts per minute. 
For the analysis of HRV, thorough visual inspection was conducted
 
to identify and 
exclude arrhythmias, artifacts, and 1-min
 
ECG waveforms lacking distinguishable R waves 
for more than
 
30 sec. The analysis of HRV generated heart rate (HR) and
 
time-domain 
measures, including mean time between adjacent QRS
 
complex peaks (the RR interval), a 
standard deviation of the
 
RR interval (SDNN), SDNN normalized for the effects of heart
 
rate 
[SDNN/(RR interval x 100)], and the square root of the mean of
 
squared differences of 
adjacent RR intervals (RMSSD).  The SDNN represents overall HRV, whereas
 
RMSSD 
represents parasympathetic influence over HR. The
 
analysis of HRV also calculated 
frequency domain parameters,
 
particularly low frequency (LF) and high frequency (HF), and
 
the ratio of these two frequency domains (LF/HF). LF is generally
 
believed to represent a 
mixture of sympathetic and parasympathetic tone, whereas HF indicates cardiac 
parasympathetic (vagal)
 
tone, and LF/HF serves as an index of sympathovagal balance. 
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Statistics  
The statistical analyses of the Buxco, ECG and HRV data in this study used SAS 
version 9.2 software (SAS Institute Inc, Cary NC).  We used PROC MIXED of SAS since it 
offers greater flexibility for the modeling of repeated measures data than PROC GLM. It is 
also suitable for analysis of large, unbalanced data with missing data at random. A linear 
mixed model with restricted maximum-likelihood estimation analysis,  least squares means 
and repeated measures ANOVA was used to determine which TIME*TRT  interactions were 
statistically significant between baseline and exposure. Multiple comparison adjustment for 
the p values and confidence limits for the differences between the least squares means was 
done using adjust=Tukey HSD (Honest Significant Difference) test. All blood gas data were 
analyzed using GraphPad Prism (GraphPad Software, Inc., La Jolla, CA) with a one-way 
analysis of variance (ANOVA) model examining the main effects of each model. All strain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
comparisons were performed using GraphPad Prism (GraphPad Software, Inc., La Jolla, CA) 
with a student t-test. Trend analysis of SDNN data during exposure and HR data during 
hypoxia challenge was performed using GraphPad Prism (GraphPad Software, Inc., La Jolla, 
CA) with a one-way ANOVA followed by a post-hoc test for linear trend between mean and 
column number. P < 0.05 was considered statistically significant. 
 
Results 
Effect of Acrolein on Heart Rate, Blood Pressure, and Heart Rate Variability 
 Heart rates increased in SH rats during all three hours of acrolein exposure (Fig. 
3.1A).  At hour 1, mean heart rates increased from baseline levels of 294.4 ± 5.4 beats per 
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minute (bpm) to 313.3 ± 15.3 bpm.  At hour 2, mean heart rates increased from baseline 
levels of 269.2 ± 3.9 bpm to 297.7 ± 16.0 bpm.  At hour 3, mean heart rates increased from 
baseline levels of 274.1 ± 6.7 bpm to 305 ± 16.7 bpm.  When each acrolein exposed rat is 
compared to itself during air exposure these changes constituted a 10.3 ± 4.22% increase 
from air at hour 1, a 10.8 ± 4.57% increase from air at hour 2 and a 14.6 ± 3.17% increase 
from air at hour 3 (p<0.05; Fig. 3.1A). Heart rate did not change in WKY rats during acrolein 
exposure.  
Before exposures commenced, the baseline BP values for all rats were calculated and 
it was determined that SH rats had an average of 44 mmHg higher baseline mean arterial 
blood pressure level than WKY rats (162.46 ± 3.71 mmHg v. 118.57 ± 4.26 mmHg, 
respectively), consistent with their hypertensive phenotype.  Mean arterial blood pressure 
increased during hour 2 of acrolein exposure in SH rats and during hour 3 of acrolein 
exposure in both SH and WKY rats (Fig. 3.1B).  In SH rats, mean arterial blood pressure 
increased from baseline levels of 150.20 ± 2.35 mmHg to 169.65 ± 4.04 mmHg at hour 2, 
constituting a 15.19 ± 2.51% increase from air (p<0.05; Fig. 3.1B).  At hour 3, mean arterial 
blood pressure increased from baseline levels of 154.14 ± 2.07 mmHg to 189.32 ± 4.06 
mmHg, constituting a 23.67 ± 2.79% increase from air in SH rats (p<0.05; Fig. 3.1B).  The 
increases in mean arterial blood pressure at hour 3 were accompanied by 22.86 ± 3.38% and 
23.31 ± 3.30% increases in systolic and diastolic blood pressure, respectively. In WKY rats, 
blood pressure significantly increased from baseline levels of 120.15 ± 2.74 mmHg to 130.24 
± 5.38 mmHg at hour 3, constituting a 14.44 ± 2.55% increase from air (p<0.05; Fig. 3.1B). 
SH rats also had a significant increase in the low frequency (LF) heart rate variability 
parameter during hour 3 of acrolein exposure (Fig. IC).  LF increased from baseline levels of 
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1.55 ± 0.37 ms
2
 to 3.07 ± 0.51 ms
2
, constituting a 109.39 ± 29.74% increase from air 
(p<0.05; Fig. 3.1C).  In addition, SH rats had a non-significant decrease in SDNN during all 
hours of acrolein exposure, but there was a significant trend in the data (p = 0.0275; r
2
 = 
0.2076) (Fig. 3.1D). There were no significant changes in RMSSD, HF, and LF/HF in SH 
rats, and there were no significant changes in any HRV parameter in WKY rats. 
 
Ventilatory Changes during Acrolein Exposure 
 SH rats had a significant increase in breathing frequency and minute volume in the 
third hour of acrolein exposure (Fig. 3.2A,B).  Breathing frequency increased from baseline 
levels of 101.33 ± 8.86 breaths per minute at baseline to 122.95 ± 12.96 breaths per minute at 
hour 3, constituting a 34 ± 8.61% increase from air (p<0.05; Fig. 3.2A).  Minute volume 
increased from 149.87 ± 11.4 ml at baseline to 181.4 ± 20.85 ml at hour 3 of acrolein 
exposure, constituting an increase of 25 ± 4.27% from air (p<0.05; Fig. 3.2B).  There were 
no significant changes in ventilatory parameters during acrolein exposure in WKY rats. 
 
Electrocardiographic Changes and Arrhythmogenesis during Acrolein Exposure 
 There were no significant changes in PR interval, QRS interval or area, ST or T wave 
area in SH and WKY rats exposed to acrolein (Supplementary Table 3.1).  WKY rats did 
have a significant increase in the ST segment, but this change occurred during exposure to air 
and is not related to acrolein exposure (Supplementary Table 3.1). There were no significant 
changes in ECG, HRV or arrhythmia after either hypoxia challenge. There were no 
significant changes in the frequency of spontaneous arrhythmia during or after acrolein 
exposure. 
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Validation of the Hypoxia Stress Test 
 All data for hypoxia validation is presented in Table 3.1.  A separate cohort of SH and 
WKY rats implanted with femoral artery catheters underwent the hypoxia stress test and 
blood samples were analyzed before exposure to the 10% chamber O2 atmosphere, during 
exposure to the 10% chamber O2 atmosphere, and after the return to normal 20% chamber O2 
concentration.   Exposure to 10% chamber O2 atmosphere caused decreases in pO2, pCO2, 
and arterial blood O2 saturation in both strains of rats. In SH rats, pO2 levels decreased from 
98.6 ± 2.42 mmHg at baseline to 50.20 ± 1.71 mmHg during exposure to 10% chamber O2 
and increased again to 94.60 ± 4.53 mmHg after O2 levels were returned to 20% (p<0.05; 
Table 3.1).  In WKY rats, pO2 levels decreased from 99.80 ± 5.16 mmHg at baseline to 54.80 
± 2.60 mmHg during exposure to 10% chamber O2 and increased again to 95.40 ± 1.89 
mmHg after O2 levels were returned to 20% (p<0.05; Table 3.1).  
In SH rats, pCO2 levels decreased from 37.00 ± 1.00 mmHg at baseline to 31.00 ± 
0.84 mmHg during exposure to 10% chamber O2 and increased again to 38.20 ± 1.80 mmHg 
after O2 levels were returned to 20% (p<0.05; Table 3.1).  In WKY rats, pCO2 levels 
decreased from 41.40 ± 2.86 mmHg at baseline to 28.60 ± 1.25 mmHg during exposure to 
10% chamber O2 and increased again to 41.80 ± 1.80 mmHg after oxygen levels were 
returned to 20% (p<0.05; Table 3.1). 
In SH rats, SaO2 levels decreased from 93.60 ± 0.51% at baseline to 79.40 ± 0.68% 
during exposure to 10% chamber O2 and increased again to 94.20 ± 0.37% after O2 levels 
were returned to 20% (p<0.05; Table 3.1).  In WKY rats, O2 saturation levels decreased from 
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94.60 ± 0.68% at baseline to 82.40 ± 0.68% during exposure to 10% chamber O2 and 
increased again to 93.40 ± 0.40% after O2 levels were returned to 20% (p<0.05; Table 3.1). 
 
Blood Pressure and Heart Rate Changes during Hypoxia Stress Test 
 Hypoxia stress test was initially performed 24 hours after a 3 hr exposure to air.  The 
10% chamber O2 concentration caused similar increases in heart rate in both the SH and 
WKY rats during the hypoxia period but did not affect systolic blood pressure in either strain 
(data not shown). 
Hypoxia stress test after acrolein exposure caused a significant increase in diastolic 
blood pressure during exposure to 10% chamber O2 in SH rats (p<0.05; Fig. 3.4A).  Diastolic 
blood pressure increased from 124.99 ± 5.16 mmHg at baseline to 135.99 ± 2.51 mmHg 
during exposure to 10% chamber O2, constituting a 12.11 ± 2.23% increase from air (p<0.05; 
Fig. 3.4A).  The hypoxia stress test caused a non-significant decrease in heart rate during the 
descend period, the time during which chamber O2 saturation decreases from 20% to 10%, in 
the SH rat and a non-significant increase in heart rate during exposure to 10% chamber O2 in 
WKY rats (Fig. 3.4B).  In addition, SH rats displayed a higher baseline blood pressure than 
WKY rats during the entire hypoxia stress test. 
 
Respiratory Changes during Hypoxia Stress Test 
 Hypoxia stress test following air exposure increased breathing frequency and minute 
volume in SH and WKY rats during the descent and hypoxia period of the stress test and 
decreased expiratory time in SH and WKY rats during the descend period (data not shown).  
The magnitudes of these changes were similar between the two strains. 
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WKY rats, but not SH rats, showed significant increases in minute volume and 
expiratory time during hypoxia stress test performed after acrolein exposure.  Minute volume 
increased from baseline levels of 125.00 ± 11.74 ml to 187.36 ± 9.49 ml, constituting a 57.93 
± 23.8% increase from air (p<0.05; Fig. 3.5A).  Expiratory time increased from baseline 
levels of 0.30 ± 0.02 sec to 0.72 ± 0.03 sec, constituting a 130.02 ± 31.60% change from air 
during the ascend period (p<0.05; Fig. 3.5B). 
 
Arrhythmogenesis, Electrocardiographic and Heart Rate Variability Changes during 
Hypoxia Stress Test 
 There were no significant changes in frequency of spontaneous arrhythmia, 
electrocardiographic or heart rate variability parameters during the hypoxia stress test after 
acrolein exposure in SH or WKY rats (Supplementary Table 3.2 and 3.3, respectively).  
 
Discussion 
 The current study demonstrates that acrolein exposure alone increases heart rate, 
mean arterial blood pressure, breathing frequency, and minute volume in the hypertensive SH 
rat, with limited effects in the normotensive WKY rat.  The cardiovascular responses in the 
SH rat during acrolein exposure were coupled with increases in the heart rate variability 
(HRV) parameter LF indicative of altered autonomic tone.  The hypoxia stress test performed 
after acrolein exposure revealed additional strain-dependent cardiopulmonary responses 
including increased diastolic blood pressure only in the SH rat and increased minute volume 
and expiratory time only in WKY rats. 
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The increases in HR and BP during acrolein exposure in the hypertensive rat may be 
related to altered autonomic tone during exposure.  While chronic exposure to acrolein in 
mice has been linked to left ventricular dilation (Ismahil et al., 2011) and progression of 
atherosclerosis (Srivastava et al., 2011), acute exposure to 3 ppm acrolein in this study 
caused significant increases in HR in SH rats during all 3 hours of exposure.   This was 
accompanied by increases in BP and the LF component of HRV and, although not 
statistically significant, a decrease in SDNN.  These findings are consistent with elevated 
sympathetic tone.  Increased sympathetic tone coupled with decreased heart rate variability is 
associated with an elevated risk of heart disease (Pope et al., 2001).  While the implications 
of these changes in rats are unclear, similar changes in humans are consistent with elevated 
sympathetic tone. In addition, intravenous injection of acrolein causes significant increases in 
blood pressure that are reversed with guanethidine, a sympatholytic drug (Green and Egle, 
1983). Despite these findings, there were no significant changes in LF/HF, a measure of 
sympathetic and parasympathetic balance.  Furthermore, LF alone may not be a reliable 
indicator of sympathetic tone and may instead reflect an interaction of the sympathetic and 
parasympathetic nervous systems (Houle and Billman, 1999).  Thus, further work is required 
to confirm linkages with altered autonomic tone.  Although WKY rats had a significant 
increase in BP in the third hour of acrolein exposure, this response was not accompanied by 
increases in HR or any significant changes in HRV. 
The hypoxia stress test revealed exaggerated cardiovascular sensitivity, characterized 
by increased diastolic blood pressure, only in acrolein-exposed SH rats.  This response may 
be due to increased vascular resistance, as in vivo acrolein exposure in SH rats has been 
shown to increase ex vivo aortic reactivity (Conklin et al., 2006). Hypoxia has been shown to 
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heighten sympathetic activation in healthy men during periods of submaximal exercise (Al 
Haddad et al., 2012).  In addition, chronic intermittent hypoxia has been shown to increase 
arterial blood pressure and impair vasodilation through increased levels of angiotensin II 
(Marcus et al., 2012).  Carotid body-mediated sensation of low blood oxygen saturation 
levels triggers reflex cardiovascular responses including tachycardia, hypertension, and 
increased cardiac output (Downing et al., 1962).  SH rats have larger carotid bodies (Habeck 
et al., 1985) and are more sensitive to the effects of hypoxia as evidenced by increased 
carotid sinus nerve activity and intracellular Ca
2+
 changes (Weil et al., 1998).  Thus, 
differential carotid body sensitivity may in part underlie the differences in responses to 
acrolein and hypoxia in normotensive and hypertensive rats.  Recent work by Wang et al. 
(2012) demonstrated that particulate matter exposure-induced cardiac arrhythmias in mice 
with heart failure were in part due to dysregulation of carotid body sensitivity.  Further 
research is required to examine the impact of carotid body sensitivity and the potential effects 
of air pollutant exposure on carotid body-mediated cardiovascular responses.  Although the 
ventilatory responses to hypoxia after the mock air exposure were similar in SH and WKY 
rats, only WKY rats exposed to acrolein had significant increases in minute volume and 
expiratory time during the hypoxia stress test. It is unclear exactly why these ventilatory 
responses occurred only in WKY and not SH rats, but it may relate to the increased 
respiratory sensitivity to air pollutant inhalation in the SH rat compared to the WKY rat. 
Previous studies have shown that SH rats respond with greater airway inflammation and 
injury after air pollution exposure than WKY rats, and underlying susceptibility in the SH rat 
may result in the nerve fibers being overloaded and unable to illicit a normal response to 
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acrolein. An acrolein-induced airway lesion in the SH rat may have precluded a normal 
ventilatory response to hypoxia during the hypoxia stress test (Leikauf et al., 1989). 
These findings demonstrate that the hypoxia stress test is a novel approach to reveal 
latent responses to air pollutants.  Researchers are becoming increasingly interested in latent 
responses to air pollution exposure, and stress tests provide a useful model to study latent 
effects that would be missed in an acute exposure setting.  Traditionally, epidemiological 
studies have estimated morbidity and mortality within 24 hours of air pollution events.  
Although this time frame reveals significant increases in cardiovascular events after air 
pollution exposure, it may miss equally severe delayed responses that can occur up to 3 days 
(Faustini et al., 2011) and even 2 weeks after exposure (Goodman et al., 2004).  Several 
stress tests have been used to determine enhanced sensitivity to air pollutants including 
exercise stress test in humans (Gold et al., 2005), dobutamine stress test in rats (Hazari et al., 
2012) and isoproterenol cardiac stress test in rats (Andre et al., 2011).  Intermittent hypoxia 
has been used to model nocturnal desaturation in sleep apnea patients (Norton et al., 2011).  
We designed a new hypoxia stress test with one prolonged (10 min) acute session of hypoxia 
followed by a return to normoxic conditions.  The effects of the 10% O2 atmosphere were 
validated by measuring blood O2 saturation in arterial blood drawn before, during and after 
hypoxia challenge.  Arterial O2 saturation, pO2 and pCO2 decreased significantly during 
hypoxia in both strains of rats.  In addition, pH was not significantly affected by hypoxia 
challenge, demonstrating that the rat completely compensates for the drop in pCO2, 
suggesting that the effects are not due to metabolic acidosis.  Normal pO2 levels in humans 
range from 80-100 mmHg, and a drop in partial pressure below 60 mmHg is required for 
hypoxemia.  Normal pCO2 levels in the human range from 35-45 mmHg and the hypoxia 
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stress test reduced pCO2 levels well below this level.  While the stress test was used in this 
context to examine susceptibility after air pollution exposure, the data suggest that it can 
easily be applied to different models to examine overall cardiovascular sensitivity.  
The exaggerated effects of acrolein in the SH rats in this study are consistent with our 
previous studies with other air pollutants indicating enhanced sensitivity in this strain (Farraj 
et al., 2011; Lamb et al., 2012).  In this study, SH rats had an average of 44 mmHg higher 
blood pressure than WKY rats.  It has long been known that hypertension increases the risk 
of cardiovascular disease and stroke (Brook et al., 2010). In addition to higher baseline blood 
pressure, SH rats have increased arterial wall thickness (Mulvany and Halpern, 1977) and 
undergo left ventricular remodeling characterized by hypertrophy, fibrosis, and changes in 
membrane channels, cellular energetics and ion regulation that combine to heighten 
myocardial sensitivity (Bernardo et al., 2010).  SH rats were not only more susceptible to HR 
and BP increases during acrolein exposure, they also had significant increases in breathing 
frequency and minute volume in the third hour of exposure.  Previous studies have found that 
acrolein, like other pulmonary irritants, causes decreases in respiratory rate (Hazari et al., 
2008). It is unclear why SH rats had increased breathing frequency at hour 3 of acrolein 
exposure, but it’s possible that these responses were secondary to the significant increases in 
HR and BP that were initiated during hours 1 and 2 of acrolein exposure.  Minute volume 
tends to increase with exercise or stress, and it has been shown to increase with acrolein 
exposures (Linhart et al., 1996).  Taken together, the results demonstrate that the SH rat has 
increased susceptibility to the adverse effects of acrolein exposure including cardiovascular 
effects that appear directly and immediately as well as a priming effects through homeostatic 
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control pathways perhaps involving autonomic reflexes that set the stage for latent 
responsiveness to various stimuli. 
The present findings demonstrate that acrolein-induced cardiovascular responses may 
result from modulation of autonomic tone, specifically increased sympathetic input to the 
heart. These findings also highlight the utility of the hypoxia stress test as a tool to unmask 
the potential for latent effects of air pollution via less appreciated mechanisms that mediate 
cardiovascular dysfunction associated with exposure to air pollution.  To further examine the 
utility of this hypoxia stress test, we will assess the effects of exposure to other gaseous and 
particulate air pollutants (e.g., ozone and diesel exhaust) in future studies. Finally, the results 
further show that pre-existing cardiovascular disease confers exaggerated sensitivity to the 
effects of a model irritant, acrolein, that are consistent with the temporal relationship between 
exposure and clinical outcomes observed in epidemiologic studies showing “delayed or 
latent” outcomes of air pollutant exposures 
 
Supplementary Data Description 
 Supplementary data includes the average of electrocardiographic parameters in SH 
and WKY rats during acrolein exposure (Supplementary Table 3.1) and the hypoxia stress 
test (Supplementary Table 3.2) as well as the average of heart rate variability parameters in 
during the hypoxia stress test (Supplementary Table 3.3).  
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Table 3.1. Arterial blood parameters during the hypoxia stress test. The hypoxia stress 
test successfully decreases pO2, pCO2 and blood oxygen saturation (SaO2) in arterial blood in 
SH and WKY rats. pH and K
+
 concentrations are also reported. Means and standard errors 
are reported. Significant differences (p < 0.05) are denoted with a *. 
Exposure Timing pO2 
(mmHg) 
pCO2 
(mmHg) 
SaO2 
(%) 
pH K
+ 
(mmol/L) 
SH Rat Baseline 98.60 ± 2.42 37.00 ± 
1.00 
93.60 ± 
0.51 
7.31 ± 
0.033 
7.66 ± 
1.10 
 10% 
Chamber O2  
50.20 ± 
1.71* 
31.00 ± 
0.84* 
79.40 ± 
0.68* 
7.47 ± 
0.044 
7.36 ± 
0.81 
 20% 
Chamber O2  
94.60 ± 4.53 38.20 ± 
1.80 
94.20 ± 
0.37 
7.39 ± 
0.048 
6.70 ± 
0.72 
WKY Rat
 Baseline 99.80 ± 5.16 41.40 ± 
2.86 
94.60 ± 
0.68 
7.41 ± 
0.045 
5.70 ± 
0.49 
 10% 
Chamber O2  
54.80 ± 
2.60* 
28.60 ± 
1.25* 
82.40 ± 
0.68* 
7.43 ± 
0.070 
5.80 ± 
0.87 
 20% 
Chamber O2  
95.40 ± 1.89 41.80 ± 
1.80 
93.40 ± 
0.40 
7.40 ± 
0.023 
5.76 ± 
0.69 
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Figure 3.1. Acrolein exposure causes increases in heart rate, mean arterial blood pressure, 
and the low frequency component of heart rate variability in SH rats. Panels A, B, C and D 
relate to heart rate, blood pressure, low frequency and SDNN values at baseline and all three 
hours of acrolein exposure, respectively. Panels A, B, C and D are presented as % change 
from air. Percent change baseline values are compared to the average % change values 
during each hour of exposure. Means and standard errors are reported. Significant differences 
from baseline percent change values (p < 0.05) are denoted with a *. Significant differences 
(p < 0.05) between SH and WKY strains at each hour are denoted with a #. There was a 
significant trend in the SDNN data (p = 0.0275; r
2 
= 0.2076) 
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Figure 3.2. Acrolein exposure causes significant increases in breathing frequency and minute  
volume in SH rats. Panels A and B relate to breathing frequency and minute volume, 
respectively,  measured at baseline, 1, 2 and 3 hours during acrolein exposure. All values are 
presented as % change from air. Percent change baseline values are compared to the average 
% change values during each hour of exposure. Significant differences from baseline percent 
change values (p < 0.05) are denoted with a *. Significant differences (p < 0.05) between SH 
and WKY strains at each hour are denoted with a #.  
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Figure 3.3. A novel hypoxia stress test may reveal latent sensitivity to a gaseous pollutant. 
Panel A describes the experimental design for the study. Rats were exposed to air for 3 hours 
on day 1 and underwent a hypoxia stress test 24 hours after air exposure. These same rats 
were given a 5 day wash out period and then exposed to 3ppm acrolein for 3 hours followed 
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by a hypoxia stress test 24 hours after acrolein exposure. The hypoxia stress test consists of a 
30 min baseline, the descend period (time it takes for oxygen saturation to decrease form 
20% to 10%, a 10 min hypoxia period (10% oxygen saturation, an ascend period (time it 
takes for oxygen saturation to increase from 10% to 20% and a 15 min period after the return 
to normal oxygen saturation (20%). Panel B represent the hypoxia stress test experimental 
setup. The rat is placed in a Buxco plethysmograph that sits over a radiotelemetry receiver. 
Ventilatory, ECG, HR, and BP data is captured during the entire stress test. For hypoxia, 
nitrogen in metered into the plethysmograph and an oxygen sensor attached to the 
plethysmograph records oxygen saturation in real-time.   
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Figure 3.4. Hypoxia stress test after acrolein exposure causes significant increases in 
diastolic blood pressure in SH rats. Panel A and B refer to diastolic blood pressure and heart 
rate, respectively, measured at baseline, the descend period, 10% hypoxia, the ascend period 
and the return to 20% oxygen saturation. All values are presented as % change from hypoxia 
challenge after air exposure. Percent change baseline values are compared to the average % 
change values during the different segments of the hypoxia challenge. Means and standard 
errors are reported. Significant differences from baseline percent change values (p < 0.05) are 
denoted with a *. Significant differences (p < 0.05) between SH and WKY strains at each 
hour are denoted with an #.   
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Figure 3.5. Hypoxia stress test after acrolein exposure causes significant increases in minute 
volume and expiratory time in WKY rats. Panels A and B relate to minute volume and 
expiratory time, respectively, measured at baseline, the descend period, 10% hypoxia, the 
ascend period and the return to 20% oxygen saturation. All values are presented as % change 
from hypoxia challenge after air exposure. Percent change baseline values are compared to 
the average % change values during the different segments of the hypoxia challenge. Means 
and standard errors are reported. Significant differences from baseline percent change values 
(p < 0.05) are denoted with a *. Significant differences (p < 0.05) between SH and WKY 
strains at each hour are denoted with a #.  
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Supplementary Data 
 
Supplementary Table 3.1. 3 hour average of electrocardiographic parameters in 
Spontaneously Hypertensive and Wistar Kyoto rats during acrolein exposure. * denotes a 
significant change from baseline (p < 0.05). Values represent means ± standard error.  
Exposure Timing PR 
Interval 
(ms) 
QRS 
Interval 
(ms) 
QTcB 
(ms) 
ST 
Level 
(mV) 
ST 
Element 
(mV) 
QRS 
Area 
(mV 
x 
Time) 
Negative 
ST Area  
(mV x 
sec) 
T 
Wave 
Area 
(mV 
x sec) 
SH Rat  
Air 
Baseline 47.53 ± 
0.44 
32.27 ± 
1.63 
85.62 
± 2.20 
-
0.055 
± 
0.01 
-0.031 ± 
0.01 
1.67 ±  
0.27 
-0.82 ± 
0.12 
0.98 
±  
0.15 
 Exposure 47.97 ± 
0.49 
37.04 ± 
2.68 
80.81 
± 0.83 
-
0.052 
± 
0.01 
-0.031 ± 
0.01 
1.93 ±  
0.33 
-0.82 ± 
0.12 
0.97 
±  
0.12 
SH Rat 
Acrolein
 
Baseline 47.13 ± 
0.67 
36.41 ± 
2.60 
88.06 
± 0.71 
-0.06 
± 
0.01 
-0.04 ± 
0.01 
1.93 ±  
0.30 
-0.90 ± 
0.13 
0.93 
±  
0.30 
 Exposure 48.09 ± 
0.90 
39.34 ± 
3.79 
88.84 
± 2.41 
-0.05 
± 
0.28 
-0.03 ± 
0.01 
2.27 ±  
0.43 
-0.82 ± 
0.09 
1.17 
±  
0.08 
WKY 
Rat Air 
Baseline 46.46 ± 
1.57 
26.78 ± 
3.98 
64.57 
± 1.85 
-0.03 
± 
0.02 
0.0002 ± 
0.02 
1.28 ±  
0.27 
-0.63 ± 
0.19 
2.50 
±  
0.60 
 Exposure 47.99 ± 
1.35 
25.08 ± 
1.67 
63.45 
± 1.56 
-0.02 
± 
0.01 
0.01 ± 
0.01* 
1.11 ±  
0.20 
-0.46 ± 
0.13 
2.39 
± 
0.37 
WKY 
Rat 
Acrolein 
Baseline 45.86 ± 
1.38 
23.84 ± 
0.77 
63.79 
± 2.70 
-
0.027 
± 
0.01 
0.01 ± 
0.01 
1.21 ±  
0.23 
-0.46 ± 
0.11 
2.41 
±  
0.55 
 Exposure 47.79 ± 
1.38 
27.83 ± 
3.96 
63.45 
± 1.49 
-0.02 
± 
0.01 
0.01 ± 
0.01 
1.40 ±  
0.20 
-0.43 ± 
0.11 
2.17 
±  
0.38 
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Supplementary Table 3.2. Average of electrocardiographic parameters in Spontaneously 
Hypertensive and Wistar Kyoto rats during the hypoxia stress test. * denotes a significant 
change from baseline (p < 0.05). Values represent means ± standard error.  
Exposure Timing PR 
Interval 
(ms) 
QRS 
Interval 
(ms) 
QTcB 
(ms) 
ST 
Level 
(mV) 
ST 
Amplitud
e 
(mV) 
QRS 
Area 
(mV x 
Time) 
Negative 
ST Area  
(mV x 
sec) 
T 
Wave 
Area 
(mV x 
sec) 
SH Rat 
Air 
Baseline 46.54 ± 
0.31 
33.33 ± 
1.75 
83.25 
± 1.04 
-0.05 
± 0.01 
-0.03 ± 
0.01 
1.59 ± 
0.23 
-0.72 ± 
0.10 
1.13 ± 
0.15 
 Descend 47.35 ± 
0.56 
33.08 ± 
1.41 
89.17 
± 2.23 
-0.05 
± 0.01 
-0.03 ± 
0.01 
1.76 ± 
0.30 
-0.80 ± 
0.12 
1.11 ± 
0.17 
 10% O2 48.67 ± 
1.00 
33.05 ± 
1.85 
87.97 
± 2.37 
-0.06 
± 0.01 
-0.03 ± 
0.01 
1.67 ±  
0.27 
-0.83 ± 
0.12 
1.23 ±  
0.17 
 Ascend 48.43 ± 
0.80 
31.24 ± 
1.70 
83.91 
± 2.55 
-0.04 
± 0.01 
-0.02 ± 
0.004 
1.44 ±  
0.29 
-0.63 ± 
0.08 
0.95 ±  
0.11 
 20% O2 47.48 ± 
0.54 
33.13 ± 
3.32 
82.81 
± 2.53 
-0.05 
± 0.01 
-0.02 ± 
0.01 
1.79 ±  
0.38 
-0.69 ± 
0.10 
1.24 ±  
0.30 
SH Rat 
Acrolein
 
Baseline 47.41 ± 
0.83 
34.78 ± 
1.55 
88.27 
± 1.13 
-0.07 
± 0.01 
-0.04 ± 
0.01 
2.25 ± 
0.43 
2.40 ± 
0.56 
1.12 ± 
0.17 
 Descend 47.70 ± 
0.53 
36.88 ± 
1.67 
92.26 
± 1.79 
-0.07 
± 0.01 
-0.05 ± 
0.01 
2.46 ± 
0.33 
1.99 ± 
0.38 
0.87 ± 
0.08 
 10% O2 
 
48.73 ± 
0.97 
36.49 ± 
2.85 
92.26 
± 2.58 
-0.06 
± 0.01 
-0.04 ± 
0.01 
2.36 ±  
0.54 
2.40 ± 
0.52 
1.07 ±  
0.12 
 Ascend 
 
49.40 ± 
0.94 
35.08 ± 
2.20 
90.10 
± 2.39 
-0.05 
± 0.01 
-0.03 ± 
0.01 
2.04 ±  
0.38 
2.54 ± 
0.65 
1.29 ±  
0.09 
 20% O2 
 
48.41 ± 
0.71 
37.43 ± 
3.83 
86.18 
± 1.41 
-0.06 
± 0.01 
-0.03 ± 
0.01 
2.22 ±  
0.45 
2.73 ± 
0.60  
1.30 ± 
 0.20 
WKY 
Rat Air 
Baseline 47.25 ± 
1.20 
24.92 ± 
1.06 
65.76 
± 1.50 
-0.03 
± 0.01 
-0.003 ± 
0.01 
1.18 ± 
0.20 
-0.54 ± 
0.10 
1.80 ± 
0.42 
 Descend 47.79 ± 
1.06 
23.18 ± 
1.13 
67.30 
± 1.97 
-0.02 
± 0.01 
0.01 ± 0.01 0.91 ± 
0.24 
-0.45 ± 
0.16 
2.14 ± 
0.30 
 10% O2 
 
47.87 ± 
1.46 
24.64 ± 
1.17 
68.37 
± 2.21 
-0.02 
± 0.01 
0.01 ± 0.01 1.12 ±  
0.19 
-0.49 ± 
0.11 
2.42 ±  
0.60 
 Ascend 
 
48.05 ± 
1.46 
23.40 ± 
0.78 
63.57 
± 2.37 
-0.02 
± 0.01 
0.01 ± 0.01 0.99 ±  
0.25 
-0.44 ± 
0.14 
2.47 ±  
0.65 
 20% O2 
 
47.92 ± 
1.52 
22.53 ± 
1.02 
63.58 
± 2.98 
-0.02 
± 0.01 
0.01 ± 0.01 1.17 ±  
0.31 
-0.49 ± 
0.15 
2.69 ±  
0.63 
WKY 
Rat 
Acrolein 
Baseline 46.67 ± 
1.51 
23.99 ± 
0.85 
65.34 
± 1.34 
-0.027 
± 0.01 
0.01 ± 0.01 1.13 ± 
0.18 
-0.44 ± 
0.12 
2.40 ± 
0.56 
 Descend 47.29 ± 
1.38 
23.32 ± 
1.39 
70.38 
± 1.79 
-0.02 
± 0.01 
0.01 ± 0.01 0.80 ±  
0.12 
-0.40 ± 
0.10 
1.99 ± 
0.38 
 10% O2 
 
48.13 ± 
1.28 
 22.42 ± 
0.69 
68.15 
± 1.92 
-0.02 
± 0.01 
0.02 ± 0.01 0.83 ±  
0.19 
-0.39 ± 
0.12 
2.40 ±  
0.52 
 Ascend 
 
48.10 ± 
1.64 
 23.04 ± 
0.59 
66.28 
± 2.37 
-0.02 
± 0.01 
0.01 ± 0.01 0.99 ±  
0.25 
-0.43 ± 
0.13 
2.47 ±  
0.65 
 20% O2 
 
46.68 ± 
1.40 
23.40 ± 
0.56 
63.06 
± 2.93 
-0.02 
± 0.01 
0.01 ± 0.01 1.39 ±  
0.28 
-0.49 ± 
0.13 
2.69 ±  
0.63 
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Supplementary Table 3.3. Average of heart rate variability parameters in Spontaneously 
Hypertensive and Wistar Kyoto rats during the hypoxia stress test. * denotes a significant 
change from baseline (p < 0.05). Values represent means ± standard error.  
 
Exposure Timing SDNN  
(ms) 
RMSSD 
(ms) 
LF 
(ms
2
) 
HF 
(ms
2
) 
LF/HF 
SH Rat 
Air 
Baseline 8.19 ± 3.34 4.01 ± 0.31 0.94 ± 0.27 2.08 ± 0.38 0.55 ± 0.06 
 Descend 6.52 ± 2.66 3.37 ± 1.38 0.78 ± 0.33 1.83 ± 0.76 0.67 ± 0.04 
 10% O2 6.07 ± 2.48 4.87 ± 0.39 0.94 ± 0.31 2.82 ± 1.02 0.51 ± 0.04 
 Ascend 7.30 ± 2.98 5.21 ± 2.13 1.97 ± 0.54 2.80 ± 0.69 0.52 ± 0.06 
 20% O2 7.65 ± 3.12 4.31 ± 1.76 0.74 ± 0.15 1.96 ± 0.49 0.50 ± 0.03 
SH Rat 
Acrolein
 
Baseline 7.25 ± 0.49 3.52 ± 0.15 0.78 ± 0.19 1.51 ± 0.25 0.49 ± 0.05 
 Descend 5.69 ± 0.57 2.94 ± 0.13 0.59 ± 0.22 1.01 ± 0.32 0.54 ± 0.06 
 10% O2 5.43 ± 0.65 3.98 ± 0.44 0.60 ± 0.23 1.78 ± 0.72 0.52 ± 0.04 
 Ascend 6.56 ± 0.96 3.91 ± 0.34 0.84 ± 0.39 2.15 ± 0.66 0.48 ± 0.06 
 20% O2 7.82 ± 0.67 3.95 ± 0.31 0.92 ± 0.15 1.82 ± 0.28 0.50 ± 0.02 
WKY 
Rat Air 
Baseline 9.90 ± 4.04 4.33 ± 1.77 0.81 ± 0.23 2.04 ± 0.65 0.43 ± 0.04 
 Descend 7.72 ± 1.16 3.32 ± 0.30 0.85 ± 0.20 1.44 ± 0.24 0.52 ± 0.07 
 10% O2 7.46 ± 0.73 4.65 ± 0.85 1.16 ± 0.33 3.04 ± 1.12 0.45 ± 0.08 
 Ascend 6.96 ± 0.44 3.92 ± 0.49 0.78 ± 0.24 1.78 ± 0.54 0.47 ± 0.06 
 20% O2 10.41 ± 4.25 5.37 ± 2.19 1.40 ± 0.53 3.48 ± 1.13 0.44 ± 0.02 
WKY 
Rat 
Acrolein 
Baseline 10.17 ± 0.86 4.34 ± 0.53 1.03 ± 0.23 2.20 ± 0.45 0.45 ± 0.03 
 Descend 8.92 ± 0.85 3.14 ± 0.28 0.43 ± 0.08 0.98 ± 0.19 0.45 ± 0.02 
 10% O2 7.16 ± 0.83  3.46 ± 0.45 0.76 ± 0.21 1.40 ± 0.33 0.53 ± 0.03 
 Ascend 9.29 ± 0.77  5.25 ± 0.71 1.49 ± 0.43 3.50 ± 0.88 0.50 ± 0.04 
 20% O2 10.26 ± 0.75 5.42 ± 0.70 1.10 ± 0.28 3.52 ± 1.09 0.45 ± 0.02 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 4 
 
Acrolein Induced Cardiovascular Dysfunction in Rats is Associated with Reduced Arterial 
Blood Oxygen and is Mediated by the Carotid Body 
 
Exposure to air pollution increases the risk of cardiovascular morbidity and mortality, 
especially in susceptible populations with underlying cardiopulmonary disease. There are 
several postulated mechanisms accounting for adverse responses, including decreases in 
blood oxygen levels following pollutant exposure. Despite several epidemiological studies 
reporting decreases in oxygen saturation following exposure to different environmental 
pollutants, the direct link between air pollution-induced hypoxia and adverse cardiovascular 
effects is not well accepted, and the exact mechanism leading to adverse cardiovascular 
events remains unclear. We hypothesized that exposure to acrolein, an unsaturated aldehyde 
and mucosal irritant found in cigarette smoke, diesel exhaust, and power plant emissions, 
would decrease blood oxygen levels and exert cardiovascular effects through a carotid body 
mediated mechanism. A cohort of Spontaneously Hypertensive (SH) rats implanted with 
radiotelemeters were exposed once for 3 hours to 3 ppm acrolein gas or filtered air with or 
without pharmacological inhibition of the carotid body in whole body plethysmograph 
chambers while another identical cohort implanted with femoral artery catheters underwent 
blood gas analysis before, during, and after acrolein exposure. Acrolein exposure caused 
significant decreases in pO2 and significant increases in pCO2 during exposure. In addition, 
acrolein exposure caused significant increases in mean arterial, systolic, and diastolic blood 
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pressure that were eliminated with carotid body inhibition. These results suggest that 
acrolein-induced cardiac events may be mediated by the carotid body.  
 
Introduction 
Multiple lines of evidence demonstrate that exposure to air pollution increases 
cardiovascular morbidity and mortality (Brook et al., 2010).  Several mechanisms have been 
postulated that overlap among gaseous and particulate pollutants including vascular oxidative 
stress, endothelial/vascular dysfunction, inflammation, and altered autonomic tone (Brook et 
al., 2010; Srebot et al., 2009). Recent epidemiological evidence suggests that a relatively 
unexplored mechanism, systemic hypoxia, may drive some of the adverse cardiovascular 
effects associated with exposure to air pollution. DeMeo et al. (2004) found associations 
between increased PM2.5 levels and decreased oxygen saturation in older individuals with 
cardiopulmonary disease. Pope et al. (1999) found negative associations between PM10 levels 
and blood oxygen saturation in 80-year-old males.  In clinical exposure studies, Gong et al. 
(2004; 2005) found that exposure to concentrated ambient particulates in healthy elderly 
volunteers also caused a drop in blood oxygen saturation.  Despite these associations, a direct 
link between hypoxia and air pollution-induced adverse cardiovascular effects has not been 
established.  
In mammals, the response to systemic hypoxia is controlled by the carotid body, a 
major sensory organ located at the bifurcation of the carotid artery that is responsible for 
sensing changes in arterial blood oxygen levels and initiating reflex cardiopulmonary 
changes to maintain homeostasis. In response to hypoxia, the carotid body triggers reflex 
increases in sympathetic tone that in turn trigger increases in blood pressure (BP), 
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ventilation, heart rate (HR), and arrhythmogenic risk (Roux et al., 2000; Liu et al., 2003; 
Lopez-Barneo et al., 2008).  Repeated cycles of hypoxia, as happens in individuals with 
obstructive sleep apnea, have been shown to cause hypertension (Freet et al., 2013).  
Hypoxia has also been shown to cause atrial fibrillation, AV block, ventricular tachycardia, 
and changes in autonomic balance associated with ventricular arrhythmias (Davies and 
Wedzicha, 1993). Parallels between carotid body-mediated effects and the cardiovascular 
responses associated with air pollution exposure suggest a linkage is plausible. 
We have previously demonstrated that exposure to particulate or gaseous air 
pollutants causes exaggerated cardiovascular effects in rat models of hypertension and heart 
failure (Carll et al., 2012; Farraj et al., 2011; Hazari et al., 2009; Lamb et al., 2012). 
Recently, we found that exposure to acrolein, an unsaturated aldehyde and mucosal irritant 
found in cigarette smoke, diesel exhaust, and power plant emissions, causes apnea (Hazari et 
al., 2008), increases blood pressure (BP) and modifies responses to a physiologic stressor in 
rats (Perez et al., 2013). In addition, Wang et al. (2012) demonstrated that cardiac 
arrhythmias in particulate-exposed heart failure mice were associated with altered carotid 
body sensitivity. These findings suggest that exposure to air pollution may trigger adverse 
cardiovascular responses through a hypoxia-driven mechanism. Hypoxia sensing is 
dependent on the activity of the H2S-generating enzyme cystathionine γ-lyase (CSE) within 
the carotid body (Peng et al., 2010). The purpose of this study was to determine if the 
cardiovascular effects of acrolein inhalation were mediated by hypoxia. We hypothesized 
that 1) exposure to acrolein will cause decreases in blood oxygen levels in hypertensive rats, 
a strain with exaggerated sensitivity to acrolein (Perez et al., 2013) and 2) inhibition of 
carotid body sensing of hypoxia via CSE inhibition will prevent the cardiovascular responses 
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to acrolein exposure. HR, BP, the electrocardiogram, and heart rate variability, an indicator 
of autonomic tone, were monitored before, during, and after exposure.  Arterial blood was 
obtained during acrolein exposure to measure oxygen content and saturation among other 
parameters. In addition, left ventricular pressure, cardiac contractility, and lusitropy were 
assessed one day after acrolein exposure.  
 
Materials and Methods 
Drugs 
Rats in exposure groups including carotid body inhibition were treated with the 
cystathionine γ-lyase enzyme (CSE) inhibitor DL-propargylglycine (PAG) (Sigma; 200 
mg/kg) administered intraperitoneally immediately before exposures. All solutions with 
drugs were prepared fresh before every experiment. Rats not treated with DL-
propargylglycine (PAG) were treated with an equivalent volume of saline administered 
intraperitoneally immediately before exposures. 
 
Animals  
Twelve week-old male Spontaneously Hypertensive (SH) (n = 28) (Charles River, 
Raleigh, NC) were housed in plastic cages (one per cage), maintained on a 12-hr light/dark 
cycle at approximately 22°C and 50% relative humidity in our Association for Assessment 
and Accreditation of Laboratory Animal Care-approved facility, and held for a minimum of 1 
week before exposure. Food (Prolab RMH 3000; PMI Nutrition International, St. Louis, MO) 
and water were provided ad libitum, and all rats were randomized by weight. All rats were 
assigned to one of four treatments groups: air exposure and saline injection; acrolein 
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exposure and saline injection; air exposure and PAG injection; and acrolein exposure and 
PAG injection. After all experiments were performed, rats were deeply anesthetized with an 
intraperitoneal injection of Euthasol (200 mg/kg Na pentobarbital and 25 mg/kg phenytoin; 
Virbac Animal Health, Fort Worth, TX) and euthanized by exsanguination. The Institutional 
Animal Care and Use Committee of the U.S. Environmental Protection Agency (US EPA) 
approved all protocols. 
 
Telemeter Implantation 
Animals were implanted with radiotelemetry transmitters to monitor heart rate (HR), 
blood pressure (BP), and heart rhythms and electrocardiographic intervals (Model TL11M2-
C50-PXT; Data Science International, Inc., St. Paul, MN).  Charles River Laboratories 
performed all telemetry implantation surgeries in accordance with methods specified by the 
vendor (Charles River Laboratories, 2005).  Animals were shipped to the US EPA 10 days 
after implantation surgeries, and animals were allowed to recover for 1 week at the US EPA 
before exposures began. 
A separate cohort of SH (n = 20) and WKY (n = 5) rats were implanted with femoral 
artery catheters in accordance with methods specified by the vendor (Charles River 
Laboratories, 2005).  Animals were shipped to the US EPA within 1 week of surgery.  The 
catheters were flushed with saline, locked with heparin and plugged immediately upon 
arrival and every two days thereafter until exposure began.  
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Acrolein Exposure  
Rats were assigned to exposure groups (air exposure and saline injection; acrolein 
exposure and saline injection; air exposure and PAG injection; acrolein exposure and PAG 
injection) and acclimated to exposure chambers for 1 hour once per day beginning two days 
before exposure. On the exposure day, rats received an intraperitoneal  injection of saline or 
PAG  and were allowed to acclimate to the chambers for 30 minutes and then baseline data 
was recorded for the next 30 minutes. All exposures (air and acrolein) took place in whole 
body plethysmography chambers (WBP; Model PLY3213, Buxco Electronics, Inc, 
Wilmington, NC), which continuously and non-invasively monitor ventilatory parameters in 
conscious animals. SH rats were then exposed to filtered air or 3 ppm acrolein for 3 hours. 
The concentration of acrolein (3 ppm) is higher than ambient levels, but it may represent 
concentrations in high combustion areas (Hazari et al., 2008). In addition, cigarette smoke 
contains up to 90 ppm acrolein (Esterbauer et al., 1991), and acrolein levels in sidestream 
tobacco smoke are as high as 10 ppm (Esterbauer et al., 1991). Acrolein gas was metered 
from a 1000 ppm cylinder into a glass mixing chamber where the gas was mixed with dry 
filtered dilution air to achieve a final concentration of 3 ppm of acrolein with a total flow of 6 
L/min.  The actual chamber concentration was measured using an HP5890 gas 
chromatograph (GMI Inc., Ramsey, MN) equipped with manual injection, a flame ionization 
detector and a DB-VRX capillary column.  The plethysmograph pressure was monitored 
using Biosystems XA software (Buxco Electronics, Inc, Wilmington, NC).  Using 
respiratory-induced fluctuations in ambient pressure, respiratory parameters including tidal 
volume, breathing frequency, inspiratory time and expiratory time were calculated and 
recorded on a breath-by-breath basis and averaged over 10 second intervals. HR, systolic and 
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diastolic BP, ECG waveforms, and ventilatory data were collected during the exposure, and 
animals were returned to their home cages after exposure.  Rats underwent left ventricular 
pressure readings 24 hours after exposure.  
 
Left Ventricular Pressure Readings 24 Hours Post Exposure 
All rats exposed to air or acrolein with or without PAG injection underwent left 
ventricular pressure (LVP) readings to measure cardiac function 24 hours after exposure. 
Left ventricular pressure readings were performed as previously described (Carll et al., to be 
submitted). Briefly, rats were anesthetized with urethane (1.5 mg/kg i.p., Sigma) and 
prepared for LVP measurement by right carotid arterial catheterization with a 2-French 
transducer (SPR-320, Millar Instruments).  The LV probe was connected via a Pressure 
Control Unit (Model 2000, Millar Instruments) to a receiver (Powerlab 4/30, ADInstruments) 
and a computer acquiring data at 1000 Hz.  The probe was advanced into the LV for a 5 min 
baseline. Rats exposed to air with saline injection and acrolein with saline injection then 
underwent a dobutamine stress test followed by vagotomy which will be described in the 
next section.  Rats exposed to air with PAG injection and acrolein and PAG injection were 
then euthanized by exsanguination.  Acquisition software (LabChart Pro version 7.3.2, 
ADInstruments) generated pressure at end diastole and end systole (EDP and ESP) and the 
maximum and minimum pressure slopes (dP/dtmax and dP/dtmin, respectively) per beat, 
indicative of contractility and relaxation rate (lusitropy), respectively. 
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Left Ventricular Pressure Readings with Dobutamine Stress Test, and Vagotomy 
  Rats exposed to air with saline injection and acrolein with saline injection were 
prepared for left ventricular pressure readings as described above, and the left jugular vein 
was cannulated for cardiac stress test by sympathomimetic infusion (dobutamine) before the 
probe was inserted into the carotid artery. The probe was advanced into the LV, and after a 5 
min baseline, freshly diluted dobutamine hydrochloride (dissolved in 0.9% NaCl saline at 20 
µg/ml and infused at a dose of 10 µg/kg/min i.v.) was infused for 2 min. Rats were observed 
for 10 min after infusion cessation, which allowed adequate time for recovery to resting heart 
rate and dP/dtmax. Animals then received bilateral vagotomy by suture occlusion followed by 
a stabilization period (3 min), another 2-min dobutamine infusion at the same dose and a 
post-infusion observation period (2.5 min). Rats were then euthanized by exsanguination.  
Acquisition software (LabChart Pro version 7.3.2, ADInstruments) generated pressure at end 
diastole and end systole (EDP and ESP) and the maximum and minimum pressure slopes 
(dP/dtmax and dP/dtmin, respectively) per beat, indicative of contractility and relaxation rate 
(lusitropy), respectively. 
 
Blood Gas Parameter Measurements During Acrolein Exposure 
Changes in blood gas parameters during acrolein exposure were determined in a 
separate cohort of rats. All rats were assigned to one of four treatments groups: air exposure 
and saline injection; acrolein exposure and saline injection; air exposure and PAG injection; 
and acrolein exposure and PAG injection. Rats implanted with femoral artery catheters were 
acclimated to whole body plethysmography chambers (WBP; Model PLY3213, Buxco 
Electronics, Inc, Wilmington, NC), for 1 hour on the two days prior to exposure.  On the day 
97 
 
of exposure, the rats were received an intraperitoneal injection of either saline or PAG. The 
exteriorized catheter was extended with a 1 ml PE50 catheter attached to a 23 gauge adapter 
and run through a pre-measured hole in the wall of the plethysmograph to allow for blood 
draws outside of the sealed exposure chamber.  Rats were acclimated to the exposure 
chambers for 30 minutes and then were exposed to either filtered air or acrolein as described 
previously. For all exposure groups, a baseline 250µl blood sample was taken after 
acclimation. For air exposed rats, additional 250 µl blood samples were taken 30 minutes 
after baseline, 1 hour after baseline, and 1 hour 15 min after baseline. For acrolein exposed 
rats, additional 250 µl blood samples were taken 30 minutes after the start of acrolein, 1 hour 
after the start of acrolein, and 15 minutes after the end of acrolein exposure. For each blood 
draw, the pin was removed from the tip of the catheter, and the heparin was allowed to exit 
the catheter.  When only blood remained, a 23-gauge adapter attached to a 1 ml syringe was 
placed on the end of the catheter and used to draw a 250µl sample.  The blood sample was 
immediately read on an OPTI CCA-TS Blood Analyzer (OPTI Medical Systems, Inc.) using 
the OPTI Cassette E-Ca which measures blood pH, PCO2, PO2, Na
+
, K
+
, Ca
2+
, total 
hemoglobin (tHb), oxygen saturation (SaO2), and hematocrit (Hct).  The catheter was flushed 
with saline and locked with heparin after each blood draw.  
 
Whole-body Plethysmograph Data Acquisition and Analysis 
All exposures were performed in whole-body plethysmography chambers (Buxco 
Electronics, Sharon, CT).  The plethysmography methodology permitted continuous 
monitoring of breathing frequency, tidal volume, minute volume, inspiratory time and 
expiratory time. Animals were acclimated to plethysmographs for 1 hour each day on the two 
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days prior to exposure before both air and acrolein exposure.  Plethysmography chambers 
(model PLY3213; Buxco Electronics) were calibrated each day before every animal loading.  
A bias flow regulator delivered fresh air (1.8 L/min) to each cylindrical chamber, preventing 
CO2 buildup within the chamber. Unrestrained animals were placed in individual cylindrical 
plethysmograph boxes containing a built-in reference chamber for measuring respiration-
induced pressure fluctuations. Data were channeled to computer software (BioSystem XA; 
Buxco Electronics) that calculated respiratory parameters.  Data were collected continuously 
for each parameter, and automated breath-by-breath analyses were performed using a 
rejection algorithm to eliminate breaths that were outside a given range.  On exposure day, 
animals were acclimated to the chambers for 30 minutes before any readings were taken.  
After acclimation, 30 minutes of baseline data were taken, and animals were exposed to 
either filtered air or 3 ppm acrolein for 3 hours.  After exposure, rats were removed and 
returned to home-cages. 
 
Radiotelemetry Data Acquisition  
Radiotelemetry methodology (Data Sciences International, Inc.) enabled constant 
monitoring of ECG data in unrestrained, un-anesthetized rats from implantation until 
euthanasia. Remote receivers (DataART3.01; Data Sciences International, Inc.) positioned 
under the home cages, and under the plethysmographs during exposure collected the ECG 
data and transferred it to the computer for storage.  In home cages, sixty-second segments of 
ECG waveforms were acquired and saved at 15 minute intervals from surgical recovery 
through euthanasia not including the exposure period.   Pre-exposure baseline data were 
collected from home cages, as well as a 30 minute baseline in exposure cages after a 30 
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minute acclimation period.  During the 3 hour exposure, sixty-second segments were 
acquired and saved at 5 minute intervals.  After exposure, rats were monitored in home cages 
until euthanasia, approximately 12 hours after the end of the final hypoxia challenge.  HR 
and BP were automatically obtained from the ECG and BP waveforms, respectively, with 
data acquisition software (DataART3.01; Data Sciences International, Inc.). 
 
Electrocardiogram, Arrhythmia Identification and Heart Rate Variability (HRV) Analysis  
ECGAuto software (EMKA Technologies, Falls Church, VA) was used
 
for automated 
analyses of ECG wave amplitudes and segment durations
 
and areas, as well as for the visual 
identification and enumeration
 
of cardiac arrhythmias.  Several parameters were determined 
for each ECG waveform: PR
 
interval; R amplitude and duration; QRS area; ST interval, 
amplitude,
 
and area; and T-wave amplitude and
 
area; QT interval, and heart
 
rate-corrected QT 
interval (QTc).  ECG parameters during
 
exposure were analyzed in terms of baseline (30 
minute recordings
 
while in the exposure chambers immediately before the beginning
 
of 
exposure) and Hours 1–3 (constituting the entire exposure period between 8:00 AM and 
11:00 AM). 
Cardiac arrhythmic events were identified in part by using the Lambeth conventions 
(Walker et al., 1988) as a guideline for the identification of arrhythmias in rats.  Arrhythmias 
were identified as atrial premature beats (APB), ventricular premature beats (VPB), sinoatrial 
blocks (SAB), atrioventricular blocks (AVB), or ventricular tachycardia (VT). Arrhythmias 
were quantified, counted and totaled over an 18 hour period prior to exposure (this 
corresponded to the same times assessed after exposure), during the 4 hour exposure period, 
or during the 18 hour period beginning immediately after exposure. Total arrhythmia counts 
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during exposure were quantified (total of 48 two-minute segments during 3 hour exposure 
period) and expressed as counts per minute. 
For the analysis of HRV, thorough visual inspection was conducted
 
to identify and 
exclude arrhythmias, artifacts, and 1 minute
 
ECG waveforms lacking distinguishable R 
waves for more than
 
30 seconds. The analysis of HRV generated heart rate (HR) and
 
time-
domain measures, including mean time between adjacent QRS
 
complex peaks (the RR 
interval), a standard deviation of the
 
RR interval (SDNN), SDNN normalized for the effects 
of heart
 
rate [SDNN/(RR interval x 100)], and the square root of the mean of
 
squared 
differences of adjacent RR intervals (RMSSD).  The SDNN represents overall HRV, whereas
 
RMSSD represents parasympathetic influence over HR. The
 
analysis of HRV also calculated 
frequency domain parameters,
 
particularly low frequency (LF) and high frequency (HF), and
 
the ratio of these two frequency domains (LF/HF). LF is generally
 
believed to represent a 
mixture of sympathetic and parasympathetic tone, whereas HF indicates cardiac 
parasympathetic (vagal)
 
tone, and LF/HF serves as an index of sympathovagal balance. 
 
Statistics  
The statistical analyses of the Buxco, ECG and HRV data in this study used SAS 
version 9.2 software (SAS Institute Inc, Cary NC).  We used PROC MIXED of SAS since it 
offers greater flexibility for the modeling of repeated measures data than PROC GLM. It is 
also suitable for analysis of large, unbalanced data with missing data at random. A linear 
mixed model with restricted maximum-likelihood estimation analysis,  least squares means 
and repeated measures ANOVA was used to determine which TIME*TRT  interactions were 
statistically significant between baseline and exposure. Multiple comparison adjustment for 
101 
 
the p values and confidence limits for the differences between the least squares means was 
done using adjust=Tukey HSD (Honest Significant Difference) test. All blood gas data were 
analyzed using GraphPad Prism (GraphPad Software, Inc., La Jolla, CA) with a one-way 
analysis of variance (ANOVA) model examining the main effects of each model.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
All strain comparisons were performed using GraphPad Prism (GraphPad Software, Inc., La 
Jolla, CA) with a student t-test. Trend analysis of SDNN data during exposure and HR data 
during hypoxia challenge was performed using GraphPad Prism (GraphPad Software, Inc., 
La Jolla, CA) with a one-way ANOVA followed by a post-hoc test for linear trend between 
mean and column number. P < 0.05 was considered statistically significant. 
 
Results 
Effects of Acrolein on Blood Parameters 
 In rats exposed to acrolein with saline injection, pO2 decreased from baseline levels 
of 101.43 ± 1.67 mmHg to 91.00 ± 3.59 mmHg 30 minutes into exposure, to 90.20 ± 1.16 
mmHg one hour into exposure, and continued to decrease to 89.80 mmHg after exposure 
ended (p < 0.05; Fig. 4.1A). Rats exposed to acrolein with saline injection and acrolein with 
PAG injection had significant increases in pCO2 during acrolein exposure. For rats exposed 
to acrolein with saline injection, pCO2 increased from baseline levels of 38.57 ± 1.15 mmHg 
to 41.85 ± 1.40 mmHg 30 minutes into exposure, to 42.00 ± 1.63 mmHg one hour into 
exposure, and remained high at 41.80 ± 1.39 mmHg after exposure ended (p < 0.05; Fig. 
4.1B). For rats exposed to acrolein with PAG injection, pCO2 increased from baseline levels 
of 36.50 ± 1.06 mmHg to 41.25 ± 0.43 mmHg 30 minutes into exposure, to 40.20 ± 0.58 
mmHg one hour into exposure (p < 0.05; Fig. 4.1B). Rats exposed to acrolein with saline 
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injection had significant decreases in K
+
 during and after exposure. Baseline K
+
 levels of 
6.64 ± 0.74 mmol/L decreased to 4.37 ± 0.24 30 minutes into exposure, to 4.63 ± 0.38 one 
hour into exposure, and increased slightly to 5.46 ± 0.54 mmol/L after exposure ended (p < 
0.05; Fig. 4.1C).  
pH, SaO2, and Na
+
 were not affected by acrolein exposure or PAG injection (Data not 
shown). WKY rats exposed to air or acrolein had no significant changes in any blood 
parameters measured (Table 4.1). 
 
Effects of Acrolein on Ventilatory Parameters 
 Rats exposed to acrolein had significant decreases in breathing frequency in the first 
30 seconds of exposure. Breathing frequency decreased significantly from 288.70 ± 23.22 
breaths/min at baseline to 153.63 ± 14.99 breaths/min 20 seconds into acrolein exposure 
(Figure 4.2A). In addition, acrolein exposed rats had significant increases in expiratory time 
(Te), a measure of apnea within the first 20 seconds of exposure. Te increased from baseline 
levels of 0.16 ± 0.038 seconds to 0.28 ± 0.037 seconds at 10 seconds into acrolein exposure 
and 0.28 ± 0.023 seconds 20 seconds into acrolein exposure (Figure 4.2B). Decreased 
breathing frequency and increased expiratory time were not seen in PAG treated rats (Data 
not shown). There were no significant changes in minute volume, tidal volume, or inspiratory 
time in rats treated with saline of PAG. 
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Effects of Carotid Body Inhibition on Blood Pressure, Heart Rate, and Temperature during 
Acrolein Exposure 
 Rats exposed to acrolein with saline injection had significant increases in mean 
arterial blood pressure (MAP), systolic blood pressure, and diastolic blood pressure during 
acrolein exposure compared to the other exposure groups (Fig. 4.3).  
For MAP at hour 2, rats exposed to acrolein with saline injection had a 3.94 ± 1.26 % 
decrease from baseline compared to rats exposed to air with saline injection (13.11 ± 1.80 % 
decrease from baseline) (p < 0.05; Data not shown). At hour 3, rats exposed to acrolein with 
saline injection had a 13.40 ± 2.53 % increase from baseline compared to rats exposed to air 
with saline injection (11.33 ± 3.37 % decrease from baseline) and rats exposed to air with 
PAG injection ( 3.75 ± 3.54 % decrease form baseline) (p < 0.05; Data not shown).  
For systolic blood pressure at hour 2, rats exposed to acrolein with saline injection 
had a 3.28 ± 1.97 % decrease from baseline compared to rats exposed to air with saline 
injection (12.03 ± 1.74 % decrease from baseline) (p < 0.05; Fig. 4.3A). At hour 3, rats 
exposed to acrolein with saline injection had a 13.80 ± 2.24 % increase from baseline 
compared to rats exposed to air with saline injection (9.85 ± 2.78 % decrease from baseline), 
rats exposed to air with PAG injection (2.65 ± 3.33 % decrease form baseline), and rats 
exposed to acrolein wih PAG injection (1.73 ± 2.34 % increase from baseline) (p < 0.05; Fig. 
4.3A).  
For diastolic blood pressure at hour 3, rats exposed to acrolein with saline injection 
had a 13.10 ± 2.61 % increase from baseline compared to rats exposed to air with saline 
injection (13.98 ± 3.72 % decrease from baseline), rats exposed to air with PAG injection 
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(5.57 ± 4.02 % decrease form baseline), and rats exposed to acrolein wih PAG injection (1.09 
± 3.74 % increase from baseline) (p < 0.05; Fig. 4.3B). 
Rats had no significant changes in heart rate during exposure regardless of exposure 
group or PAG injection (Fig. 4.3C). 
 Rats exposed to acrolein with saline injection had a significantly smaller decrease in 
temperature during hour 2 of acrolein exposure (Fig. 4.3D). Temperature decreased from 
baseline levels of 38.45 ± 0.13 
o
C to 37.62 + 0.19 
o
C at hour 2 in rats exposed to acrolein 
with saline injection compared to rats exposed to air with saline injection (38.59 ± 0.24 
o
C at 
baseline to 37.33 ± 0.18 
o
C at hour 2), rats exposed to air with PAG injection (37.93 ± 0.10 
o
C at baseline to 36.95 ± 0.14 
o
C at hour 2), and rats exposed to acrolein with PAG injection 
(37.88 ± 0.28 
o
C at baseline to 36.59 ± 0.29 
o
C at hour 2). For rats exposed to acrolein with 
saline injection, this constituted a 0.019 ± 0.004 % decrease from baseline at hour 2 
compared to a 0.041 ± 0.005 % decrease from baseline in rats exposed to air with saline 
injection (p < 0.05; Fig. 4.3D). 
 
Differences in Measurements of Contractility 24 Hours after Acrolein Exposure 
 Rats exposed to acrolein with saline injection had a significant decrease in dP/dTmax, 
a measure of cardiac contractility, 24 hours after exposure compared the control air exposure 
with saline injection. Rats exposed to acrolein with saline injection had dp/dTmax levels of 
5672.56 ± 630.63 mmHg/s compared to rats exposed to air with saline injection (8992.40 ± 
971.39 mmHg/s) (p < 0.05; Fig.4.4). This decrease was eliminated with PAG injection (Fig. 
4.4). 
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The Effect of Acrolein Exposure on Measurements of Cardiac Function 
 Rats exposed to acrolein had significant decreases in baseline dP/dTmax 24 hours after 
exposure that were reversed with bilateral vagotomy. At baseline, rats exposed to acrolein 
with saline injection had average dP/dTmax values of 5672.56 ± 630.63 mmHg/s compared to 
8992.40 ± 971.39 mmHg/s in air exposed rats with saline injection (p < 0.05; Fig. 4.5A). 
After bilateral vagotomy, acrolein exposed rats with saline injection had baseline dP/dTmax 
values of 14365.65 ± 1243.72 mmHg/s compared to 11588.65 ± 1305.35 mmHg/s in air 
exposed rats with saline injection (Fig. 4.5A). Rats exposed to acrolein had significant 
increases in dP/dTmax during dobutmaine infusion I. Acrolein exposed rats had a 111.37 ± 
16.19 % increase from baseline compared to a 58.68 ± 12.66 % increase from baseline in rats 
exposed to air (p < 0.05; Fig. 4.5). This increase in dP/dTmax was eliminated after vagotomy 
(Fig. 4.5B) 
 
Discussion 
The current study demonstrates four major points: 1) that acrolein exposure-induced 
apnea is associated with decreases in arterial pO2 and increases in pCO2 in SH rats, 
suggesting hypoxemia, 2) hypoxemia was only evident in acrolein-exposed SH rats, but not 
rats with normal blood pressure, 3) acrolein exposure-induced cardiovascular responses 
including increased blood pressure and diminished contractility and elevated core body 
temperature are prevented by pharmacologic blockade of the carotid body, the hypoxia 
sensing organ, and 4) carotid body-mediated cardiovascular responses are associated with an 
oscillating autonomic pattern characterized by an early increase in sympathetic tone followed 
by a rebound increase in parasympathetic tone. Decreases in pO2 during acrolein exposure 
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demonstrate the potential for hypoxemia and downstream peripheral chemoreceptor- 
mediated responses to hypoxia. Acrolein exposure alone caused significant increases in mean 
arterial, systolic, and diastolic blood pressure that were prevented with carotid body 
inhibition.  Acrolein exposure caused significant reductions in baseline dP/dTmax, a measure 
of cardiac contractility, which was reversed with carotid body inhibition. Bilateral vagotomy 
one day after exposure reversed significant decreases in baseline contractility, demonstrating 
that the reduction in contractility was likely mediated by increases in parasympathetic tone. 
Acrolein exposure significantly decreased pO2 in hypertensive rats, suggesting that 
the animals were hypoxic. Acrolein, like other environmental pollutants, stimulates airway 
irritant sensory nerves (Lee et al., 1992; Oortgiesen et al., 2000), especially chemosensitive 
bronchopulmonary C-fibers, in part by activation of transient receptor potential vanilloid 1 
cation channels (TRPV1) present on the peripheral terminals of these fibers (Hazari et al., 
2008). Upon activation of these fibers, a chemorflex is elicited that is characterized by apnea 
and bronchospasm (Coleridge and Coleridge, 1994), which in part may explain the responses 
observed. We found significant decreases in breathing frequency in SH rats immediately 
after the start of acrolein as well as significant increases in expiratory time, a marker of 
apnea, consistent with our previous findings (Hazari et al., 2008). While this may explain the 
initial drop in pO2, the apnic response was transient, lasting only 30 seconds. Thus, apnea 
alone likely does not explain the decrease in pO2 that was detected up to an hour into 
exposure and that persisted for 30 minutes after a 1-hour exposure to acrolein.  Other 
potential explanations include inflammatory and edematous responses, although such 
responses are common at higher concentrations. Janssens et al. (1994) reported decreases in 
arterial pO2 after acrolein smoke exposure in sheep and attributed the responses to acrolein-
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induced airway resistance and edema. Acrolein exposure has been shown to increase lung 
lymph flow and extracellular lung water coupled with airway damage and pulmonary edema 
(Hales et al., 1992). While acrolein exposure decreased pO2 in SH rats, no such change was 
evident in similarly exposed WKY rats and may be related to underlying differences in 
sensitivity to air pollution. Previous studies have shown that the SH rat responds with greater 
airway inflammation, edema, and injury after air pollution exposure than WKY rats (Farraj et 
al., 2009; Kodavanti and Costa, 2001). In addition, SH rats have larger carotid bodies 
(Habeck et al., 1985) and are more sensitive to the effects of hypoxia as evidenced by 
increased carotid sinus nerve activity and intracellular Ca2+ changes (Weil et al., 1998). 
Although there were significant reductions in pO2 with acrolein exposure in SH rats, 
there were no significant changes in blood oxygen saturation (i.e. SaO2). pO2 is a measure of 
dissolved oxygen in plasma, while SaO2 measures the percentage of hemoglobin sites bound 
with oxygen. The discrepancy in pO2 and SaO2 is likely due to the fact that SaO2 is well 
buffered from rapid decreases due to the sigmoidal nature of the oxy-hemoglobin 
dissociation curve (Urbano and Mohsenin, 2006). Because a large drop in pO2 is required to 
alter SaO2,, reductions in pO2 may be a more sensitive indicator of a pollutant’s effect on 
blood oxygen levels.  Additionally, epidemiological studies linking reduction in SaO2 and 
pollutant exposure are based on pulse oximetry recordings (Gong et al., 2004; Gong et al., 
2005) derived from light absorbance readings of a sensor usually placed on a finger. This 
measurement is not as sensitive as direct analysis of arterial blood, and demonstrates the 
increased sensitivity of the system used in this study. Decreases in arterial pO2 were coupled 
with significant increases in pCO2. Importantly, the body is significantly more sensitive to 
systemic changes in pCO2 and the magnitude of the change in pCO2 with acrolein exposure 
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in this study has been demonstrated to be sufficient to trigger activation of the carotid body 
(Iturriaga et al., 2005). Thus, the small but significant decrease in pO2 and the increase in 
pCO2 during acrolein exposure suggest that carotid body activation took place.  
In addition to changes in arterial blood gas parameters, acrolein exposure 
significantly decreased K
+
 in hypertensive rats. Hypokalemia, defined as less than 
3.5mmol/L K
+
 in arterial blood, may occur in diseases with high aldosterone levels such as 
hypertension and is a result of abnormal renal regulation of K
+ 
(Halperin and Kamel, 1998). 
SH rats are known to have kidney dysfunction (Hulstrom, 2012), but there are no reports of 
acrolein causing hypokalemia in humans or rodent models. Although it is unclear why 
acrolein exposure causes decreases in K
+
, acute hypokalemia has been shown to sensitize the 
heart to hypoxic injury (Shapiro et al., 1998). We did not see reductions in K
+
 to the level of 
hypoxemia, but reduced K
+
 has been shown to have multiple adverse effects of 
cardiovascular function including cardiac arrhythmias, acceleration of kidney disease 
progression, and exacerbated hypertension (Asmar et al., 2012). Hypokalemia can lead to 
elevated aldosterone levels and increased blood pressure (Abad-Cardiel et al., 2013), and rats 
fed a high salt diet had increased sensitivity of the carotid body that was attributed to low 
potassium levels (Elias et al., 2004). Reductions in K
+
 during acrolein exposure may be a 
potential driver of increased blood pressure and may influence the carotid body response to 
hypoxia following acrolein exposure. 
Acrolein-induced blood pressure and temperature changes may be related to early 
decreases in arterial pO2 and increases in pCO2, as has been demonstrated in other studies. 
For example, acute exposure to high altitudes with low oxygen tension in humans increases 
systemic arterial blood pressure and precipitates acute mountain sickness (Rhodes et al., 
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2011). Also, cats exposed to short term anoxia had decreased pO2 and increased pCO2 
coupled with significant increases in arterial blood pressure (Yang et al., 1994). In addition, 
acrolein exposure-induced decreases in pO2 in sheep were accompanied by increases in 
pulmonary arterial pressure and pulmonary vascular resistance (Janssens et al., 1994). Such 
blood pressure increases may have been triggered by increased sympathetic tone mediated by 
the carotid body in response to hypoxia.  Although HRV assessments have not yet been 
analyzed, acrolein exposure in our previous study caused an increase in LF, the low 
frequency domain parameter indicative of sympathetic tone (Perez et al., 2013). On the other 
hand, blood pO2 levels below 60 mm Hg are required for significant activation of the carotid 
body in humans suggesting that carotid body sensing of pO2 may not be the driver for these 
responses.  While the changes in pO2 may not have reached threshold levels necessary for 
activation of the carotid body, the carotid body may have been impacted to a greater extent 
by acrolein-induced increases in pCO2.  The carotid body is much more sensitive to changes 
in pCO2 and increases in pCO2 as small as 5 mmHg have been shown to activate the carotid 
body (Whipp, 1994). In addition to blood pressure increases, acrolein exposure resulted in an 
increase in body temperature compared to control animals. Although the reason for this 
finding is unclear, sympathetic activation has been shown to increase body temperature by 
stimulating vasoconstriction (Constanzo, 2006). In addition, Loyola et al. (1991) reported 
that increases in core body temperature activate chemosensory discharges from the carotid 
nerve, suggesting that acrolein induced increases in body temperature may be related to 
carotid body signaling during exposure. In mammals, the response to systemic hypoxia is 
controlled by the carotid body, and blood pressure and temperature responses following 
decreases in arterial pO2 may be controlled by the carotid body chemoreceptor response.  
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Pharmacological inhibition of carotid body sensing prevented acrolein-induced 
increases in MAP, systolic, and diastolic blood pressure during exposure and the reduction in 
cardiac contractility one day after exposure. These responses suggest that carotid body 
signaling may be influencing the cardiovascular response to acrolein. Carotid body signal 
transduction is dependent on hydrogen sulfide production by the cystathionine γ-lyase (CSE) 
enzyme that generates hydrogen sulfide from cysteine (Peng et al., 2010). PAG 
pharmacologically inhibits the carotid body through inhibition of the CSE enzyme, and it has 
been shown to inhibit responses to hypoxia in the carotid body of rats (Peng et al., 2010). 
The prevention of acrolein-induced blood pressure increases in PAG-treated rats is of great 
interest because hypoxia is associated with increased myocyte apoptosis and is implicated in 
cardiac remodeling and progression to heart failure (Bao et al., 2011). In addition, hypoxia 
has been shown to cause atrial fibrillation, AV block, and ventricular tachycardia as well as 
changes in autonomic balance associated with ventricular arrhythmias (Davies and 
Wedzicha, 1993). Oral exposure to acrolein in mice has been shown to cause inflammation 
and dilated cardiomyopathy characterized by increased left ventricular dilation (increased 
end diastolic volume), contractile dysfunction (decreased dp/dTmax), and impaired relaxation 
(Ismahil et al., 2011). Recent work by Wang et al. (2012) demonstrated that cardiac 
arrhythmias in particulate-exposed heart failure mice were in part due to altered sensitivity of 
the carotid body.  Furthermore, exposures to the air pollutants tobacco smoke (Adgent, 
2006), sulfur dioxide and nitrogen dioxide (Hoppenbrouwers et al., 1981) have been linked 
to abnormal cardiopulmonary sensitivity responses to hypoxia.  Collectively, these finds 
provide plausibility for a role for hypoxia in the mediation of some of the adverse 
cardiovascular effects of air pollution. 
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 Acrolein exposure caused a decrease in cardiac contractility one day after exposure 
as determined by assessments of left ventricular pressure, which may have stemmed from a 
shift in autonomic tone.  We have previously determined (Carll et al., to be submitted) that 
early increases in sympathetic tone with diesel exhaust exposure are followed by rebound 
increases in parasympathetic tone after exposure. An increase in contractility during exposure 
to acrolein, although not directly measured, is possible and would be consistent with the 
increase in blood pressure in this study and previous demonstrations of elevated sympathetic 
tone during acrolein exposure. Forthcoming assessments of QA interval, an indirect measure 
of cardiac contractility derived from ECG and blood pressure signals, and HRV will shed 
light on contractility responses during exposure and potential associations with altered 
autonomic tone.  Acrolein-induced increases in contractility are plausible given that other 
acrolein-induced cardiovascular responses were prevented by carotid body inhibition in this 
study and carotid body activation in dogs has been shown to increase cardiac contractility 
(Vatner and Rutherford, 1978). The baseline decrease in contractility was likely 
parasympathetically controlled, as bilateral vagotmoy reversed significant decreases in 
baseline contractility one day after exposure. The prevention of the acrolein-induced decrease 
in contractility with PAG pretreatment suggests that the impaired contractility response one 
day after exposure with acrolein was a compensatory mechanism characterized by rebound 
increases in parasympathetic tone mediated by carotid body chemoreceptor signaling.  
Acrolein exposed rats showed enhanced sensitivity to dobutamine, a sympathetic 
agonist, one day after exposure. With an intact autonomic nervous system, rats exposed to 
acrolein had a markedly significant increase in dP/dTmax, a measure of contractility, in 
response to dobutamine infusion one day after exposure. It is unclear whether this is due to 
112 
 
effects by the autonomic nervous system, or if the increases in contractility are the result of 
other factors. This response may be due to increased vascular resistance, as has been found 
with exposure to acrolein (Green and Egle, 1983), and may not be the result of exaggerated 
sympathetic tone. Alternatively, acrolein activates TRP fibers/receptors (Hazari et al., 2008), 
which are plentiful in the heart, suggesting that the enhanced sensitivity may be occurring 
only at the level of the heart. Increases in contractility during dobutamine infusion were 
eliminated with bilateral vagotomy. Although the mechanism causing the responses one day 
after exposure are difficult to decipher,  the body has many ways to respond to air pollutants, 
and it is likely that more than one mechanism is activated upon inhalation of different 
pollutants. Future studies will include pharmacological block of parasympathetic nerve 
activity to the heart with atropine to fully gauge the role of the parasympathetic response. It 
is conceivable that the carotid body mediated physiologic responses to hypoxia trigger 
sympathetic-driven cardiovascular responses during exposure followed by parasympathetic-
driven responses after acrolein exposure (Figure 4.6).  
 The present findings demonstrate for the first time that acrolein exposure may 
cause changes in blood pressure and cardiac function through carotid body chemoreceptor 
signaling. In addition, exposure to irritants known to illicit apnea can affect blood gas 
concentrations and stimulate chemorecepter activation with downstream cardiovascular 
consequences. These findings also highlight the previously underexplored role of hypoxia 
signaling during air pollution exposure and reveal the complex interplay between 
chemoreceptor signaling and the autonomic nervous system. 
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Table 4.1. Arterial blood parameters during acrolein exposure in WKY rats. Means and 
standard errors are reported.  
Exposure pO2 
(mmHg) 
pCO2 
(mmHg) 
SaO2 
(%) 
pH K
+ 
(mmol/L) 
Na
+ 
(mmol/L) 
Baseline 109 ± 2.77 36.6 ± 1.86 94.8 ± 
0.66 
7.27 ± 
0.05 
7.66 ± 
1.10 
149.8 ± 
2.96 
30 minutes  101.4 ± 4.53 36.7 ± 2.09 94.4 ± 
0.24 
7.28 ± 
0.04 
7.36 ± 
0.81 
147.2 ± 
1.98 
1 Hour  102.6 ± 4.71 35.4 ± 1.47 93.40 ± 
0.68 
7.27 ± 
0.05 
6.70 ± 
0.72 
152.2 ± 
1.47 
Post 
Exposure 
98 ± 2.19 36.7 ± 0.68 93.4 ± 
0.40 
7.41 ± 
0.02 
5.70 ± 
0.49 
143.6 ± 
0.51 
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Figure 4.1. Acrolein exposure causes significant decreases in arterial blood oxygen and 
potassium and significant increases in arterial carbon dioxide. SH rats implanted with 
femoral artery catheters were injected with saline or PAG carotid body inhibitor and exposed 
115 
 
to 3 ppm acrolein or air control. Panel A, B, and C refer to pO2, pCO2, and K
+
, respectively, 
measured at baseline, 30 minutes into acrolein exposure, 1 hour into acrolein exposure, and 
15 minutes post exposure. Means and standard errors are reported. Significant differences 
from baseline values (p < 0.05) are denoted with a *. 
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Figure 4.2. Acrolein exposure causes significant decreases in breathing frequency and 
significant increases in expiratory time immediately after the beginning of exposure. Panels 
A and B refer to breathing frequency and expiratory time, respectively. Means and standard 
errors are reported. Significant differences from baseline (p < 0.05) are denoted with a *. 
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Figure 4.3. Carotid body inhibition attenuates blood pressure and temperature increases 
during acrolein exposure. Panel A, B, C, and D refer to systolic blood pressure, diastolic 
blood pressure, heart rate, and core body temperature respectively. Means and standard errors 
are reported. Significant differences between groups (p < 0.05) are denoted with a *. 
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Figure 4.4. Carotid body inhibition reverses decreases in dP/dTmax, a measure of 
contractility, 24 hours post acrolein exposure. Means and standard errors are reported. 
Significant differences between groups (p < 0.05) are denoted with a *. 
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Figure 4.5. Decrease contractility one day after exposure is likely mediated by the 
parasympathetic nervous system, while dobutamine infusion reveals significant increases in 
contractility that is reversed by vagotomy. Panel A refers to baseline values of dP/dTmax 24 
hours post exposure. Means and SEMs are reported. Significant differences (p < 0.05) from 
air exposed rats with saline injection are denoted with a *. Panel B refers to dP/dTmax values 
24 hours post exposure during 2 minute dobutamine infusion. Percent change values from 
baseline and SEMs are reported. Significant differences between groups (p < 0.05) are 
denoted with a *. 
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Acrolein-Induced Cardiovascular Dysfunction is Mediated by Carotid 
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Figure 4.6. Acrolein-induced cardiovascular dysfunction is mediated by carotid body sensing 
of hypoxia. We propose that adverse cardiovascular events following acrolein exposure are 
likely due to the carotid body response to hypoxia leading to increased sympathetic tone and 
downstream cardiac effects. 
 
 
 
 
 
 
 
 
Chapter 5 
 
Conclusions and Implications 
 
 
This dissertation research project sought to uncover the potential mechanisms 
responsible for the adverse cardiovascular events associated with air pollution exposure. This 
goal is predicated on a wealth of epidemiological studies showing that exposure to air 
pollution causes increased cardiovascular morbidity and mortality, especially in individuals 
with underlying cardiopulmonary diseases. Because epidemiological and experimental data 
exists that suggest that hypoxia may play a role in the adverse cardiovascular effects of air 
pollution, we tested the hypothesis that hypoxia mediates in part the cardiovascular effects of 
air pollution. Spontaneously Hypertensive (SH) rats were used to model humans with 
hypertension, a subgroup with acute sensitivity to the effects of air pollution exposure.   A 
number of studies were carried out in the SH rat to determine 1) if exposure to whole or 
filtered DE and the toxic DE component acrolein cause adverse cardiovascular responses in 
hypertensive rats compared to normotensive controls, 2) if a hypoxia stress test reveals 
altered sensitivity in the hypertensive rat following acrolein exposure, 3) if acrolein exposure 
itself causes decreases in blood oxygen levels, and 4) if the adverse cardiovascular effects of 
acrolein are mediated by chemoreflex signaling in the carotid body.  
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Divergent Responses to Whole and Filtered Diesel Exhaust Inhalation in Spontaneously 
Hypertensive Rats.  
The initial set of experiments was a characterization study that examined the effects 
of two concentrations of whole and filtered DE exposure in hypertensive (SH) and normal 
(WKY) rats. Exposure to fDE, but not wDE, caused immediate electrocardiographic 
alterations in cardiac repolarization (ST depression) and atrioventricular conduction block 
(PR prolongation) as well as bradycardia in SH rats.  Exposure to wDE, but not fDE, caused 
post-exposure ST depression and increased sensitivity to the pulmonary C fiber agonist 
capsaicin in SH rats.  The divergent responses of fDE and wDE highlight the real challenge 
of studying complex pollutants such as DE. It is apparent from this study that the gaseous 
and particulate components of DE may be functioning through separate mechanisms and 
therefore eliciting different responses. This is of great importance in epidemiological studies 
because human exposures are rarely confined to a single pollutant exposure, and this study 
demonstrates that multiple pollutants have the ability to interact and cause multiple 
responses. Most of the responses in this study were seen with exposure to the gaseous 
components of DE. It is possible that gases trigger immediate pulmonary effects through 
nasal irritation. Gases will also quickly react with pulmonary receptors and elicit 
cardiovascular responses such as bradycardia. Another possibility is that in wDE exposure, 
particles and gases interact and alter the chemistry of the pollutant itself, leading to altered 
responses compared to separate components alone. This demonstrates the need to model 
multipollutant environments to understand interactions of constituents.  
Notably, the responses to fDE occurred with the low concentration (150µg/m
3
), 
showing the importance of modeling lower concentrations in experimental designs. Although 
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seemingly counterintuitive, lower concentrations of pollutants may cause more effects than 
higher concentrations because lower doses of pollutants may activate receptors while higher 
doses can overload the sensory network and blunt downstream responses. In a study that 
examined causes for emergency room visits for elevated blood pressure, ambient levels of 
NO2, SO2, PM2.5, and PM10 all had significant associations with increased hypertension-
related hospitalizations (Szyszkowicz et al., 2012). Researchers are becoming more and more 
interested in environmentally relevant concentrations, and the most recent American Heart 
Association statement on particulate matter air pollution and cardiovascular disease includes 
recommendations that experimental studies better “describe the physiological relevance in 
humans and the fundamental details of the mechanisms underlying the intermediate general 
mediating pathways” (Brook et al., 2010). Future studies should take into account actual 
exposure concentrations of human populations and extrapolate those concentrations to the 
animal model.  
One of the important findings of this study was that the gaseous components of DE 
caused significant ST depression, a finding associated with myocardial ischemia. Although 
myocardial ischemia was not directly measured, the potential of reduced oxygen availability 
was of great interest and influenced the direction of subsequent studies. It turns out that 
several studies have found decreases in oxygen saturation in humans following exposure to 
PM and CAPs (DeMeo et al., 2004; Gong et al., 2004; Gong et al., 2005), which spurred our 
interest in examining arterial blood oxygen levels in the final study. These findings were in 
the development of the hypothesis that hypoxia is a mechanism by which the adverse 
cardiovascular responses following air pollution exposure take place. Another major 
conclusion from this study that affected the direction of the research was the finding that SH 
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rats were more sensitive to the effects of DE compared to WKY rats.  Multiple 
epidemiological studies have demonstrated that adverse events following PM exposure are 
heightened in susceptible populations such as the elderly (Pope et al., 2002) and individuals 
with diabetes (Zanobetti and Schawart, 2001), preexisting heart disease (Katsouyanni et al., 
2001) or heart failure (Goldberg et al., 2001). Clinically, hypertension can be a major risk 
factor for adverse responses to air pollution. There may be several reasons for this including 
inability to alter heart rate variability to respond to stressors as well as increased risk of 
arrhythmia with hypertension that could predispose to more severe responses to air 
pollutants.  Hypertension is associated with several remodeling events that can lead to 
heightened susceptibility including increased protein synthesis such as myosin and collagen, 
mutations in genes encoding ion channels that lead to increased action potential duration, 
altered calcium homeostasis leading to changes in cellular energetics, and decreased 
sensitivity of β-adrenergic receptors (Swynghedauw, 1999). These changes may explain why 
hypertension predisposes to adverse responses to air pollution seen clinically. Our studies 
used the SH rat to model hypertension. The SH rat is an excellent model for hypertension, 
and has been shown to develop increased vascular resistance, high systemic blood pressure, 
and increased activation of the rennin-angiotensin system (Kodavanti et al., 2000). 
Clinically, there are several different causes of hypertension including aging, obesity, and 
insulin resistance. This is important to remember when extrapolated results from the SH rats. 
In addition, SH rats have larger carotid bodies (Habeck et al., 1985) and are more sensitive to 
the effects of hypoxia as evidenced by increased carotid sinus nerve activity and intracellular 
Ca2+ changes (Weil et al., 1998). Despite hypertension originating in the kidney of the SH 
rat, it can still be used as a model for humans because increased blood pressure leads to 
125 
 
similar phenotypes seen in diverse human populations such as high blood pressure, evidence 
of cardiac remodeling, and vascular dysfunction.  
Modern diesel engines have much stricter emissions criteria, creating much cleaner 
exhaust emissions and limiting some of the more toxic air pollutants created by older diesel 
engines (EPA Diesel, http://www.epa.gov/otaq/marine.htm). The diesel engine used in this 
study was an older Yanmar L70 V diesel generator that did not have the more stringent 
emission standards. Despite more efficient and cleaner engines in our modern diesel vehicles, 
this study is still extremely relevant because diesel engines have an extremely long life span, 
so many older, less efficient engines are on the road today and will be for decades to come. 
In addition, the use of the newer diesel engines has not been adopted in the majority of the 
developing world where air pollution is a major public health concern and particulate matter 
levels are significantly higher than those in the United States. In addition, our studies found 
that the gaseous components of DE causes most of the responses, so even fuel that greatly 
reduces the sulfur content and particulate matter levels could still create emissions that 
contain toxic gases. Because most of the responses observed in this study occurred with the 
gaseous components of DE in hypertensive rats, we decided to focus on the effects of 
acrolein, a key toxic gas found in DE, for future studies. 
 
Acrolein Exposure Causes Significant Increases in Heart Rate and Blood Pressure in 
Hypertensive Rats. 
 DE is a chemically complex source of ambient PM and thus defining modes of action 
is challenging.  In addition to PM, DE also consists of a mixture of gases including nitrogen 
oxides (NOx), sulfur oxides (SOx), carbon monoxide (CO), and volatile organics including 
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aldehydes, benzene, and polycyclic aromatic hydrocarbons. The previous study with DE 
revealed the importance of the gaseous components in driving the majority of cardiovascular 
responses during exposure. Because of the complexity of DE and the importance of the 
gaseous components in driving the cardiovascular responses, we decided to focus on a toxic 
gaseous component of DE for future studies to explore the mechanisms controlling 
cardiovascular responses to air pollution exposure. Acrolein is an α,β-unsaturated aldehyde 
that is formed during the combustion of organic materials and is a toxic component of 
cigarette smoke and internal combustion engine exhaust (Baeuchamp et al., 1985). Acrolein 
exposure in SH rats increased heart rate, blood pressure, breathing frequency, minute 
volume, and the heart rate variability parameter LF, suggesting a potential role for increased 
sympathetic tone. Increased sympathetic tone is associated with an elevated risk of heart 
disease (Pope et al., 2001) and may have driven the adverse cardiovascular effects of 
acrolein.   Green and Egle (1983) found that intravenous injection of acrolein in rats causes 
significant increases in blood pressure that are reversed with guanethidine, a sympatholytic 
drug. The acrolein concentration used in the study was 3ppm. In ambient air, 0.04 - 0.08 ppm 
acrolein have been measured (Costa and Amdur, 1996), but cigarette smoke contains up to 90 
ppm acrolein (Esterbauer et al., 1991), and acrolein levels in sidestream tobacco smoke are 
as high as 10 ppm (Esterbauer et al., 1991). Acrolein is a highly reactive gas that will react 
with any nucleophile it contacts in the airway. Acrolein may react with cysteine residues of 
TRP channels that activate pulmonary C fibers (Takahashi and Mori, 2011). Pulmonary C 
fiber activation in the lung can lead to reflex cardiac responses, characterized by apnea and 
bradycardia (Widdicombe and Lee, 2001).  It is clear from the data, however, that acrolein 
exposure also causes hypoxia, which through the carotid body led to reflex increases in heart 
127 
 
rate and blood pressure among other changes.  It is likely that both responses are occurring 
with the irritant response initiated first as evidenced by the immediate ventilatory responses 
with exposure.  Signals from the pulmonary receptors, baroreceptors, and chemoreceptors 
will all be integrated in the brain stem, and it is likely that interpreting multiple signals leads 
to diverse responses in autonomic tone to balance conflicting input. The hypertensive rat was 
clearly more susceptible to the effects of acrolein, a finding that supports our previous 
findings with DE as well as epidemiological data.  Although acrolein exposure alone 
suggested enhanced sensitivity in hypertensive rats, we decided to conduct a stress test to 
further delineate the enhanced susceptibility in rats with underlying hypertension. A stress 
test is a common way to reveal enhanced sensitivity or the potential for adverse responses 
because increased cardiovascular effort causes reduced oxygen availability to tissues and 
may provoke autonomic imbalance (Goldberger et al., 2006).  Numerous studies have shown 
that stress tests trigger many adverse cardiovascular effects including increased cardiac 
arrhythmias and deleterious changes in heart rate (HR), heart rate variability (HRV), an 
indirect indicator of cardiac autonomic tone, and ECG parameters (Watanabe et al., 2001). 
Multiple studies have shown that hypertensive individuals have abnormal responses to high 
altitude with low atmospheric oxygen. In addition, exposures to the air pollutants tobacco 
smoke (Adgent, 2006), sulfur dioxide and nitrogen dioxide (Hoppenbrouwers et al., 1981) 
have been linked to abnormal cardiopulmonary sensitivity responses to hypoxia. These 
findings suggest that exposure to hypoxia may be a useful stress test to unmask the latent 
effects of air pollution. 
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Hypoxia Stress Test Reveals Exaggerated Cardiovascular Effects in Hypertensive Rats after 
Exposure to the Air Pollutant Acrolein 
The studies with DE and acrolein revealed heightened sensitivity in SH rats, but we 
wanted to further determine the importance of underlying susceptibility in adverse 
cardiovascular events 24 hours after acrolein exposure. Epidemiological studies indicate that 
effects of air pollution exposure are not always immediate, usually manifesting some time 
after exposure. For example, Peters et al. (2004) showed that humans exposed to traffic were 
more susceptible to myocardial infarction up to 24 hours after exposure. In addition, patients 
with implanted cardioverter defibrillators had increased incidence of life-threatening 
arrhythmias up to 2 days after air pollution exposure (Peters et al., 2000). These findings 
suggest that techniques that help manifest latent responses may be useful in uncovering 
subtle subclinical effects of air pollution exposure.  This approach is predicated on the idea 
that air pollution primes the cardiovascular system to exaggerated responses to subsequent 
nonspecific stressors and has been put to practice in the form of exercise stress testing in 
humans (Gold et al., 2005) and dobutamine and isoproterenol pharmacologic challenge in 
rats (Hazari et al., 2012; Andre et al., 2011). A novel stress test was developed that set out to 
mimic the heightened sensitivity of individuals with hypertension to sub-atmospheric oxygen 
as happens at high altitude. In order to determine latent responses of acrolein exposure, we 
developed an acute hypoxia stress test that involved short-term exposure to a 10% oxygen 
atmosphere. The hypoxia stress test after acrolein exposure revealed increased diastolic blood 
pressure only in hypertensive rats and increased minute volume and expiratory time only in 
normotensive rats.  The hypoxia stress test further demonstrated the enhanced susceptibility 
of the hypertensive rat and created an additional stress test to determine enhanced sensitivity 
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to air pollutants. Importantly, hypoxia stress test caused ventilatory responses in WKY rats 
that were absent in the SH rat. Researchers often assume that enhanced susceptibility means 
a greater response, but it can also mean the lack of a response when one is expected or 
required to compensate for an environmental insult. This is critical to remember when 
defining susceptibility and looking for risk factors in the clinic. Future studies should 
incorporate additional pollutants to further define the usefulness of this stress test. Given that 
acrolein induced blood pressure and heart rate changes are preceded by apnea in hypertensive 
rats (Hazari et al., 2008), we explored the possibility that acrolein exposure causes drops in 
blood oxygen levels.  
 
Acrolein Exposure Causes Significant Decreases in pO2 and Significant Increases in pCO2 in 
Hypertensive Rats. 
 Acrolein exposure caused significant decreases in arterial blood pO2 and significant 
increases in arterial blood pCO2 in hypertensive rats. While we did not see significant 
reductions in SaO2 as found in humans exposed to air pollution, this is likely due to the fact 
that SaO2 is well buffered from rapid decreases due to the sigmoidal nature of the oxy-
hemoglobin dissociation curve (Urbano and Mohsenin, 2006). Additionally, the 
epidemiological studies linking reduction in SaO2 and pollutant exposure were based on 
pulse oximetry recordings (Gong et al., 2004; Gong et al., 2005). These measurements are 
not as sensitive as direct analysis of arterial blood, as used in this study. This is important to 
note as reductions in pO2 may be a more sensitive indicator of a pollutant’s effect on blood 
oxygen levels because a large drop in pO2 is required to alter SaO2. Normal pO2 levels in 
humans and rats range from 80-100 mmHg, and a drop in partial pressure below 60 mmHg is 
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required for hypoxemia. Although we did not see a decrease to this extent, small decreases in 
pO2 as well as small increases in pCO2 are able to activate the carotid body. Acrolein 
exposure also caused an increase in pCO2 and increases in pCO2 as small as 5 mmHg have 
been shown to activate the body’s response to hypoxia (Whipp, 1994). Importantly, hypoxia 
is associated with increased sympathetic tone and increased blood pressure, which were both 
observed in our exposure studies with acrolein. In addition to these changes, SH rats also had 
significant decreases in K
+
 during acrolein exposure. The reason for this is unclear, but it 
may be related to increased aldosterone levels in the SH rat from acrolein-induced increases 
in blood pressure. Changes in blood gas parameters only occurred in SH rats. Future studies 
should treat SH rats with antihypertensive drugs and determine if the blood gas levels remain 
unchanged with acrolein exposure. This would allow us to determine if underlying 
hypertension is responsible for the reduction in pO2. This could be extremely important in 
clinical studies looking at the effects of air pollutants on oxygen saturation because 
susceptible populations could have a more severe decrease in SaO2 and be potentially more 
susceptible to harmful effects. The fact that acrolein exposure resulted in decreased pO2, 
increased pCO2, and significant increases in blood pressure and heart rate suggests that the 
carotid body may be mediating some of the cardiovascular responses to acrolein, a possibility 
that was examined in the final study. 
 
Pharmacological Inhibition of the Carotid Body Attenuates Blood Pressure Increases during 
Acrolein Exposure. 
In order to determine if the cardiovascular effects of acrolein exposure are mediated 
by the chemoreflex response to hypoxia, we pharmacologically inhibited the carotid body 
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prior to acrolein exposure using the CSE-inhibitor PAG . Control rats exposed to acrolein 
had significant increases in MAP, systolic, and diastolic blood pressure, consistent with our 
previous study with acrolein (Perez et al., 2013). Pretreatment with the CSE-inhibitor PAG 
blocked acrolein-induced blood pressure increases, suggesting that the carotid body is at least 
in part mediating the cardiovascular response to acrolein. Acrolein also diminished cardiac 
contractility one day after exposure; this response was also blocked by pre-treatment with 
PAG. The prevention of the acrolein-induced decrease in contractility with PAG pretreatment 
suggests that the impaired contractility response one day after exposure with acrolein was a 
compensatory mechanism characterized by rebound increases in parasympathetic tone 
mediated by carotid body chemoreceptor signaling. Early autonomic responses triggered by 
the carotid were likely characterized by increased sympathetic tone during exposure, which 
were followed by rebound increases in parasympathetic tone after exposure. This explanation 
is strengthened by the fact that bilateral vagotomy reversed decreases in contractility 24 
hours after exposure, suggesting parasympathetic mediation. While these findings combined 
with the blood oxygenation data strongly suggest a role for the carotid body, mediation by 
the carotid body may be further demonstrated by measuring carotid body nerve impulse 
formation during exposure to acrolein to confirm increased carotid body activity. Another 
option is to look at activation of the sympathetic trunk. Carotid body signaling leads to 
increased sympathetic activation, which increases blood pressure, ventilation, heart rate, and 
arrhythmogenicity (Lopez-Barneo et al., 2008). Measurement of sympathetic nerve activity 
during or immediately following acrolein exposure would further strengthen the hypothesis 
that the carotid body is mediating the cardiovascular response. Acrolein served as an 
excellent positive control pollutant in this study, but it may be useful to repeat the 
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experiments with a less irritating air pollutant to determine if the carotid body is still 
involved. Because acrolein reacts so quickly with the lung and causes a significant irritant 
response, exposure to a less irritating air pollutant may determine if carotid body activation is 
related to the irritant response or separate mechanisms. We are currently analyzing ECG, 
HRV, and arrhythmogenesis, and these results will give more insight into the potential 
importance of the carotid body in the response to acrolein exposure and may provide 
additional evidence of autonomic modulation. 
 We also looked at the effects of dobutamine, a sympathomimetic, on contractility one 
day after acrolein exposure. Acrolein exposed rats showed enhanced sensitivity to 
dobutamine one day after exposure. This response may be due to increased vascular 
resistance, as has been found with exposure to acrolein, and may not be the result of 
exaggerated sympathetic tone. Increases in contractility during dobutamine infusion were 
eliminated with bilateral vagotomy. Although the mechanism causing the responses one day 
after exposure are difficult to decipher,  the body has many ways to respond to air pollutants, 
and it is likely that more than one mechanism is activated upon inhalation of different 
pollutants. The type, size, shape, and reactivity of the pollutant as well as the duration of 
exposure and underlying susceptibility of the individual or animal will determine the 
differential activation of pulmonary reflex responses, baroreceptor reflex responses, 
chemoreceptor reflex responses and other physiological responses.  These responses, 
particularly in a multipollutant setting as evident from our findings with whole and filtered 
DE can often times lead to opposing effects.   
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Summary and Broad Perspective of Findings. 
There are several postulated mechanisms of action explaining the cardiovascular 
effects associated with exposure to air pollution including irritant or sensory receptor 
activation leading to changes in autonomic balance, activation of systemic inflammatory 
pathways that impact vascular function, and direct effects of translocated air pollution 
components (Brook et al., 2010).  Based on our findings, air pollutant-induced hypoxia is a 
potential mechanism controlling adverse cardiac responses. This study provides evidence that 
exposure to air pollution, especially irritants like acrolein, may cause decreases in blood 
oxygen levels that activate the carotid body and lead to increased blood pressure and heart 
rate and impaired contractility. This is of potentially great interest to the field of air pollution 
epidemiology because the potential repercussions of decreased oxygen availability in cardiac 
morbidity and mortality following exposure to air pollution are underexplored.  
This research also helps fill significant data gaps in our current understanding of the 
effects of air pollution on cardiovascular health. The American Heart Association (AHA) 
scientific statement on PM air pollution and cardiovascular disease states that mechanistic 
studies should “investigate the interaction between preexisting traditional cardiovascular risk 
factors and PM exposure, as well as the potential of air pollutants to exacerbate or worsen 
these risk factors” (Brook et al., 2010). All of the studies focus on a rat model of 
hypertension, a known susceptibility factor for humans exposed to air pollution (Dong et al., 
2013). We found heightened sensitivity to DE and acrolein in hypertensive rats compared to 
normotensive controls. The hypertensive phenotype was associated with increased 
electrocardiographic abnormalities, increased sensitivity to hypoxia stress test, and 
significant changes to blood pressure and heart rate with air pollutant exposure. Importantly, 
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decreased pO2 and carotid body activation were only observed in the hypertensive rat, 
suggesting that hypertensive individuals may be at risk through previously understudied 
mechanisms. This research adds a wealth of new data that better characterizes hypertension 
as a risk factor for cardiac dysfunction in air pollution exposures. These findings are 
consistent with epidemiological data and suggest further exploration of the interactions 
between air pollutants and the physiological and biological sequelae in hypertension. In 
addition, the AHA recommends that exposure studies “expand our knowledge related to the 
“responsible” PM pollution constituents (eg, metals, organic compounds, semiquinones, 
endotoxin, and VOC and SVOC compounds), size fractions (eg, UFPs), sources (eg, traffic, 
power generation, and biomass combustion), and mixtures of pollutants” (Brook et al., 
2010). Our studies with DE examined the separate effects of whole (particles + gases) and 
filtered (gases alone) components and found that greater toxicity (PR prolongation and ST 
depression) was associated with the gaseous components of DE. This study demonstrated for 
the first time that whole DE and particulate-free DE from the same diesel engine source 
trigger divergent electrocardiographic responses. Subsequent studies revealed enhanced 
sensitivity to the pulmonary irritant acrolein and suggest that the toxic gases found in DE 
may be responsible for some of the cardiac responses following exposure.  
All of the epidemiological studies that examine changes in oxygen saturation 
following air pollution exposure relied on pulse oximetry measurements (Gong et al., 2004; 
Gong et al., 2005), a device placed on the finger that measures arterial blood oxygen 
saturation using light absorbance. This measurement is not as sensitive as direct analysis of 
arterial blood and demonstrates the increased sensitivity of the system used in this study. 
This presents a great strength of our mechanistic studies, and shows that even with small 
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decreases in SaO2 in humans during air pollution exposure, the potential reductions in pO2 
may be significantly greater. Therefore, little to no changes in SaO2 may underestimate the 
cardiovascular risk associated with hypoxic responses attributed to air pollution exposure. In 
addition, we found significant cardiac effects during exposure to DE at a relatively low 
concentration (150 µg/m
3
). This finding is significant because responses may not follow 
conventional dose-response relationships, thus complicating standard setting. In addition, 
most of the adverse cardiac effects we found were in the filtered DE, suggesting that gaseous 
components of DE may be driving some of the responses. There are currently no NAAQS 
standards for most of the gaseous components of DE. This presents a potential gap in current 
human risk factor settings because diesel components such as acrolein are known to cause 
adverse effects, even at low doses. Furthermore, whole DE with its full complement of 
particulate and gaseous constituents elicited fewer effects than DE gases alone. This suggests 
the possibility that constituents interact and/or elicit divergent and potentially opposing 
mechanisms of toxicity, which may complicate the hazard identification and risk assessment 
of multipollutant air sheds. This research provides important information for risk assessment 
and fills data gaps in our knowledge of pollutant effects on the heart, but it also raises 
additional questions and provides future study directions in animal models and humans. 
Multiple questions still exist regarding the role of hypoxia in air pollutant-induced 
cardiovascular dysfunction. Our studies utilized pharmacologic inhibition of the carotid body 
with PAG, but there are additional methods that may more reliably inhibit carotid body 
signaling. Peng et al. (2010) used the CSE knockout mouse which has a genetic deletion of 
the CSE enzyme and therefore has a severely impaired carotid body response to hypoxia. 
Although PAG has been shown to inhibit the carotid body in rats (Peng et al., 2010), we did 
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not directly measure carotid body signaling, so similar findings to our inhibition studies in a 
knockout model would provide additional evidence for carotid-body mediation of the 
cardiovascular effects of acrolein exposure. In addition, the role of the vasculature was not a 
focus of this research, but vasoconstriction following acrolein exposure could be a potential 
driver of the sustained decreases in oxygen we found during exposure. Hypoxia is known to 
cause pulmonary vasoconstriction (Voelkel et al., 2013), and studies have found that acrolein 
causes increased blood pressure and vasoconstriction as well as depletion of antioxidants 
(Yousefipour et al., 2005). Measurements of vascular tone could provide potential 
explanations for sustained decreases in oxygen and large increases in blood pressure 
observed in these studies. Also, the role of pulmonary receptors in driving the irritant 
response to acrolein is an important avenue to consider. Acrolein elicits a host of responses in 
pulmonary cells including epithelial damage, activation of stress kinases, induction of mucus 
secretion, and altered production of inflammatory mediators (Moretto et al., 2012). 
Pharmacological inhibition or knock out models of specific pulmonary receptors such as 
TRPV receptors may reveal that the downstream cardiac responses to acrolein are mediated 
by a primary response in the lung. Finally, there are several epidemiological studies linking 
exposure to air pollutants with decreased oxygen saturation (Gong et al., 2004; Gong et al., 
2005), but all of these studies used pulse oximetry to measure SaO2. Pulse oximetry is not as 
sensitive as direct analysis of arterial blood and small changes in SaO2 may be coupled with 
large decreases in pO2 due to the sigmoidal shape of the oxy-hemoglobin dissociation curve. 
Ideally, serial blood draws in humans exposed to air pollution would provide more robust 
measurements of changes in blood gases during exposure.  This may reveal even more 
significant decreases in oxygen levels during exposure and would add tremendous strength to 
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the hypothesis that air pollutant-induced hypoxia is driving the cardiac responses during 
exposure.  
Taken together, the findings of these studies further characterize the effects of DE and 
acrolein exposure on cardiac health, suggest divergent responses with gaseous constituents of 
DE relative to whole DE, demonstrate that underlying disease confers greater susceptibility 
to adverse cardiac responses following air pollution exposure, and provide evidence that the 
adverse cardiovascular effects of acrolein exposure are due, at least in part, to carotid body 
reflex signally leading to increased sympathetic tone followed by rebound increases in 
parasympathetic tone. The findings described in this research dissertation provide biological 
plausibility to the epidemiological findings that link air pollution to adverse cardiovascular 
effects, which may reduce uncertainty in standard setting and facilitate risk assessment. 
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